Search Result
        
        
            
                Results for "
topoisomerases
" in MedChemExpress (MCE) Product Catalog:
            
         
        
        
            
                
            
            
            
                
            
            
                
                    3
Biochemical Assay Reagents
 
                    
                 
            
            
                
            
            
            
                
            
            
                
            
            
            
                
                    44
Isotope-Labeled Compounds
 
                    
                 
            
            
            
                
            
            
                
            
         
        
            
            
                
                    
                    
                        
                            | Cat. No. | 
                            Product Name | 
                            Target | 
                            Research Areas | 
                            Chemical Structure | 
                        
                    
                    
                        
                            
                            - 
                                
                                    - HY-161980
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                 | 
                                                
                                                    
                                                        Infection
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Topoisomerases/ribosomes-IN-1 (compound 30f) is an inhibitor of ribosomes and topoisomerases, and has inhibitory effects on constitutively macrolide-resistant bacteria. Topoisomerases/ribosomes-IN-1 can inhibit bacterial protein synthesis (IC50: 0.647 μM) and DNA replication (IC50: 0.218 μM) .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                             
                        
                            
                            - 
                                
                                    - HY-149002
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                        Apoptosis
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Topoisomerase I/II inhibitor 4 (compound F16) is a potent topoisomerase I (Topo I) and II (Topo II) dual inhibitor. Topoisomerase I/II inhibitor 4 inhibits cell proliferation, invasion and migration and induces apoptosis. Topoisomerase I/II inhibitor 4 can be used for liver cancer research .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                             
                        
                            
                            - 
                                
                                    - HY-169106
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                        Apoptosis
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Topoisomerase inhibitor 4 (compound 45) is a potent Topoisomerase1/2 inhibitor. Topoisomerase inhibitor 4 causes cell cycle arrest in the G2/M phase by inducing Apoptosis. Topoisomerase inhibitor 4 has antitumor activity .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                             
                        
                            
                            - 
                                
                                    - HY-168849
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                        Bacterial
                                                    
                                                 | 
                                                
                                                    
                                                        Infection
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Topoisomerase inhibitor 5 (compound 158) is a Bacterial Topoisomerase Inhibitor inhibitor with the lowest inhibitory concentration of 0.125 μg/mL. Topoisomerase inhibitor has antituberculous activity .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                             
                        
                            
                            - 
                                
                                    - HY-156969
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                        Btk
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Topoisomerase I inhibitor 11 is a potent inhibitor of Topoisomerase I. Topoisomerase I inhibitor 11 can bind to BTK .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                             
                        
                            
                            - 
                                
                                    - HY-116933
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                        Bacterial
                                                    
                                                 | 
                                                
                                                    
                                                        Infection
                                                    
                                                        Inflammation/Immunology
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Murrayanol is a natural carbazole alkaloid with a variety of biological activities. Murrayanol shows anti-inflammatory, topoisomerase I and topoisomerase II (Topoisomerase) inhibition activities. Murrayanol also as a mosquitocidal and antimicrobial .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                             
                        
                            
                            - 
                                
                                    - HY-N15319
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     Canangine 
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                        Fungal
                                                    
                                                 | 
                                                
                                                    
                                                        Infection
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Eupolauridine (Canangine) is a selective DNA topoisomerase II inhibitor with IC50 values of 20 μM for fungal topoisomerase I and 33 μM for human topoisomerase I. Eupolauridine exerts antifungal activity by inhibiting the catalytic activity of topoisomerase II and stabilizing its cleavage complex with DNA, leading to DNA damage. Eupolauridine is promising for research of fungal infectious diseases  .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                             
                        
                            
                            - 
                                
                                    - HY-N4329
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                 | 
                                                
                                                    
                                                        Others
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Nidulalin A is a DNA topoisomerase II inhibitor with an IC50 of 2.2 μM. Nidulalin A has an IC50 of 172 μM for DNA topoisomerase I. Nidulalin A has certain cytotoxicity .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                             
                        
                            
                            - 
                                
                                    - HY-117543
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     AMP-53;  6-Ethoxyazonafide 
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Ethonafide (AMP-53) is an anthracene-containing derivative of Amonafide that belongs to the Azonafide series of anticancer agents. Ethonafide (AMP-53) inhibits topoisomerase II activity by stabilizing the enzyme-DNA complex, involving both topoisomerase IIα and β .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                             
                        
                            
                            - 
                                
                                    - HY-174837
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Topoisomerase IIα-IN-11 (Compound 16h) is a potent Topoisomerase IIα inhibitor. Topoisomerase IIα-IN-11 shows significant inhibition on melanoma A2058 cell lines (IC50 3-6 μM). Topoisomerase IIα-IN-11 is promising for research of cancers (especially melanoma) .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                             
                        
                            
                            - 
                                
                                    - HY-146437
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Topoisomerase I inhibitor 6 (Compound 3) is a potent inhibitor of Topoisomerase I. Topoisomerase I inhibitor 6 is able to trap DNA-Top1 cleavage complex and found to be less cytotoxic in non-cancerous cell line. Topoisomerase I inhibitor 6 has the potential for the research of cancer diseases .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                             
                        
                            
                            - 
                                
                                    - HY-124552
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        DNA/RNA Synthesis
                                                    
                                                        Topoisomerase
                                                    
                                                 | 
                                                
                                                    
                                                        Others
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Epolactaene is a potent Topoisomerase II and DNA Polymerase inhibitor with IC50 values of 10, 25, 94 µM for Topoisomerase II, DNA Polymerase α, DNA Polymerase β, respectively .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                             
                        
                            
                            - 
                                
                                    - HY-160774
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Drug-Linker Conjugates for ADC
                                                    
                                                        Topoisomerase
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Val-Cit-PABC-DOX (compound 10109), an epsilon-poly-L-lysine-based drug conjugate, is an agent-linker conjugate for ADC by using a DNA topoisomerase I and topoisomerase II inhibitor, Doxorubicin (HY-15142), linked via the linker, Val-Cit-PABC .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                             
                        
                            
                            - 
                                
                                    - HY-162342
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Topoisomerase I inhibitor 14 (Compound 4h) is an inhibitor for Topoisomerase I. Topoisomerase I inhibitor 14 inhibits proliferation of A549 and C6 with IC50s of 4.56 μM and 13.17 μM, without significant toxicity in healthy cells NIH3T3 (IC50 is 74.44 μM), which exhibits anticancer potency .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                             
                        
                            
                            - 
                                
                                    - HY-W278582
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                        Apoptosis
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Topoisomerase II inhibitor 14 is a potent topoisomerase II inhibtor. Topoisomerase II inhibitor 14 induces apoptosis and arrests cell cycle at S phase and G2-M phases. Topoisomerase II inhibitor 14 exhibits antioxidant effect and decreases the level of GSH, MDA, and NO. Topoisomerase II inhibitor 14 can be used for the study of neck squamous cell carcinoma (HNSCC) .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                             
                        
                            
                            - 
                                
                                    - HY-163118
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                        Apoptosis
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Topoisomerase II inhibitor 17 (compound 4c) is an inhibitor of thiazolopyrimidine topoisomerase (Topoisomerase) Top II (IC50: 0.23 μM). Topoisomerase II inhibitor 17 can significantly cause cell cycle disruption and apoptosis .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                             
                        
                            
                            - 
                                
                                    - HY-162381
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Topoisomerase II inhibitor 19 (compound 5h) is a DNA intercalator and topoisomerase II inhibitor (IC50 value of 0.34 μM). Topoisomerase II inhibitor 19 would induce detectable potent damage in ctDNA .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                             
                        
                            
                            - 
                                
                                    - HY-155645
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                        Apoptosis
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Topoisomerase II inhibitor 15 (compound 2g) is a Topoisomerase II inhibitor. Topoisomerase II inhibitor 15 potently is an apoptotic inducer with greater selectivity against head and neck tumors .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                             
                        
                            
                            - 
                                
                                    - HY-123363
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     F-11782 
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Tafluposide (F-11782) is a DNA topoisomerase inhibitor. Tafluposide has antitumor activity .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                             
                        
                            
                            - 
                                
                                    - HY-172229
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                        Bacterial
                                                    
                                                 | 
                                                
                                                    
                                                        Infection
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    NBTI 5463 is a bacterial type II topoisomerases (topoisomerase II) inhibitor with antibacterial activity. NBTI 5463 inhibits GyrA and TopoIV in Pseudomonas aeruginosa and Escherichia coli. NBTI 5463 binds to topoisomerase II to prevent DNA cleavage and religation, inhibiting bacterial DNA replication and transcription. NBTI 5463 is promising for research of Gram-negative bacterial infection .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                             
                        
                            
                            - 
                                
                                    - HY-174227
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                        Bacterial
                                                    
                                                 | 
                                                
                                                    
                                                        Infection
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Topoisomerase inhibitor 6 (Compound REDX05931) is a dual irreversible inhibitor of DNA gyrase and topoisomerase IV (MIC=0.06 μg/mL against fluoroquinolone-resistant S. aureus). Topoisomerase inhibitor 6 blocks DNA strand break-reunion, inducing lethal DNA damage. Topoisomerase inhibitor 6 is promising for research of Gram-positive bacterial infections (e.g., S. aureus, S. pneumoniae) .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                             
                        
                            
                            - 
                                
                                    - HY-175853
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                        Apoptosis
                                                    
                                                        Caspase
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Topoisomerase II-IN-24 is a Topoisomerase IIα inhibitor with an IC50 of 41.67 μM. Topoisomerase II-IN-24 can inhibit cancer cells proliferation, induce G2/M phase arrest and induce apoptosis. Topoisomerase II-IN-24 can be used for the research of cancer, such as colon cancer .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                             
                        
                            
                            - 
                                
                                    - HY-107133
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                        Cytochrome P450
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Simmitecan hydrochloride, a 9-substituted lipophilic Camptothecin (HY-16560) derivative, is a potent topoisomerase I inhibitor. Simmitecan hydrochloride is an anticancer agent  .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                             
                        
                            
                            - 
                                
                                    - HY-149309
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                 | 
                                                
                                                    
                                                        Infection
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Topoisomerase inhibitor 2 (18C) is a bacterial topoisomeraseinhibitor that exhibits potent broad-spectrum activity against multidrug-resistant Gram-negative bacteria .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                             
                        
                            
                            - 
                                
                                    - HY-W781148
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Sutopin-2 is a topoisomerase II inhibitor. Suptopin-2 affects cell cycle progression and stability of microtubules. Sutopin-2 induces cell cycle arrest by regulating the nucleocytoplasmic transport of cyclin B1 .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                             
                        
                            
                            - 
                                
                                    - HY-146497
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Topoisomerase I inhibitor 7 (Compound 8) is a potent inhibitor of Topoisomerase I. Topoisomerase I inhibitor 7 significantly inhibits tumor growth (up to 79%) and increases the lifespan (153%) of mice bearing P388 lymphoma transplants. Topoisomerase I inhibitor 7 indicates prospects for further search of new antitumor agent candidates among the heteroarene-fused anthraquinones .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                             
                        
                            
                            - 
                                
                                    - HY-19024
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     NSC 336628 
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Merbarone (NSC 336628) is an orally active inhibitor of topoisomerase II. Merbarone acts primarily by blocking topoisomerase II-mediated DNA cleavage without stabilizing topo II-DNA covalent complexes. Merbarone is an anticancer agent   .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                             
                        
                            
                            - 
                                
                                    - HY-173458
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                 | 
                                                
                                                    
                                                        Infection
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    NBTIs-IN-7 (compound 276) is a novel bacterial topoisomerase (NBTIs) inhibitor. NBTIs-IN-7 induces both single- and double-strand DNA strand breaks in the presence of gyrase .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                             
                        
                            
                            - 
                                
                                    - HY-125930A
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                        DNA/RNA Synthesis
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    T-2513 hydrochloride is a selective topoisomerase I inhibitor. T-2513 hydrochloride binds covalently to and stabilizes the topoisomerase I-DNA complex and inhibits DNA replication and RNA synthesis, ultimately leading to cell death .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                             
                        
                            
                            - 
                                
                                    - HY-125930
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                        DNA/RNA Synthesis
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    T-2513 is a selective topoisomerase I inhibitor. T-2513 binds covalently to and stabilizes the topoisomerase I-DNA complex and inhibits DNA replication and RNA synthesis, ultimately leading to cell death .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                             
                        
                            
                            - 
                                
                                    - HY-162101
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Topoisomerase inhibitor 3 (compound 9) is a potent Topoisomerase inhibitor. Topoisomerase inhibitor 3 shows antiproliferative and anti-tumor activity .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                             
                        
                            
                            - 
                                
                                    - HY-113642
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    CP-67804 is a quinolone derivative, is a topoisomerase II-targeted agent. CP-67804 effectively enhances DNA cleavage mediated by eukaryotic topoisomerase II. CP-67804 has potential as an antineoplastic agent .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                             
                        
                            
                            - 
                                
                                    - HY-162587
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Fagopyrine is a DNA topoisomerase I (Topo I) inhibitor. Fagopyrine is a photosensitizer that can be used in the study of tumors  .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                             
                        
                            
                            - 
                                
                                    - HY-B0063
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     ST1481 
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Gimatecan (ST1481) is a potent topoisomerase I inhibitor. Gimatecan is an orally bioavailable camptothecin analogue with antitumor activity .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                             
                        
                            
                            - 
                                
                                    - HY-147861
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                        Apoptosis
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Topoisomerase II inhibitor 11 (compound 3d) is a potent Topoisomerase II inhibitor, with an IC50 of 2.89 μM. Topoisomerase II inhibitor 11 shows 92.46% inhibition on renal cancer cell line A498 with an IC50 of 3.5 μM. Topoisomerase II inhibitor 11 causes cell cycle arrest at the G2/M phase leading to cell proliferation inhibition and pro-apoptotic activity .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                             
                        
                            
                            - 
                                
                                    - HY-146316
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Topoisomerase II inhibitor 6 (Compound 5), a tryptanthrin derivative, is a potent and selective inhibitor of topoisomerase II. Topoisomerase II inhibitor 6 exhibits antiproliferative activity on different tumor cell lines. Topoisomerase II inhibitor 6 blocks the cell cycle of CCRF-CEM in the G2 phase and induces DNA DSB. Topoisomerase II inhibitor 6 has the potential for the research of cancer diseases .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                             
                        
                            
                            - 
                                
                                    - HY-155693
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                        Parasite
                                                    
                                                 | 
                                                
                                                    
                                                        Infection
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Topoisomerase II inhibitor 16 (compound CT3) is a selective, orally active, brain-penetrant and irreversible trypanosomal topoisomerase II inhibitor by stabilizing double-stranded DNA:enzyme cleavage complexes. Topoisomerase II inhibitor 16 has the potential for Chagas disease research .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                             
                        
                            
                            - 
                                
                                    - HY-143265
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                        Apoptosis
                                                    
                                                        Caspase
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Topoisomerase I inhibitor 2 (ZML-8) is a highly selective inhibitor of DNA topoisomerase I (Top1). Topoisomerase I inhibitor 2 inhibits Top1 activity and results DNA damage. Topoisomerase I inhibitor 2 blocks G2/M phase and induces apoptosis, exhibits anti-tumor effect .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                             
                        
                            
                            - 
                                
                                    - HY-N3488
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                        Bacterial
                                                    
                                                        Fungal
                                                    
                                                 | 
                                                
                                                    
                                                        Infection
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Isodiospyrin, a natural dimeric naphthoquinone, is a human DNA topoisomerase I (Topoisomerase) inhibitor. Isodiospyrin can prevent both DNA relaxation and kinase activities of human topoisomerase I. Isodiospyrin shows anticancer, antibacterial and antifungal activities   .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                             
                        
                            
                            - 
                                
                                    - HY-N10367
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Corydamine, 3-arylisoquinoline alkaloid, is a potent DNA topoisomerase I/II inhibitor. Corydamine has anti-cancer activity .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                             
                        
                            
                            - 
                                
                                    - HY-N12129
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Cathepsin
                                                    
                                                 | 
                                                
                                                    
                                                        Others
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    6,6′-Dihydroxythiobinupharidine is a cysteine proteases inhibitor. 6,6′-Dihydroxythiobinupharidine can enhance DNA cleavage mediated by human topoisomerase IIα and IIβ ~8-fold and ~3-fold, respectively  .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                             
                        
                            
                            - 
                                
                                    - HY-19024R
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Merbarone (Standard) is the analytical standard of Merbarone. This product is intended for research and analytical applications. Merbarone (NSC 336628) is an orally active inhibitor of topoisomerase II. Merbarone acts primarily by blocking topoisomerase II-mediated DNA cleavage without stabilizing topo II-DNA covalent complexes. Merbarone is an anticancer agent   .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                             
                        
                            
                            - 
                                
                                    - HY-162271
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                        Fungal
                                                    
                                                 | 
                                                
                                                    
                                                        Infection
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Antibacterial agent 187 (IKE7) is a derivative containing imidazole and triazolacridone structures that target yeast topoisomerase II. Antibacterial agent 187 has antifungal activity and MIC value of resistance to fluconazole (HY-B0101) is 32-64 μg/mL .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                             
                        
                            
                            - 
                                
                                    - HY-152965
 
                                    - 
                                        
                                    
 
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                             
                        
                            
                            - 
                                
                                    - HY-B0395D
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     (1R,2S,7R)-DU-6859a;  DU-6857 
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                        Bacterial
                                                    
                                                 | 
                                                
                                                    
                                                        Inflammation/Immunology
                                                    
                                                 | 
                                            
                                            
                                                
                                                    (R)-Sitafloxacin (DU-6857), a stereoisomer of Sitafloxacin (DU-6859a), is also an inhibitor of topoisomerases, with an IC50 of 0.18 μg/mL of DNA gyrase . 
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                             
                        
                            
                            - 
                                
                                    - HY-W713570
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Nectandrin B is an inhibitor of DNA topoisomerases I and II, which is found in Saururus chinensis. Nectandrin B is promising for research of cancers .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                             
                        
                            
                            - 
                                
                                    - HY-167671
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    BE-10988 is a DNA topoisomerase inhibitor. BE-10988 inhibits the growth of Doxorubicin (HY-15142A)-resistant and vincristine-resistant P388 mouse leukemia cell lines by increasing the formation of DNA topoisomerase complexes .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                             
                        
                            
                            - 
                                
                                    - HY-145397
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        ADC Payload
                                                    
                                                        Topoisomerase
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    (4-NH2)-Exatecan, a topoisomerase inhibitor, is a derivative of Exatecan. (4-NH2)-Exatecan can be used in the synthesis of antibody-drug conjugates (ADCs) (US20200306243A1, compound A) .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                             
                        
                            
                            - 
                                
                                    - HY-N6054
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Parasite
                                                    
                                                        Topoisomerase
                                                    
                                                 | 
                                                
                                                    
                                                        Infection
                                                    
                                                        Inflammation/Immunology
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Niranthin, a lignan with a wide spectrum of pharmacological activities. Niranthin is a potent and non-competitive inhibitor of heterodimeric type IB topoisomerase of L. donovani. Niranthin can be used for the research of drug-resistant leishmaniasis research.
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                             
                        
                            
                            - 
                                
                                    - HY-13727A
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     BBR 2778 
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Pixantrone (BBR 2778) dimaleate is a topoisomerase II inhibitor and DNA intercalator, with anti-tumor activity.
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                             
                        
                            
                            
                                
                                    - HY-164143
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    T638 is a topoisomerase II (TOP2) inhibitor. T638 inhibits TOP2A activity with a IC50 of 0.7 uM. T638 strongly inhibits cancer cell growth .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-13622B
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     BN 80927 TFA 
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Elomotecan TFA is a potent inhibitor of topoisomerases I and II. Elomotecan TFA is a camptothecin analog belonging to the homocamptothecin family (hCPT). Elomotecan TFA reduces the proliferation of different tumor cells with higher potency than other anticancer agents of reference targeting topoisomerases I and II .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-174404
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                        Apoptosis
                                                    
                                                        Bcl-2 Family
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Topoisomerase II inhibitor 23 is a potent topoisomerase II inhibitor (IC50 = 0.94 μM). Topoisomerase II inhibitor 23 shows high selectivity and exceptional cytotoxic activity in MCF-7, HepG2, and HCT116 cells. Topoisomerase II inhibitor 23 induces cell cycle arrest at the G1 phase, leading to inhibition of cell proliferation. Topoisomerase II inhibitor 2 induces apoptosis by up-regulating the pro-apoptotic Bax level and down-regulating the anti-apoptotic Bcl-2 level.
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-148719
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    ARN24139(compound 3f) is a topoisomerase II (topoII) inhibitor with the IC50 of 7.3 μM. ARN24139 can inhibit cancer cell proliferation and is well tolerated in vivo .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-13622A
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     BN 80927 free base 
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Elomotecan (BN 80927 free base) is a potent inhibitor of topoisomerases I and II. Elomotecan is a camptothecin analog belonging to the homocamptothecin family (hCPT). Elomotecan reduces the proliferation of different tumor cells with higher potency than other anticancer agents of reference targeting topoisomerases I and II .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-13622
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     BN 80927 
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Elomotecan hydrochloride (BN 80927) is a potent inhibitor of topoisomerases I and II. Elomotecan hydrochloride (BN 80927) is a camptothecin analog belonging to the homocamptothecin family (hCPT). Elomotecan hydrochloride (BN 80927) reduces the proliferation of different tumor cells with higher potency than other anticancer agents of reference targeting topoisomerases I and II .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-13727
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     BBR 2778 free base 
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Pixantrone (BBR 2778 (free base)), a mitoxantrone analog, is a topoisomerase II inhibitor and DNA intercalator, with anti-tumor activity.
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-12888
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                        Bacterial
                                                    
                                                 | 
                                                
                                                    
                                                        Infection
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    AZD5099, an antibacterial agent, is a potent and selective bacterial topoisomerase II inhibitor. AZD5099 potently inhibits the infections caused by Gram-positive and fastidious Gram-negative bacteria .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-N15597
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     NSC 34757 
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Melicopidine (NSC 34757) is a DNA topoisomerase inhibitor, which is an acridone alkaloid found in the bark of Medicosma subsessilis. Melicopidine exerts potential antitumor activity by binding to DNA or inhibiting related enzyme activity .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-177548
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Drug Derivative
                                                    
                                                        ADC Payload
                                                    
                                                        Topoisomerase
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Fmoc-Val-Cit-PAB-Exatecan is a precursor form of Exatecan (HY-13631). Exatecan (DX-8951) is a DNA topoisomerase I inhibitor, with an IC50 of 2.2 μM (0.975 μg/mL), and can be used in cancer research .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-13727B
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     BBR 2778 hydrochloride 
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Pixantrone (BBR 2778 (free base)) hydrochloride, a mitoxantrone analog, is a topoisomerase II inhibitor and DNA intercalator, with anti-tumor activity  .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-177546
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Drug Derivative
                                                    
                                                        ADC Payload
                                                    
                                                        Topoisomerase
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    DBCO-PEG3-GGFG-Exatecan is a derivative of Exatecan (HY-13631). Exatecan (DX-8951) is a DNA topoisomerase I inhibitor, with an IC50 of 2.2 μM (0.975 μg/mL), and can be used in cancer research .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-W665464
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Drug Derivative
                                                    
                                                        Topoisomerase
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    (Rac)-7-Ethyl-10-hydroxycamptothecin is the derivative of (±)-10-Hydroxycamptothecin (HY-N0275). (±)-10-Hydroxycamptothecin is an indole alkaloid that inhibits the activity of topoisomerase I and has a broad spectrum of anticancer activity .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-145399
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     SG 3932;  AZ-0133 
                                                 | 
                                                
                                                    
                                                        Drug-Linker Conjugates for ADC
                                                    
                                                        Topoisomerase
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    AZ14170133 (SG 3932) is a Drug-Linker Conjugates for ADC, which comprises a topoisomerase inhibitor and a linker for ligand unit connecting. AZ14170133 can be used to synthesis antibody-drug conjugate (ADC) .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-N6054R
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Reference Standards
                                                    
                                                        Parasite
                                                    
                                                        Topoisomerase
                                                    
                                                 | 
                                                
                                                    
                                                        Infection
                                                    
                                                        Inflammation/Immunology
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Niranthin (Standard) is the analytical standard of Niranthin. This product is intended for research and analytical applications. Niranthin, a lignan with a wide spectrum of pharmacological activities. Niranthin is a potent and non-competitive inhibitor of heterodimeric type IB topoisomerase of L. donovani. Niranthin can be used for the research of drug-resistant leishmaniasis research.
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-N0872
 
                                    - 
                                        
                                    
 
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-119425R
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Razoxane (Standard) is the analytical standard of Razoxane. This product is intended for research and analytical applications. Razoxane (ICRF 159) is an antiangiogenic topoisomerase II inhibitor, can be used for the research of renal cell carcinoma (RCC) .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-118581
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Coralyne chloride is a protoberberine alkaloid with potent anti-cancer activities. Coralyne chloride acts as a potent topoisomerase I poison and induces Top I mediated DNA cleavage . Coralyne chloride can be used for preparing?coralyne derivatives?as DNA binding fluorescent probes .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-13631N
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     (9R)-DX8951f 
                                                 | 
                                                
                                                    
                                                        Drug Derivative
                                                    
                                                        ADC Payload
                                                    
                                                        Topoisomerase
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    (9R)-Exatecan (DX8951f) is the (1R,9S) stereoisomer of Exatecan (HY-13631). Exatecan (DX-8951) is a DNA topoisomerase I inhibitor, with an IC50 of 2.2 μM (0.975 μg/mL), and can be used in cancer research.
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-13727AR
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     BBR 2778 (Standard) 
                                                 | 
                                                
                                                    
                                                        Reference Standards
                                                    
                                                        Topoisomerase
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Pixantrone (Standard) is the analytical standard of Pixantrone. This product is intended for research and analytical applications. Pixantrone (BBR 2778) dimaleate is a topoisomerase II inhibitor and DNA intercalator, with anti-tumor activity.
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-145397A
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        ADC Payload
                                                    
                                                        Topoisomerase
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    (R)-(4-NH2)-Exatecan is the R enantiomer of (4-NH2)-Exatecan (Compound A). (R)-(4-NH2)-Exatecan, a topoisomerase inhibitor, is a derivative of Exatecan. (R)-(4-NH2)-Exatecan can be used in the synthesis of antibody-drug conjugates (ADCs) .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-148820
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Drug-Linker Conjugates for ADC
                                                    
                                                        Topoisomerase
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Br-Val-Ala-NH2-bicyclo[1.1.1]pentane-7-MAD-MDCPT (Formula V) is a agent-linker conjugate that composed of a potent topoisomerase I inhibitor and a linker to make an antibody agent conjugate (ADC), ABBV-969 .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-120747
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Bacterial
                                                    
                                                        DNA/RNA Synthesis
                                                    
                                                 | 
                                                
                                                    
                                                        Infection
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    A-65282 is an antibacterial agent. A-65282 inhibits P4 DNA unknotting with an IC50 value of 8 µg/mL. A 65281 induces DNA breakage mediated by calf thymus topoisomerase II .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-106582
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     MST 16 
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Sobuzoxane (MST-16) is an orally active topoisomerase II inhibitor. Sobuzoxane causes irreversible inhibition of cell division. Sobuzoxane can be used in the study of non-Hodgkin's lymphoma that is resistant to conventional chemotherapy or has recurred .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-13611
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     BN 80915 
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Diflomotecan (BN 80915) is a potent and orally active inhibitor of topoisomerase I. Diflomotecan (BN 80915) causes enhanced plasma stability and has the superior preclinical anti-tumour activity compared with other established compounds  .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-13631T
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     (1R,9S)-DX8951f 
                                                 | 
                                                
                                                    
                                                        Drug Derivative
                                                    
                                                        ADC Payload
                                                    
                                                        Topoisomerase
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    (1R,9S)-Exatecan (DX8951f) is the (1R,9S) stereoisomer of Exatecan (HY-13631). Exatecan (DX-8951) is a DNA topoisomerase I inhibitor, with an IC50 of 2.2 μM (0.975 μg/mL), and can be used in cancer research .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-163487
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     AZD8205 drug-linker 
                                                 | 
                                                
                                                    
                                                        Drug-Linker Conjugates for ADC
                                                    
                                                        Topoisomerase
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Puxitatug samrotecan drug-linker (AZD8205 drug-linker) is a drug-linker conjugate for ADC, which comprises a topoisomerase I inhibitor and a linker. Puxitatug samrotecan drug-linker can be used to synthesis antibody-drug conjugate (ADC), Puxitatug samrotecan (HY-171689) .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-173243
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Drug-Linker Conjugates for ADC
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Val-Ala-PAB-SN38 is a drug-linker conjugate for ADC, composed of ADC linker Val-Ala-PAB (HY-125933) and SN38 (HY-13704), which is the active metabolite of the Topoisomerase I inhibitor Irinotecan (HY-16562) .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-173243A
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Drug-Linker Conjugates for ADC
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Val-Ala-PAB-SN38 TFA is a drug-linker conjugate for ADC, composed of ADC linker Val-Ala-PAB (HY-125933) and SN38 (HY-13704), which is the active metabolite of the Topoisomerase I inhibitor Irinotecan (HY-16562) .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-139909
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Drug-Linker Conjugates for ADC
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    CL2E-SN-38, a highly releasable and structurally stable antibody-SN-38-conjugate, is a part of the antibody drug conjugate (ADC). SN-38, the active metabolite of Irinotecan from camptothecins, is an Topoisomerase I inhibitor .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-156723
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    9-Chloromethyl-10-hydroxy-11-F-Camptothecin is a novel camptothecin derivatives. 9-Chloromethyl-10-hydroxy-11-F-Camptothecin is a DNA topoisomerase I (Topo I) inhibitor, can be used in anticancer research .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-139909A
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Drug-Linker Conjugates for ADC
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    CL2E-SN-38 TFA, a highly releasable and structurally stable antibody-SN-38-conjugate, is a part of the antibody drug conjugate (ADC). SN-38, the active metabolite of Irinotecan from camptothecins, is an Topoisomerase I inhibitor .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-177495
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Drug-Linker Conjugates for ADC
                                                    
                                                        Topoisomerase
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    LD-38 is a drug-linker conjugate for ADC. LD-38 consists of a topoisomerase 1 inhibitor (Exatecan) (HY-13631) and a highly hydrophilic stable and cleavable linker. LD-38 can be used for synthesis of ADC  .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-143484
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Bacterial
                                                    
                                                 | 
                                                
                                                    
                                                        Infection
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    844-TFM is a NBTI (novel bacterial topoisomerase inhibitor) DNA gyrase inhibitor, with an IC50 of 1.5 μM. 844-TFM exhibits bactericidal properties against M. abscessus .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-119425
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     ICRF 159 
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Razoxane (ICRF 159), a EDTA (HY-Y0682) derivative, is an orally active antiangiogenic topoisomerase II inhibitor. Razoxane has antineoplastic, antiangiogenic, and antimetastatic activities. Razoxanecan be used for the research of renal cell carcinoma (RCC),  lung cancer and melanoma cancer  .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-N0872R
 
                                    - 
                                        
                                    
 
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-137466
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    ARN-21934 is a potent, highly selective, blood-brain barrier (BBB) penetrant inhibitor for human topoisomerase II α over β. ARN-21934 inhibits DNA relaxation with an IC50 of 2 μM as compared to the anticancer agent Etoposide (IC50=120 μM). ARN-21934 exhibits a favorable in vivo pharmacokinetic profile and is a promising lead compound for anticancer research .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-106556
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     Rubidazon;  Rubidazone 
                                                 | 
                                                
                                                    
                                                        DNA/RNA Synthesis
                                                    
                                                        Topoisomerase
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Zorubicin (Rubidazon) is a derivative of Daunorubicin (HY-13062A). Zorubicin interacts with topoisomerase II and inhibits DNA polymerases. Zorubicin can be used for the research of acute leukemias and sarcomas     .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-175741
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Parasite
                                                    
                                                        Topoisomerase
                                                    
                                                 | 
                                                
                                                    
                                                        Infection
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    IID432 is a Trypanosoma cruzi Topoisomerase II inhibitor with an EC50 of 8  nM for Trypanosoma cruzi. IID432, a single dose of 25 mg/kg, can achieve relapse-free parasite clearance in mouse models of chronic Chagas disease. IID432 can be used for Chagas disease research .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-175203
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                        ADC Payload
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Topi MF-6 is a DNA topoisomerase I (Top1) inhibitor. Topi MF-6 has superior cytotoxicity against gastrointestinal cancer cells. Topi MF-6 can be used as an ADC payload .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-100777
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    DACA (XR 5000) is a blood-brain barrier-penetrating topoisomerase I and II inhibitor.  DACA can be used in the research of colorectal cancer, leukemia and lung cancer    .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-114684
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                 | 
                                                
                                                    
                                                        Others
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    A20832 is a specific resolvase inhibitor that blocks both the recombination and topoisomerase activities of resolvase. A20832 inhibits the site-specific recombination reaction mediated by the Tn3-encoded resolvase protein at the strand cleavage step and has no effect on synapsis .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-N10495
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Antibiotic
                                                    
                                                        Bacterial
                                                    
                                                        Topoisomerase
                                                    
                                                 | 
                                                
                                                    
                                                        Infection
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Seconeolitsine, an antibiotic, and is an inhibitor of targeting topoisomerase I (TopA). Seconeolitsine also is a new antimicrobial agent that can inhibit S. pneumoniae growth. Seconeolitsine can inhibit TopA relaxation activity with an IC50 value of 17 μM. Seconeolitsine can be used for the research of S. pneumoniae infections resistant to other antibiotics .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-164792
 
                                    - 
                                        
                                    
 
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-121782
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Bacterial
                                                    
                                                        DNA/RNA Synthesis
                                                    
                                                 | 
                                                
                                                    
                                                        Infection
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    A 65281 is a potent DNA gyrase inhibitor with an IC50 value of 0.1 µg/mL. A 65281 induces DNA breakage mediated by calf thymus topoisomerase II. A 65281 inhibits P4 DNA unknotting with an IC50 value of 8 µg/mL .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-145427
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        DNA-PK
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    NU5455 is a potent, selective, and orally active inhibitor of DNA-PKcs. NU5455 administration increases both the efficacy and the toxicity of a parenterally administered topoisomerase inhibitor. NU5455 enhances the activity of Doxorubicin released locally in liver tumor xenografts without inducing any adverse effect .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-149410
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    MSN8C, an analog of mansonone E, is a novel catalytic inhibitor of human DNA topoisomerase II. MSN8C induces cancer cell apoptosis. MSN8C shows significant anti-tumor cell proliferation activity in vitro .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-175272
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Drug-Linker Conjugates for ADC
                                                    
                                                        Topoisomerase
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    DBCO-PEG8-VKG-CPT2 is a drug-linker conjugate for ADC. DBCO-PEG8-VKG-CPT2 consists of a topoisomerase 1 inhibitor (7-MAD-MDCPT) (HY-132162) and a stable and cleavable linker (DBCO-PEG8-VKG) (HY-175426). DBCO-PEG8-VKG-CPT2 can be used for synthesis of ADCs .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-B0013
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     (-)-Ofloxacin lactate 
                                                 | 
                                                
                                                    
                                                        Bacterial
                                                    
                                                        DNA/RNA Synthesis
                                                    
                                                 | 
                                                
                                                    
                                                        Infection
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Lavofloxacin lactate ((-)-ofloxacin lactate) is a class of broad-spectrum antimicrobials that can kill or inhibit a variety of bacteria. Lavofloxacin lactate binds to DNA rotase and topoisomerase IV, resulting in blocked DNA replication and repair, thus inhibiting bacterial growth. Lavofloxacin lactate can be used to study resistance mechanisms in bacteria, including studying resistance genes and mutations .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-143483
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Bacterial
                                                    
                                                 | 
                                                
                                                    
                                                        Infection
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    NBTIs-IN-5 (Compound 5r) is a NBTI (Novel Bacterial Topoisomerase Inhibitor) DNA gyrase inhibitor with an IC50 of 1.5 μM against Mycobacterium abscessus (Mabs) DNA gyrase. NBTIs-IN-5 inhibits Mabs bamboo bacterial growth with an MIC90 of 0.4 μM .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-W715630
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Salvicine is a DNA topoisomerase II inhibitor (IC50=3 μM). Salvicine increases the interaction between DNA and Topo II by interacting with the ATPase domain, inhibiting DNA degradation and ATP hydrolysis. Salvicine has anticancer activities, including inhibiting Topo II, causing DNA damage, overcoming multidrug resistance, and inhibiting tumor cell adhesion  .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-134290
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    8-Chloro-ATP, an ATP (HY-B2176) analog, is a topoisomerase II (Topo II) inhibitor. 8-Chloro-ATP inhibits DNA synthesis and induces DNA double-stranded breaks (DSBs). 8-Chloro-ATP inhibits Topo II-catalyzed ATP hydrolysis .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-158230
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    SN-398 is a derivative of Camptothecin (HY-158230), which is an antitumor drug. Acting by inhibiting mammalian DNA topoisomerase I (Topo I), stabilizing the Topo I-DNA complex prevents DNA rewiring to induce Topo I mediated DNA breaks. In Hela cell tests, SN-398 shows stronger antitumor activity than SN-38 (HY-13704) (IC50=1.562 μM). SN-398 can be used to study the anti-proliferation and growth inhibition of Topo I in cancer cells .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-176762
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                 | 
                                                
                                                    
                                                        Infection
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    TOP3B-IN-1 (NSC-260610) is a Topoisomerase IIIβ (TOP3B) inhibitor. TOP3B-IN-1 fails to induce the formation of TOP3B cleavage complexes (TOP3Bccs) with both DNA and RNA, and destabilizes TOP3Bccs. TOP3B-IN-1 can be used as a control compound for the development of inhibitors targeting TOP3B .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-100777R
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                        Reference Standards
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    DACA (Standard) is the analytical standard of DACA (HY-100777). This product is intended for research and analytical applications. DACA (XR 5000) is a blood-brain barrier-penetrating topoisomerase I and II inhibitor. DACA can be used in the research of colorectal cancer, leukemia and lung cancer    .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-173703
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                        Drug Intermediate
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    β-Glu-PAB(CH2NH2)-Exatecan (Compound 9a) is a topoisomerase I inhibitor. β-Glu-PAB(CH2NH2)-Exatecan binds to the topoisomerase I-DNA complex to prevent DNA strand reconnection, thereby inducing DNA breakage and cell apoptosis. β-Glu-PAB(CH2NH2)-Exatecan can be specifically cleaved by β-glucuronidase highly expressed in the tumor microenvironment to release Exatecan for cytotoxic effect. β-Glu-PAB(CH2NH2)-Exatecan is also an intermediate of Mal((3S,3aR,6S,6aR) -hexahydrofuro [3, 2-B]furan-3,6-diamine-PEG12)-β -Glu-Pab-Exatecan. β-Glu-PAB(CH2NH2)-Exatecan is promising for research of cancers .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-134290A
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    8-Chloro-ATP tetrasodium, an ATP (HY-B2176) analog, is a topoisomerase II (Topo II) inhibitor. 8-Chloro-ATP tetrasodium inhibits DNA synthesis and induces DNA double-stranded breaks (DSBs). 8-Chloro-ATP tetrasodium inhibits Topo II-catalyzed ATP hydrolysis .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-156403
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    AuM1Phe, an N-Heterocyclic carbene (NHC) metal complexe, blocks the human topoisomerase I activity and actin polymerization reaction. AuM1Phe affects the growth of MDA-MB-231 breast cancer cells, with an IC50 value of 1.2 μM .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-164152
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Antibody-Drug Conjugates (ADCs)
                                                    
                                                        Topoisomerase
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    ADC Control Human IgG1-Deruxtecan (DAR 4) is a humanized monoclonal antibody that is an isotype control of ADC human IgG1-Deruxtecan and can inhibit DNA topoisomerase I. The antibody portion is Human IgG1 kappa, Isotype Control (HY-P99001), and the drug-linker conjugate for ADC is Deruxtecan (HY-13631E) .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-164152A
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Antibody-Drug Conjugates (ADCs)
                                                    
                                                        Topoisomerase
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    ADC Control Human IgG1-Deruxtecan (DAR 8) is a humanized monoclonal antibody that is an isotype control of ADC human IgG1-Deruxtecan and can inhibit DNA topoisomerase I. The antibody portion is Human IgG1 kappa, Isotype Control (HY-P99001), and the drug-linker conjugate for ADC is Deruxtecan (HY-13631E) .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-122594
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                
                                                    BNS-22 is a DNA topoisomerase II (TOP2) catalytic inhibitor with the IC50 values of 2.8 μM and 0.42 μM for human TOP2α and TOP2β, respectively. BNS-22 induces abnormal division and has anti-proliferative activity . 
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-178330
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Others
                                                    
                                                        Topoisomerase
                                                    
                                                 | 
                                                
                                                    
                                                        Infection
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    IKE16 is a fungi-selective eukaryotic topoisomerase II inhibitor, with an IC50 value of 13.68 μM. IKE16 suppresses both the DNA relaxation activity and the decatenation activity of yTOPOII selectively. IKE16 shows moderate activity against standard fungal strains (Candida albicans ATCC 10231, Saccharomyces cerevisiae ATCC 89763) with a minimum inhibitory concentration (MIC) of 2 μg/mL against S. cerevisiae ATCC 89763. IKE16 exhibits high cytotoxicity against human cells, with an EC50 of 0.07 μM in HepG2 and 0.045 μM in HEK-293. IKE16 can be used for the study of antifungal infection .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-145851
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        HDAC
                                                    
                                                        Topoisomerase
                                                    
                                                        Apoptosis
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Top/HDAC-IN-1 (Compound 29b) is a topoisomerase/HDAC dual inhibitor with IC50s of 18, 230, 790, 87, and 5250 nM for HDAC1, HDAC2, HDAC3, HDAC6, and HDAC8, respectively. Top/HDAC-IN-1 exhibits potent antitumor activities against the HCT116 cell line with the IC50 of 180 nM. Top/HDAC-IN-1 efficiently induces apoptosis with G2 cell cycle arrest in HCT116 cells .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-16560
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     Campathecin;  (S)-(+)-Camptothecin;  CPT 
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                        ADC Payload
                                                    
                                                        MicroRNA
                                                    
                                                        Influenza Virus
                                                    
                                                        Apoptosis
                                                    
                                                        Fungal
                                                    
                                                        Antibiotic
                                                    
                                                 | 
                                                
                                                    
                                                        Infection
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Camptothecin (CPT), a kind of alkaloid, is a DNA topoisomerase I (Topo I) inhibitor with an IC50 of 679 nM . Camptothecin (CPT) exhibits powerful antineoplastic activity against colorectal, breast, lung and ovarian cancers, modulates hypoxia-inducible factor-1α (HIF-1α) activity by changing microRNAs (miRNA) expression patterns in human cancer cells  .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-175216
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Drug-Linker Conjugates for ADC
                                                    
                                                        Topoisomerase
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Maleimide-Ph(3,5-F)-PEG4-Val-Ala-MF-6 is a drug-linker conjugate for ADC. Maleimide-Ph(3,5-F)-PEG4-Val-Ala-MF-6 consists of a topoisomerase 1 inhibitor (Topi MF-6) (HY-175203) and a cleavable linker (Maleimide-Ph(3,5-F)-PEG4-Val-Ala) (HY-175218). Maleimide-Ph(3,5-F)-PEG4-Val-Ala-MF-6 can be used for synthesis of ADCs .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-152473
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Topoisomerase IIα-IN-6 (Compound 47d) is an inhibitor of DNA topoisomerase IIα/β. Topoisomerase IIα-IN-6 inhibits human topoisomerase IIα and human topoisomerase IIβ with IC50 values of 0.67 µM and 0.55 µM, respectively. Topoisomerase IIα-IN-6 has stable metabolism .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-144774
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                        DNA/RNA Synthesis
                                                    
                                                        Apoptosis
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Topoisomerase I inhibitor 5 is an effective topoisomerase inhibitor with IC50 value of. Topoisomerase I inhibitor 5 can interfere with DNA and significantly inhibit the activity of Topoisomerase I. Topoisomerase I inhibitor 5 can arrest cell cycle at the G1 phase and induce MCF-7 cells apoptosis. Topoisomerase I inhibitor 5 has potency in reversing P-gp-mediated resistance to Adriamycin .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-158061
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                        Apoptosis
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Topoisomerase II inhibitor 20 (Compound 3e) is a potent topoisomerase II (Topoisomerase II) inhibitor with an IC50 of 0.98 µM. Topoisomerase II inhibitor 20 induces apoptosis and has broad-spectrum anticancer activity .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-153401
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Topoisomerase II inhibitor 13 is a topoisomerase II (Topo II) inhibitor. Topoisomerase II inhibitor 13 shows antiproliferative activity against several cancer cells. Topoisomerase II inhibitor 13 induces cancer cells apoptosis .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-160005
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     NSC 781517 
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                        DNA/RNA Synthesis
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    LMP517 (NSC 781517) is a potent and non-camptothecin Topoisomerase I and II (TOP1 and TOP2) dual inhibitor. LMP517 can induce TOP1 and TOP2 cleavage complexes (TOP1ccs and TOP2ccs). LMP517 can induce cancer cells DNA damage and γH2AX production. LMP517 can be used for the research of cancer, such as small cell lung cancer  .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-178145
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Drug-Linker Conjugates for ADC
                                                    
                                                        Topoisomerase
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Mc-Lys(PEG12)-Cap-Ala-Ala-PABC-exatecan (compound 12) is a Drug-Linker Conjugate for ADC. Mc-Lys(PEG12)-Cap-Ala-Ala-PABC-exatecan contains the ADC linker (Mc-Lys(PEG12)-Cap-Ala-Ala-PABC) (HY-178146) and a DNA topoisomerase I inhibitor Exatecan (HY-13631). Mc-Lys(PEG12)-Cap-Ala-Ala-PABC-exatecan can be used for the development of ADC targeting HER2-positive breast cancer .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-148058
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Topoisomerase I inhibitor 8 is a potent topoisomerase I inhibitor. Topoisomerase I inhibitor 8 is a hexacyclic analogue of camptothecin, and displays cytotoxic effect against tumor cells .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-146227
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                        Apoptosis
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    DNA topoisomerase II inhibitor 1 (compound 8ed) is a potent DNA topoisomerase II inhibitor. DNA topoisomerase II inhibitor 1 shows anti-proliferative activity. DNA topoisomerase II inhibitor 1 induces apoptosis and cell cycle arrest at sub G1 phase .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-143266
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                        Apoptosis
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Topoisomerase I inhibitor 3 (Compound ZML-14) is a topoisomerase I inhibitor and can interact with topoisomerase I-DNA complex. Topoisomerase I inhibitor 3 induces HepG2 cell apoptosis and arrests cell cycle at G2/M phase .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-147877
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Topoisomerase II inhibitor 12 (Compound 8c) is a topoisomerase II (topo II) inhibitor, working as a DNA non-intercalator. Topoisomerase II inhibitor 12 shows antineoplastic activity .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-B0268A
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     Enoxacin sesquihydrate; AT-2266 hydrate; CI-919 hydrate 
                                                 | 
                                                
                                                    
                                                        Bacterial
                                                    
                                                        DNA/RNA Synthesis
                                                    
                                                        MicroRNA
                                                    
                                                        Antibiotic
                                                    
                                                 | 
                                                
                                                    
                                                        Infection
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Enoxacin hydrate (Enoxacin sesquihydrate), a fluoroquinolone, interferes with DNA replication and inhibits bacterial DNA gyrase (IC50=126 µg/ml) and topoisomerase IV (IC50=26.5 µg/ml). Enoxacin hydrate is a miRNA processing activator and enhances siRNA-mediated mRNA degradation and promotes the biogenesis of endogenous miRNAs. Enoxacin hydrate has potent activities against gram-positive and -negative bacteria. Enoxacin hydrate is a cancer-specific growth inhibitor that acts by enhancing TAR RNA-binding protein 2 (TRBP)-mediated microRNA processing    .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-128946
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Drug-Linker Conjugates for ADC
                                                    
                                                 | 
                                                
                                                    
                                                        Inflammation/Immunology
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    CL2A-SN-38 is a agent-linker conjugate composed of a potent a DNA Topoisomerase I inhibitor SN-38 and a linker CL2A to make antibody agent conjugate (ADC). CL2A-SN-38 provides significant and specific antitumor effects against a range of human solid tumor types. CL2A-SN-38 uses hydrolyzable linker to deliver active agents within tumor cells and in the tumor microenvironment, resulting in bystander effects .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-B0268
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     AT 2266;  CI 919 
                                                 | 
                                                
                                                    
                                                        Bacterial
                                                    
                                                        DNA/RNA Synthesis
                                                    
                                                        MicroRNA
                                                    
                                                        Antibiotic
                                                    
                                                 | 
                                                
                                                    
                                                        Infection
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Enoxacin (AT 2266), a fluoroquinolone, interferes with DNA replication and inhibits bacterial DNA gyrase (IC50=126 µg/ml) and topoisomerase IV (IC50=26.5 µg/ml). Enoxacin is a miRNA processing activator and enhances siRNA-mediated mRNA degradation and promotes the biogenesis of endogenous miRNAs. Enoxacin has potent activities against gram-positive and -negative bacteria. Enoxacin is a cancer-specific growth inhibitor that acts by enhancing TAR RNA-binding protein 2 (TRBP)-mediated microRNA processing    .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-156464
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                 | 
                                                
                                                    
                                                        Infection
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Topoisomerase I inhibitor 10 (compound 13) is a leishmanial topoisomerase IB inhibitor. Topoisomerase I inhibitor 10 has antileishmanial activity against L. donovani promastigotes, with the IC50 of 27.91 μM .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-162341
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Topoisomerase I inhibitor 15 (compound 4b) is an inhibitor of topoisomerase I with anticancer activity. Topoisomerase I inhibitor 15 inhibits A549 cells with an IC50 of 7.34 μM .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-161082
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Topoisomerase I inhibitor 12 (compound 12), a Camptothecin (HY-16560)-based derivative, is a potent Topoisomerase I inhibitor. Topoisomerase I inhibitor 12 shows anticancer activity .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-177434
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     Precem-TcT;  M 9140 
                                                 | 
                                                
                                                    
                                                        Antibody-Drug Conjugates (ADCs)
                                                    
                                                        Transmembrane Glycoprotein
                                                    
                                                        Topoisomerase
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Precemtabart tocentecan (Precem-TcT; M 9140) is an anti-CEACAM5 (carcinoembryonic antigen-related cell adhesion molecule 5) antibody-drug conjugate (ADC). Precemtabart tocentecan consists of a tumor-specific anti-CEACAM5 monoclonal antibody Precemtabart (HY-P990940), a highly hydrophilic and stable cleavable β-glucuronide linker, and a topoisomerase 1 inhibitor payload Exatecan (HY-13631), and the drug-linker conjugate for ADC is Mal-Gly-PAB-Exatecan-D-glucuronic acid (HY-153179). Precemtabart tocentecan inhibits the growth of CEACAM5-positive cancer cells. Precemtabart tocentecan exhibits significant antitumor activity in CEACAM5-expressing xenograft models. Precemtabart tocentecan can be used for the study of CEACAM5-expressing advanced solid tumors, especially mCRC .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-169628
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Topoisomerase I/II inhibitor 7 (Compound 5h) is a Topoisomerase I/II inhibitor .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-171747
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Antibody-Drug Conjugates (ADCs)
                                                    
                                                        EGFR
                                                    
                                                        Topoisomerase
                                                    
                                                        Apoptosis
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    AMT-562 is an antibody-drug conjugate (ADC) consisting of a novel anti-HER3 antibody Ab562 (HY-P991505) conjugated to the linker Mc-VC-PAB and the topoisomerase I inhibitor Exatecan (HY-13631). The ADC toxic molecule and linker portion are MC-VA-PAB-Exatecan (HY-147270). AMT-562 can induce apoptosis and has antitumor activity against pancreatic, esophageal, and gastric cancers  .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-158061A
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                        Apoptosis
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Topoisomerase II inhibitor 20 TFA is a potent topoisomerase II inhibitor with IC50 of 0.98 µM. Topoisomerase II inhibitor 20 TFA can induce apoptosis and has broad-spectrum anticancer activity .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-156462
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                 | 
                                                
                                                    
                                                        Infection
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Topoisomerase I inhibitor 9 (compound 3d) is a leishmanial topoisomerase IB inhibitor. Topoisomerase I inhibitor 9 has antileishmanial activity against L. donovani promastigotes, with the IC50 of 34.81μM .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-146163
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                        Apoptosis
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Topoisomerase II inhibitor 7 (compound 3a) is a potent inhibitor of topoisomerase II alpha subtype, with an IC50 of 3.19 μM. Topoisomerase II inhibitor 7 can induce cell cycle arrest and apoptosis .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-19825
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                        ADC Payload
                                                    
                                                        Antibiotic
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Rebeccamycin, an antitumor antibiotic, inhibits DNA topoisomerase I. Rebeccamycin appears to exert its primary antineoplastic effect by poisoning topoisomerase I and has negligible effect on protein kinase C and topoisomerase II  .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-126333
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Topoisomerase II inhibitor 1 (compound 89) is a highly efficient and selective topoisomerase IIα inhibitor .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-143281
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Topoisomerase II inhibitor 5 (Compound E24) is a DNA topoisomerase II inhibitor with anticancer activities .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-152187
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                        Apoptosis
                                                    
                                                 | 
                                                
                                                    
                                                        Others
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Topoisomerase IIα-IN-5 is a topoisomerase II (topo II) α catalytic inhibitor. Topoisomerase IIα-IN-5 intercalates into DNA and binds to the DNA minor groove. Topoisomerase IIα-IN-5 exhibits better efficacy and less genotoxicity than Etoposide (HY-13629) .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-162380
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Topoisomerase II inhibitor 18 (Compound IV) is a Quinoxaline derivative, which inhibits topoisomerase II with IC50 of 7.5 μM. Topoisomerase II inhibitor 18 inhibits proliferation, cell cycle at S phase and induces apoptosis in PC-3 cells. Topoisomerase II inhibitor 18 reveals antitumor activity against cancer .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-143402
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Topoisomerase I/II inhibitor 2 (compound 1a) is a potent Topoisomerase inhibitor (IC50= 9.82 μM on Huh7 cells and 6.83 μM on LM9 cells). Topoisomerase I/II inhibitor 2 has dual inhibition on DNA topoisomerase I/II, also can obviously reduce the growth of xenograft tumor in mice model. Topoisomerase I/II inhibitor 2 has the potential value in researching liver cancer .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-16742B
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Antibiotic
                                                    
                                                        Bacterial
                                                    
                                                        Topoisomerase
                                                    
                                                 | 
                                                
                                                    
                                                        Infection
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Gepotidacin mesylate hydrate is an orally active triazaacenaphthylene antibiotic and bacterial type II topoisomerase inhibitor. Gepotidacin mesylate hydrate inhibits bacterial DNA replication by blocking topoisomerase enzymes. Gepotidacin mesylate hydrate selectively inhibits topoisomerase IV and the B subunit of DNA gyrase  .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-16562
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     (+)-Irinotecan;  CPT-11;  VAL-413(free base) 
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                        Autophagy
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Irinotecan ((+)-Irinotecan) is a topoisomerase I inhibitor, preventing religation of the DNA strand by binding to topoisomerase I-DNA complex .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-B0268R
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     AT 2266 (Standard); CI 919 (Standard) 
                                                 | 
                                                
                                                    
                                                        Reference Standards
                                                    
                                                        Bacterial
                                                    
                                                        DNA/RNA Synthesis
                                                    
                                                        MicroRNA
                                                    
                                                        Antibiotic
                                                    
                                                 | 
                                                
                                                    
                                                        Infection
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Enoxacin (Standard) is the analytical standard of Enoxacin. This product is intended for research and analytical applications. Enoxacin (AT 2266), a fluoroquinolone, interferes with DNA replication and inhibits bacterial DNA gyrase (IC50=126 μg/ml) and topoisomerase IV (IC50=26.5 μg/ml). Enoxacin is a miRNA processing activator and enhances siRNA-mediated mRNA degradation and promotes the biogenesis of endogenous miRNAs. Enoxacin has potent activities against gram-positive and -negative bacteria. Enoxacin is a cancer-specific growth inhibitor that acts by enhancing TAR RNA-binding protein 2 (TRBP)-mediated microRNA processing   [4].
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-175171
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                        VEGFR
                                                    
                                                        c-Met/HGFR
                                                    
                                                        EGFR
                                                    
                                                        Estrogen Receptor/ERR
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Anticancer agent 276 (Compound 5) is a multi-target anticancer agent. Anticancer agent 276 has a potent anticancer activity against human tumor cells with IC50s of 6.90 and 4.48 μM for HEPG2 and MCF7 cells, respectively. Anticancer agent 276 shows strong and stable interactions across multiple targets, including Topoisomerase II, VEGFR2, c-Met, EGFR and ERα .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-168739
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                        Reactive Oxygen Species (ROS)
                                                    
                                                        Apoptosis
                                                    
                                                        Survivin
                                                    
                                                        Bcl-2 Family
                                                    
                                                        IAP
                                                    
                                                        DNA/RNA Synthesis
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Topoisomerase I inhibitor 17 (Compound 7h) is a Topoisomerase I (Top1) inhibitor. Topoisomerase I inhibitor 17 reduces DDX5 and reverses the locking of Top1 activity by DDX5. Topoisomerase I inhibitor 17 induces Top1-mediated DNA damage and promotes reactive oxygen species (ROS) production. Topoisomerase I inhibitor 17 induces Apoptosis (reduces antiapoptotic proteins XIAP, Bcl-2, Survivin and up-regulates pro-apoptotic proteins Bax, γH2AX). Topoisomerase I inhibitor 17 also blocks the progression of the G2/M checkpoint and induces cell cycle arrest. Topoisomerase I inhibitor 17 significantly inhibits colony formation and cell migration in colorectal cancer cells. Topoisomerase I inhibitor 17 effectively reduces tumors in human PDX tumor mice .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-159783
 
                                    - 
                                        
                                    
 
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-150044
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        DNA/RNA Synthesis
                                                    
                                                        Topoisomerase
                                                    
                                                        Bacterial
                                                    
                                                 | 
                                                
                                                    
                                                        Infection
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Type II topoisomerase inhibitor 1 is a potent and selective E. coli DNA gyrase inhibitor (IC50: 1.7 nM), and forms hydrogen bonds with Asp73 residue. Type II topoisomerase inhibitor 1 inhibits topoisomerase IV activity (IC50: 0.98 μM). Type II topoisomerase inhibitor 1 can be used in the research of antibacterial area  .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-W178011
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     4,4'-Sulfonylbis(2-methylphenol) 
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Topoisomerase IIα-IN-9 (NSC85582) is a bisphenol compound that has a moderate inhibitory effect on DNA topoisomerase Topoisomerase II (IC50: 571 μM). Topoisomerase IIα-IN-9 also exhibits a certain cell growth inhibitory effect, with IC50s of 117 μM and 218 μM for K562 and CHO, respectively .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-152479
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Topoisomerase IIα-IN-7 is an DNA topoisomerase IIα inhibitor with an IC50 value of 7.7 µM. Topoisomerase IIα-IN-7 has broad-spectrum cytotoxicity to leukemia, lung, colon, melanoma, ovarian, kidney, prostate and breast cancer cells. Topoisomerase IIα-IN-7 has metabolic stability .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-143301
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Topoisomerase I inhibitor 4 (compound 7a) is a topoisomerase I inhibitor. Topoisomerase I inhibitor 4 inhibits HepG2, A549, MCF-7 and HeLa cancer cells proliferation with IC50s of 1.20, 2.09, 1.56 and 1.92 μM, respectively. Topoisomerase I inhibitor 4 can be used for the research of cancer .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-170557
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                        Apoptosis
                                                    
                                                        Mitochondrial Metabolism
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Topoisomerase IIα-IN-10 (Compound 13r) is an inhibitor of Topoisomerase IIα. It binds to the active site of DNA when complexed with Topoisomerase IIα, and this binding is stabilized through interactions with DNA base pairs and amino acid residues. Topoisomerase IIα-IN-10 can induce Apoptosis by intercalating DNA and inhibiting Topoisomerase IIα, thereby disrupting the mitochondrial membrane potential and inhibiting the growth of HCT116 cell lines, with an IC50 of 4.37 μM against HCT116 cells. Topoisomerase IIα-IN-10 can be used for research in the field of cancer treatment .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-146020
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Topoisomerase IIα-IN-1 (compound 2) is a potent DNA-binding ligands and topoisomerase IIα inhibitor. Topoisomerase IIα-IN-1 exhibits high antiproliferative activity against human cancer cell lines .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-B0268AR
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     Enoxacin sesquihydrate (Standard); AT-2266 hydrate (Standard); CI-919 hydrate (Standard) 
                                                 | 
                                                
                                                    
                                                        Reference Standards
                                                    
                                                        Bacterial
                                                    
                                                        DNA/RNA Synthesis
                                                    
                                                        MicroRNA
                                                    
                                                        Antibiotic
                                                    
                                                 | 
                                                
                                                    
                                                        Infection
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Enoxacin (hydrate) (Standard) is the analytical standard of Enoxacin (hydrate). This product is intended for research and analytical applications. Enoxacin hydrate (Enoxacin sesquihydrate), a fluoroquinolone, interferes with DNA replication and inhibits bacterial DNA gyrase (IC50=126 μg/ml) and topoisomerase IV (IC50=26.5 μg/ml). Enoxacin hydrate is a miRNA processing activator and enhances siRNA-mediated mRNA degradation and promotes the biogenesis of endogenous miRNAs. Enoxacin hydrate has potent activities against gram-positive and -negative bacteria. Enoxacin hydrate is a cancer-specific growth inhibitor that acts by enhancing TAR RNA-binding protein 2 (TRBP)-mediated microRNA processing   [4].
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-162805
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        NO Synthase
                                                    
                                                        Topoisomerase
                                                    
                                                        Apoptosis
                                                    
                                                        NF-κB
                                                    
                                                 | 
                                                
                                                    
                                                        Inflammation/Immunology
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    iNOS/TopoI-IN-1 (compound AuL9) is a multi-target hybrid molecule with anti-tumor, anti-inflammatory and antioxidant activities. iNOS/TopoI-IN-1 inhibits the growth of breast cancer cells MCF-7 and MDA MB-231 in vitro with IC50 of 3.5 μM and 6.3 μM, respectively, and induces DNA damage and apoptosis of breast cancer cells by inhibiting human topoisomerase I (TopoI) (Ki=2.72 μM). In addition, NOS/TopoI-IN-1 inhibits the expression of iNOS by inhibiting the activation of NF-kB (Ki=1.49 μM) .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-161385
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Topoisomerase I inhibitor 21 (Compound 3e) is an inhibitor for Topoisomerase I through stabilization of enzyme-DNA complex. Topoisomerase I inhibitor 21 exhibits antiproliferative activity in 39 human cancer cells (JFCR39) with mean GI50 39 nM .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-122014
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                 | 
                                                
                                                    
                                                        Others
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    39625 is a camptothecin ketone analogue, a stable, potent and selective topoisomerase I inhibitor, active against purified topoisomerase I and cytotoxic to cancer cells.
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-143280
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Topoisomerase II inhibitor 4 (compound E17) is a potent Topoisomerase II inhibitor. Topoisomerase II inhibitor 4 triggers G2/M cell cycle arrest and shows anti-tumor activity with strong cytotoxic and anti-proliferative effect .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-146188
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Topoisomerase II inhibitor 8 (compound 22) is a potent topoisomerase II inhibitor, with an IC50 of 0.52 μM. Topoisomerase II inhibitor 8 exhibits good anti-proliferative activities and can arrest the cell cycle at G2/M phase .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-146021
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Topoisomerase IIα-IN-2 (compound 5) is a potent DNA-binding ligands and topoisomerase IIα inhibitor. Topoisomerase IIα-IN-2 exhibits high antiproliferative activity against human cancer cell lines. Topoisomerase IIα-IN-2 significantly induces DNA damage and arrests cancer cells at G2/M phase .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-147801
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                        Apoptosis
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Topoisomerase IIα-IN-3 (Compound 12c) is a DNA intercalative topoisomerase-IIα inhibitor. Topoisomerase IIα-IN-3 arrests cell cycle at the G0/G1 phase and induces apoptosis .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-N0354
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Virus Protease
                                                    
                                                        Topoisomerase
                                                    
                                                        Apoptosis
                                                    
                                                 | 
                                                
                                                    
                                                        Infection
                                                    
                                                        Metabolic Disease
                                                    
                                                        Inflammation/Immunology
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Anthraquinone is used as a precursor for dye formation and agrochemicals, existing in different organisms, such as bacteria, fungi, plants, and some animals. Anthraquinone has biological activities: anticancer, antiinflammatory, diuretic, antiarthritic, antifungal, antibacterial, antimalarial and antioxidant. Anthraquinone also plays an important role in the primary metabolism of plants by acting on the electron transport chain through the inhibition of energy transfer in the photosynthetic process. Anthraquinone can intercalates into DNA and inhibits the topoisomerase II (topo II) enzyme, resulting in cell death via Apoptosis    .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-146504
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                        PI3K
                                                    
                                                        Apoptosis
                                                    
                                                        Reactive Oxygen Species (ROS)
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Topoisomerase I/II inhibitor 3 (compound 7) is a potent topoisomerase I (Topo I) and II (Topo II) dual inhibitor. Topoisomerase I/II inhibitor 3 can inhibit cell proliferation, invasion and migration, and induce apoptosis by inhibiting PI3K/Akt/mTOR signaling pathway. Topoisomerase I/II inhibitor 3 can be used for liver cancer research .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-13768D
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     SKF 104864A acetate; NSC 609669 acetate 
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Topotecan acetate is a topoisomerase inhibitor.
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-173634
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Drug-Linker Conjugates for ADC
                                                    
                                                        Topoisomerase
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Mal((3S,3aR,6S,6aR)-Hexahydrofuro[3,2-b]furan-3,6-diamine-PEG12)-β-Glu-PAB-Exatecan (LP1) is a drug-linker conjugate composed of a potent a DNA Topoisomerase I inhibitor Exatecan (HY-13631) and a linker Mal((3S,3aR,6S,6aR)-Hexahydrofuro[3,2-b]furan-3,6-diamine-PEG12)-β-Glu-PAB (HY-173635) to make antibody agent conjugate (ADC), AZD0516 (HY-173639) .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-178174
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        DNA/RNA Synthesis
                                                    
                                                        Topoisomerase
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    MGB4 is a DNA minor groove binder. MGB4 binds to ARE-containing DNA and inhibition of topoisomerase I activity. MGB4 can impacts key cellular pathways, including inhibition oftranslation and alterations in sphingolipid and amino acid metabolism. MGB4 also reduces spermine and spermidine metabolism companied with Doxorubicin (HY-15142A). MGB4 can be used for the research of cancer, such as Prostate cancer .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-157402
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                        EGFR
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Topoisomerase II/EGFR-IN-1 is topoisomerase II/EGFR dual inhibitor. Topoisomerase II/EGFR-IN-1 has superior cytotoxic activity to MCF-7, A549 and HCT-116 cell lines, displays strong apoptotic activity and can be used for the research of cancer .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-119892
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     NSC 320846;  BAY-H 2049 
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Batracylin (NSC320846) is a potent DNA Topoisomerases I and DNA Topoisomerases II inhibitor. Batracylin shows cytotoxicity and antiproliferative activity. Batracylin induces DNA breaks .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-123589
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Bacterial
                                                    
                                                 | 
                                                
                                                    
                                                        Others
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Gyramide A is a compound mentioned in the study of the protective effect of Qnr protein on bacterial topoisomerase. Qnr has no protective effect on it, and its activity is different from that of other topoisomerase inhibitors.
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-W031307
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Topoisomerase IIα-IN-8 (compound 15) is a weak human DNA topoisomerase IIa (htIIa) inhibitor, with an IC50 of 462 ± 38.0 μM .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-147839
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                        Apoptosis
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Topoisomerase II inhibitor 10 (compound 32a) is a potent topoisomerase II inhibitor with an IC50 value of 7.45 μM. Topoisomerase II inhibitor 10 causes cell cycle arrest at G2-M phase and induces apoptosis of HepG-2 cells. Topoisomerase II inhibitor 10 has excellent anti-proliferative activities against HepG-2, MCF-7, and HCT-116 cells .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-175700
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                        Apoptosis
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    YCJ-02 is a selective Topoisomerase I (Top I) inhibitor. YCJ-02 can inhibit cell proliferation and induce apoptosis and G2/M phase arrest. YCJ-02 can induce DNA damage and increaseγ-H2AX levels. YCJ-02 can promote Top I deqradation via a ubiquitin/26S proteasome pathway.  YCJ-02 increases the expressions of pro-apoptotic proteins Bad, Bax, and cleaved
 
caspase-3. YCJ-02 shows broad-spectrum antitumor activity. YCJ-02 can be used for the research of cancer, such as intrahepatic cholangiocarcinoma (ICC) .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-106307
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     BD84 
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Retelliptine (BD84), a derivative of ellipticine, is an inhibitor of Topoisomerase II with anticancer activity. Retelliptine can bind to DNA and inhibit Topoisomerase II during DNA replication  .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-16562S1
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Isotope-Labeled Compounds
                                                    
                                                        Topoisomerase
                                                    
                                                        Autophagy
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Irinotecan-d10 (hydrochloride) is the deuterium labeled Irinotecan. Irinotecan ((+)-Irinotecan) is a topoisomerase I inhibitor, preventing religation of the DNA strand by binding to topoisomerase I-DNA complex  .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-16562S
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     (+)-Irinotecan-d10; CPT-11-d10; VAL-413-d10 
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                        Autophagy
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Irinotecan-d10 is a deuterium labeled Irinotecan ((+)-Irinotecan). Irinotecan ((+)-Irinotecan) is a topoisomerase I inhibitor, preventing religation of the DNA strand by binding to topoisomerase I-DNA complex .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-175269
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        DNA Alkylator/Crosslinker
                                                    
                                                        DNA/RNA Synthesis
                                                    
                                                        Topoisomerase
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    MGB1Y is a noncovalent DNA minor groove binder (MGB). MGB1Y potently inhibits cancer cells proliferation and topoisomerase I activity. MGB1Y downregulates their breast cancer-related genes in MCF7 and MDA-MB-231 cells. MGB1Y has a broad-spectrum anticancer activity, such as breast cancer, colon cancer, and leukemia .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-B0879
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Phosphatase
                                                    
                                                        Sirtuin
                                                    
                                                        Reverse Transcriptase
                                                    
                                                        Topoisomerase
                                                    
                                                        SARS-CoV
                                                    
                                                        Parasite
                                                    
                                                        Apoptosis
                                                    
                                                 | 
                                                
                                                    
                                                        Infection
                                                    
                                                        Cardiovascular Disease
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Suramin is a reversible and competitive protein-tyrosine phosphatases (PTPases) inhibitor . Suramin is a potent inhibitor of sirtuins: SirT1 (IC50=297 nM), SirT2 (IC50=1.15 μM), and SirT5 (IC50=22 μM) . Suramin is a competitive inhibitor of reverse transcriptase (DNA topoisomerase II: IC50=5 μM)  . Suramin is a potent SARS-CoV-2 RNA-dependent RNA polymerase (RdRp) inhibitor .Suramin efficiently inhibits IP5K and is an antiparasitic, anti-neoplastic and anti-angiogenic agent   .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-162091
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Topoisomerase I inhibitor 13 (Compound G11) is a Topo I inhibitor that inhibits cancer cell proliferation. Topoisomerase I inhibitor 13 significantly inhibits tumor growth in vivo .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-16562R
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     (+)-Irinotecan (Standard); CPT-11 (Standard); VAL-413(free base) (Standard) 
                                                 | 
                                                
                                                    
                                                        Reference Standards
                                                    
                                                        Topoisomerase
                                                    
                                                        Autophagy
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Irinotecan (Standard) is the analytical standard of Irinotecan. This product is intended for research and analytical applications. Irinotecan ((+)-Irinotecan) is a topoisomerase I inhibitor, preventing religation of the DNA strand by binding to topoisomerase I-DNA complex .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-151453
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                        Apoptosis
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Topoisomerase IIα-IN-4 (F2) is a non-intercalative ATP-competitive human DNA topoisomerase II inhibitor with an IC50 value of 3.8 and 10.1 μM for TopoIIα and TopoIIβ, respectively. Topoisomerase IIα-IN-4 shows potent potency in apoptosis induction and cell cycle arrest in HepG2 cells. Topoisomerase IIα-IN-4 exhibits strong antitumor activities against human cancer cell lines, it can be used for the research of cancer .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-168632
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                        Apoptosis
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Topoisomerase I/II inhibitor 6 (compound 3i) is a potent inhibitor of topoisomerase I and II with IC50s of 4.77 and 15 µM, respectively. Topoisomerase I/II inhibitor 6 shows antiproliferative activities against human melanoma LOX IMVI cancer cell line with IC50 values of 26.7 and 25.4 µM, respectively. Topoisomerase I/II inhibitor 6 provokes substantial levels of early, late apoptosis and increases the expression level of active caspase-3 .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-175034
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                        Apoptosis
                                                    
                                                        MDM-2/p53
                                                    
                                                        Bcl-2 Family
                                                    
                                                        Caspase
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Topoisomerase I/II-IN-1 is a dual inhibitor of topoisomerase I/II. Topoisomerase I/II-IN-1 induces G2/M arrest and apoptosis in cancer cells by upregulating p53, p21, and Bax mRNA levels, caspase-3 protein levels, and the Bax/Bcl-2 ratio, while downregulating Bcl-2. Topoisomerase I/II-IN-1 is useful in the study of various cancers, including melanoma, renal cancer, colorectal cancer, and breast cancer .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-B0879A
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     Suramin hexasodium salt 
                                                 | 
                                                
                                                    
                                                        Phosphatase
                                                    
                                                        Sirtuin
                                                    
                                                        Reverse Transcriptase
                                                    
                                                        Topoisomerase
                                                    
                                                        SARS-CoV
                                                    
                                                        Parasite
                                                    
                                                        Apoptosis
                                                    
                                                 | 
                                                
                                                    
                                                        Infection
                                                    
                                                        Cardiovascular Disease
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Suramin sodium salt	(Suramin hexasodium salt) is a reversible and competitive protein-tyrosine phosphatases (PTPases) inhibitor . Suramin sodium salt is a potent inhibitor of sirtuins: SirT1 (IC50=297 nM), SirT2 (IC50=1.15 μM), and SirT5 (IC50=22 μM) . Suramin sodium salt is a competitive inhibitor of reverse transcriptase (DNA topoisomerase II: IC50=5 μM)  . Suramin sodium salt is a potent SARS-CoV-2 RNA-dependent RNA polymerase (RdRp) inhibitor . Suramin sodium salt efficiently inhibits IP5K and is an antiparasitic, anti-neoplastic and anti-angiogenic agent   .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-13061
 
                                    - 
                                        
                                    
 
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-146189
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                        Apoptosis
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Topoisomerase II inhibitor 9 (Compound 19b) is a Topo II inhibitor with an IC50 of 0.97 μM. Topoisomerase II inhibitor 9 is also a classical DNA-intercalator with an IC50 of 43.51 μM. Topoisomerase II inhibitor 9 arrests the cell cycle at the G2/M phase and induces apoptosis in Hep G‐2 cells .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-14821
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     ST-1968 
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Namitecan is a potent topoisomerase I inhibitor, with antitumor property.
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-N6800
 
                                    - 
                                        
                                    
 
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-118942
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     ARC 111 
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Topovale (ARC 111) is a topoisomerase I inhbitor. Topovale is an antitumor agent, and shows low nM cytotoxicity against a panel of cancer cells. Topovale induces reversible topoisomerase I (TOP1) cleavage complexes in tumor cells .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-N6800A
 
                                    - 
                                        
                                    
 
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-B0879AR
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     Suramin hexasodium salt (Standard) 
                                                 | 
                                                
                                                    
                                                        Reference Standards
                                                    
                                                        Phosphatase
                                                    
                                                        Sirtuin
                                                    
                                                        Reverse Transcriptase
                                                    
                                                        Topoisomerase
                                                    
                                                        SARS-CoV
                                                    
                                                        Parasite
                                                    
                                                        Apoptosis
                                                    
                                                 | 
                                                
                                                    
                                                        Infection
                                                    
                                                        Cardiovascular Disease
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Suramin (sodium salt) (Standard) is the analytical standard of Suramin (sodium salt). This product is intended for research and analytical applications. Suramin sodium salt (Suramin hexasodium salt) is a reversible and competitive protein-tyrosine phosphatases (PTPases) inhibitor . Suramin sodium salt is a potent inhibitor of sirtuins: SirT1 (IC50=297 nM), SirT2 (IC50=1.15 μM), and SirT5 (IC50=22 μM) . Suramin sodium salt is a competitive inhibitor of reverse transcriptase (DNA topoisomerase II: IC50=5 μM)  . Suramin sodium salt is a potent SARS-CoV-2 RNA-dependent RNA polymerase (RdRp) inhibitor . Suramin sodium salt efficiently inhibits IP5K and is an antiparasitic, anti-neoplastic and anti-angiogenic agent   .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-16742C
 
                                    - 
                                        
                                    
 
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-121309
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     Adriamycin aglycone;  Adriamycinone 
                                                 | 
                                                
                                                    
                                                        Endogenous Metabolite
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Doxorubicinone is a metabolite of an anti-cancer chemotherapy agent Doxorubicin . Doxorubicin is a potent human DNA topoisomerase I and topoisomerase II inhibitor with IC50s of 0.8 μM and 2.67 μM, respectively.
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-115990
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                        Bacterial
                                                    
                                                 | 
                                                
                                                    
                                                        Infection
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Topoisomerase IV inhibitor 2 (compound 7d) is a potent DNA topoisomerase IV (TOPO IV) inhibitor with IC50s of 0.23 μM and 0.43 μM for TOPO IV and DNA gyrase, respectively. Topoisomerase IV inhibitor 2 has anti-bacterial activity, with MICs of 0.972 μM and 0.608 μM in Staphylococcus aureus Newman and Escherichia coli ATCC8739, respectively .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-115991
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                        Bacterial
                                                    
                                                 | 
                                                
                                                    
                                                        Infection
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Topoisomerase IV inhibitor 2 (compound 5d) is a potent DNA topoisomerase IV (TOPO IV) inhibitor with IC50s of 0.35 μM and 0.55 μM for TOPO IV and DNA gyrase, respectively. Topoisomerase IV inhibitor 2 has anti-bacterial activity, with MICs of 1.985 μM and 0.744 μM in Staphylococcus aureus Newman and Escherichia coli ATCC8739, respectively .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-119458
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                        TMV
                                                    
                                                        Fungal
                                                    
                                                 | 
                                                
                                                    
                                                        Infection
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Luotonin A is an antiviral and antiphytopathogenic fungus agent. Luotonin A has good antiviral activity against tobacco mosaic virus (TMV). Luotonin A also has certain inhibitory activity on topoisomerase I and topoisomerase II. Luotonin A shows antitumor activity  .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-15552
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     Podophyllotoxin 
                                                 | 
                                                
                                                    
                                                        Microtubule/Tubulin
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Podofilox (Podophyllotoxin) is a potent inhibitor of microtubule assembly and DNA topoisomerase II.
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-13768A
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     SKF 104864A hydrochloride; NSC 609669 hydrochloride 
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                        Autophagy
                                                    
                                                        Apoptosis
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Topotecan Hydrochloride (SKF 104864A Hydrochloride) is a Topoisomerase I inhibitor with potent antineoplastic activities.
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-14812
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     Cositecan;  BNP 1350 
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Karenitecin (Cositecan) is a topoisomerase I inhibitor, with potent anti-cancer activity.
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-N10115
 
                                    - 
                                        
                                    
 
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-18350A
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     LMP776 hydrochloride 
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Indimitecan hydrochloride is a topoisomerase I (Top1) inhibitor with anticancer activities .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-N6714
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                        Androgen Receptor
                                                    
                                                        Estrogen Receptor/ERR
                                                    
                                                        Apoptosis
                                                    
                                                 | 
                                                
                                                    
                                                        Infection
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Alternariol is an orally ingested mycotoxin produced by Alternaria, capable of inhibiting the activity of topoisomerase I and II (topoisomerase I, topoisomerase II). Alternariol has weak estrogenic (Estrogen Receptor/ERR) and androgen/antiandrogen (Androgen Receptor) effects. Alternariol can induce apoptosis, trigger cell cycle arrest, suppress innate immune responses, and exhibit anti-tumor activity. Alternariol has genotoxic, mutagenic, and endocrine-disrupting effects     .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-13761
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     VM26 
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Teniposide is a podophyllotoxin derivative, acts as a topoisomerase II inhibitor, and used as a chemotherapeutic agent.
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-13566A
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     CKD-602 
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Belotecan hydrochloride (CKD-602 hydrochloride), a Topoisomerase I inhibitor, is a synthetic camptothecin derivative.
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-16568
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     (+)-Irinotecan hydrochloride trihydrate; CPT-11 hydrochloride trihydrate 
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                        Autophagy
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Irinotecan hydrochloride trihydrate ((+)-Irinotecan hydrochloride trihydrate) is a topoisomerase I inhibitor with antitumor activity .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-16742
 
                                    - 
                                        
                                    
 
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-N8473
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     (+)-Pericosine A 
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Pericosine A ((+)-Pericosine A) is a topoisomerase II (Topoisomerase II) inhibitor that can be isolated from the Periconia byssoides strain. Pericosine A has significant antitumor activity in vitro and in vivo and can be used in cancer research. Pericosine A also inhibits the protein kinase epidermal growth factor receptor .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-169509
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        PARP
                                                    
                                                        Necroptosis
                                                    
                                                        Topoisomerase
                                                    
                                                        RIP kinase
                                                    
                                                        Mixed Lineage Kinase
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Topoisomerase I/II Inhibitor 8 (Compound Ru7) is a dual catalytic inhibitor of Topoisomerase I/II, capable of inducing DNA damage and PARP-1 activation, which subsequently leads to the activation of RIPK1, RIPK3, and MLKL, ultimately triggering necroptosis. Topoisomerase I/II Inhibitor 8 demonstrates remarkable anticancer activity by effectively targeting the nuclei of cancer cells and inducing cell death through necroptosis, showing great clinical potential in circumventing drug resistance in cancer treatment .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-16228
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Genz-644282 is a non-camptothecin topoisomerase I inhibitor, used for cancer research.
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-B0067A
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     SM-5887 hydrochloride 
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                        Bacterial
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Amrubicin (SM-5887) hydrochloride is a DNA topoisomerase II inhibitor, used for the research of cancer.
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-18350
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     LMP776 
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Indimitecan (LMP776) is a topoisomerase I (Top1) inhibitor with anticancer activities .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-15753
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     NSC 71795 
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Ellipticine (NSC 71795) is a potent antineoplastic agent; inhibits DNA topoisomerase II activities.
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-B0067
 
                                    - 
                                        
                                    
 
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-15753A
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     NSC 71795 hydrochloride 
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Ellipticine (NSC 71795) hydrochloride is a potent antineoplastic agent; inhibits DNA topoisomerase II activities.
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-171945
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     ABBV-400;  Temab-A 
                                                 | 
                                                
                                                    
                                                        Antibody-Drug Conjugates (ADCs)
                                                    
                                                        Topoisomerase
                                                    
                                                        c-Met/HGFR
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Telisotuzumab Adizutecan (ABBV-400) is an anti- c-Met antibody-drug conjugate (ADC). Telisotuzumab Adizutecan consists of a humanized anti-c-Met antibody Telisotuzumab (HY-P99391), a stable and cleavable linker (TGA-Val-Ala-NH2-bicyclo[1.1.1]pentane), a topoisomerase 1 inhibitor (7-MAD-MDCPT) (HY-132162), and the drug-linker conjugate for ADC is TGA-Val-Ala-NH2-bicyclo[1.1.1]pentane-7-MAD-MDCPT (HY-171946). Telisotuzumab Adizutecan has a significant anti-tumor activity in advanced solid tumors, such as colorectal, gastric and non-small cell lung cancer  .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-N11698
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     Allopsoralen 
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                 | 
                                                
                                                    
                                                        Infection
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Bakuchicin (Allopsoralen) is a compound that can be found in Psoralea corylifolia. It has certain inhibitory activity against topoisomerase II. In the cell model infected with Simian virus 40 (SV40), the IC50 of Bakuchicin against topoisomerase II is 404 μM. Bakuchicin can be used in the research of the anti-infection field .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-121309S
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     Adriamycin aglycone-d3; Adriamycinone-d3 
                                                 | 
                                                
                                                    
                                                        Endogenous Metabolite
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Doxorubicinone-d3 is the deuterium labeled Doxorubicinone. Doxorubicinone is a metabolite of an anti-cancer chemotherapy agent Doxorubicin . Doxorubicin is a potent human?DNA topoisomerase I?and?topoisomerase II?inhibitor with?IC50s of 0.8 μM and 2.67 μM, respectively.
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-162959
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Bacterial
                                                    
                                                        Topoisomerase
                                                    
                                                        DNA/RNA Synthesis
                                                    
                                                 | 
                                                
                                                    
                                                        Infection
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    BWC0977 is a potent bacterial topoisomerase inhibitor that inhibits bacterial DNA replication via inhibition of DNA gyrase and topoisomerase IV. BWC0977 exhibits a minimum inhibitory concentration (MIC90) of 0.03-2 µg/mL against MDR (Multi-Drug Resistant) Gram-negative bacteria .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-106702A
 
                                    - 
                                        
                                    
 
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-13758
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     BMS-247615 
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    TAS-103 is a dual inhibitor of DNA topoisomerase I/II, used for cancer research.
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-13758A
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     BMS-247615 dihydrochloride 
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    TAS-103 dihydrochloride is a dual inhibitor of DNA topoisomerase I/II, used for cancer research.
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-W653896
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Isotope-Labeled Compounds
                                                    
                                                        Androgen Receptor
                                                    
                                                        Apoptosis
                                                    
                                                        Topoisomerase
                                                    
                                                        Estrogen Receptor/ERR
                                                    
                                                 | 
                                                
                                                    
                                                        Infection
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Alternariol-d2 is deuterium labeled Alternariol. Alternariol is an orally ingested mycotoxin produced by Alternaria, capable of inhibiting the activity of topoisomerase I and II (topoisomerase I, topoisomerase II). Alternariol has weak estrogenic (Estrogen Receptor/ERR) and androgen/antiandrogen (Androgen Receptor) effects. Alternariol can induce apoptosis, trigger cell cycle arrest, suppress innate immune responses, and exhibit anti-tumor activity. Alternariol has genotoxic, mutagenic, and endocrine-disrupting effects      .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-N6714R
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Reference Standards
                                                    
                                                        Topoisomerase
                                                    
                                                        Androgen Receptor
                                                    
                                                        Estrogen Receptor/ERR
                                                    
                                                        Apoptosis
                                                    
                                                 | 
                                                
                                                    
                                                        Infection
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Alternariol (Standard) is the analytical standard of Alternariol. This product is intended for research and analytical applications. Alternariol is an orally ingested mycotoxin produced by Alternaria, capable of inhibiting the activity of topoisomerase I and II (topoisomerase I, topoisomerase II). Alternariol has weak estrogenic (Estrogen Receptor/ERR) and androgen/antiandrogen (Androgen Receptor) effects. Alternariol can induce apoptosis, trigger cell cycle arrest, suppress innate immune responses, and exhibit anti-tumor activity. Alternariol has genotoxic, mutagenic, and endocrine-disrupting effects     .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-118590A
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                        DNA/RNA Synthesis
                                                    
                                                        Apoptosis
                                                    
                                                        Fungal
                                                    
                                                 | 
                                                
                                                    
                                                        Infection
                                                    
                                                        Cardiovascular Disease
                                                    
                                                        Inflammation/Immunology
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    ICRF-196 is an racemic mixture of the (S,S)- and (R,R)-isomers of ICRF-193 (HY-118590). ICRF-193 is a DNA Topoisomerase II inhibitor.  ICRF-193 can inhibit DNA syntheses and induces apoptosis. ICRF-193 exhibits anti-cancer and anti-inflammation effects. ICRF-193 shows cardioprotective effect against anthracycline toxicity to cardiomyocytes. ICRF-193 can be used for the researches of cancer, infection, inflammation and cardiovascular disease, such as acute promyelocytic leukemia      .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-147182
 
                                    - 
                                        
                                    
 
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-16562A
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     (+)-Irinotecan hydrochloride; CPT-11 hydrochloride;  VAL-413 
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                        Autophagy
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Irinotecan hydrochloride ((+)-Irinotecan hydrochloride) is a topoisomerase I inhibitor mainly used to treat colon cancer and rectal cancer .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-N2331
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Proscillaridin A is a potent poison of topoisomerase I/II activity with IC50 values of 30 nM and 100 nM, respectively .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-13618
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     J 107088;  PF 804950 
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Edotecarin is a potent inhibitor of topoisomerase I that can induces single-strand DNA cleavage, with IC50 of 50 nM.
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-121309R
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     Adriamycin aglycone (Standard); Adriamycinone (Standard) 
                                                 | 
                                                
                                                    
                                                        Reference Standards
                                                    
                                                        Endogenous Metabolite
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Doxorubicinone (Standard) is the analytical standard of Doxorubicinone. This product is intended for research and analytical applications. Doxorubicinone is a metabolite of an anti-cancer chemotherapy agent Doxorubicin . Doxorubicin is a potent human DNA topoisomerase I and topoisomerase II inhibitor with IC50s of 0.8 μM and 2.67 μM, respectively.
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-118590
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                        DNA/RNA Synthesis
                                                    
                                                        Apoptosis
                                                    
                                                        Fungal
                                                    
                                                 | 
                                                
                                                    
                                                        Infection
                                                    
                                                        Cardiovascular Disease
                                                    
                                                        Inflammation/Immunology
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    ICRF-193 is a DNA Topoisomerase II inhibitor. (S,S)- and (R,R)-isomers ICRF-193 make up an racemic mixture, ICRF-196 (HY-118590A). ICRF-193 can inhibit DNA syntheses and induces apoptosis. ICRF-193 exhibits anti-cancer and anti-inflammation effects. ICRF-193 shows cardioprotective effect against anthracycline toxicity to cardiomyocytes. ICRF-193 can be used for the researches of cancer, infection, inflammation and cardiovascular disease, such as acute promyelocytic leukemia      .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-13670A
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     GI147211 dihydrochloride; OSI-211 dihydrochloride 
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Lurtotecan dihydrochloride (GI147211), a semisynthetic Camptothecin analog, is a topoisomerase I inhibitor. Lurtotecan dihydrochloride has anticancer effects .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-13565
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     NSC 655649;  BMS 181176;  BMY 27557 
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Becatecarin is a rebeccamycin analog with antitumor effects. Becatecarin intercalates into DNA and inhibites the catalytic activity of topoisomerases I/II.
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-10982
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     AS1413 
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Amonafide is a topoisomerase II inhibitor and DNA intercalator that induces apoptotic signaling by blocking the binding of Topo II to DNA.
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-100309
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     9-Amino-20(S)-camptothecin;  9-Amino-CPT 
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    9-Aminocamptothecin (9-Amino-CPT) is a topoisomerase I inhibitor with potent anticancer activity .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-N0275
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     (±)-10-HCPT 
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    (±)-10-Hydroxycamptothecin is an indole alkaloid that inhibits the activity of topoisomerase I and has a broad spectrum of anticancer activity.
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-13551B
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     m-AMSA (gluconate);  Acridinyl anisidide (gluconate) 
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                        Autophagy
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Amsacrine gluconate is an inhibitor of topoisomerase II, and acts as an antineoplastic agent which can intercalates into the DNA of tumor cells.
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-13725
 
                                    - 
                                        
                                    
 
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-W897655
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     O-Acetylcamptothecin 
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                 | 
                                                
                                                    
                                                        Others
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    20-O-Acetylcamptothecin (O-Acetylcamptothecin) is a derivative of Camptothecin (HY-16560) and an inhibitor of Topoisomerase I .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-13726
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     Oxantrazole;  NCS 349174 
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Piroxantrone (Oxantrazole) is a potent DNA topoisomerase II-targeting anthrapyrazole antitumor agent. Piroxantrone displays cardiotoxicity  .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-13725A
 
                                    - 
                                        
                                    
 
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-173478
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                        Bacterial
                                                    
                                                        Antibiotic
                                                    
                                                 | 
                                                
                                                    
                                                        Infection
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    OSUAB-0284 is a bacterial topoisomerase inhibitor. OSUAB-0284 has significant anti-staphylococcal activity, especially against methicillin-resistant Staphylococcus aureus (MRSA). OSUAB-0284 exerts its antibacterial effect by inhibiting bacterial topoisomerase. OSUAB-0284 can be used to study infections caused by drug-resistant bacteria such as MRSA .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-117688
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        HDAC
                                                    
                                                        Topoisomerase
                                                    
                                                        Apoptosis
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    WJ35435 is a dual-targeted anticancer hybrid that induces anti-HDAC (in particular HDAC1 and HDAC6) and anti-topoisomerase I activities that causes DNA damage associated with a low DNA repair capability and induces cell cycle arrest at G1- and G2-phase to apoptosis. WJ35435 induces histone H3 acetylation and phosphorylation, α-tubulin acetylation and γ-H2AX formation to achieve anti-HDAC effect. WJ35435 is promising for research of cancer .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-U00248
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     MJ-III65;  NSC706744 
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    LMP744 (MJ-III65) is a DNA intercalator and Topoisomerase I (Top1) inhibitor with antitumor activity .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-N12747
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                 | 
                                                
                                                    
                                                        Others
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Dichlorogelignate (compound 4) is a selective inhibitor of topoisomerase II (Topo II). Dichlorogelignate has 100% inhibition at 50 μM .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-121649
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    AQ4 is a topoisomerase II inhibitor and DNA intercalator as a chemically stable cytotoxic agent in many human tumor lines .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-B0526
 
                                    - 
                                        
                                    
 
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-U00248A
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     MJ-III65 hydrochloride; NSC706744 hydrochloride 
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    LMP744 hydrochloride (MJ-III65 hydrochloride) is a DNA intercalator and Topoisomerase I (Top1) inhibitor with antitumor activity .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-120185
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     UCT-1003 
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                 | 
                                                
                                                    
                                                        Infection
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Saintopin is an antitumor antibiotic. Saintopin is also an inhibitor of DNA topoisomerases I and II. Saintopin induces DNA cleavage  .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-15142
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     Hydroxydaunorubicin hydrochloride;  ADR 
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                        ADC Payload
                                                    
                                                        AMPK
                                                    
                                                        Autophagy
                                                    
                                                        Apoptosis
                                                    
                                                        HIV
                                                    
                                                        HBV
                                                    
                                                        Mitophagy
                                                    
                                                        Antibiotic
                                                    
                                                        Bacterial
                                                    
                                                 | 
                                                
                                                    
                                                        Infection
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Doxorubicin hydrochloride (Hydroxydaunorubicin hydrochloride; ADR), a cytotoxic anthracycline antibiotic, is an anti-cancer chemotherapy agent. Doxorubicin hydrochloride is a potent human DNA topoisomerase I and topoisomerase II inhibitor with IC50s of 0.8 μM and 2.67 μM, respectively. Doxorubicin hydrochloride reduces basal phosphorylation of AMPK and its downstream target acetyl-CoA carboxylase. Doxorubicin hydrochloride induces apoptosis and autophagy   .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-117657
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                        Bacterial
                                                    
                                                 | 
                                                
                                                    
                                                        Inflammation/Immunology
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    (-)-BO 2367, an antimicrobial quinolone, is a strong mammalian and bacterial topoisomerase II inhibitor. (-)-BO 2367 shows IC50 values with 3.8 μM, 0.5 μM, and 1 μM against the DNA relaxation activity of L1210 topoisomerase II and the supercoiling activities of Escherichia coli gyrase and Micrococcus luteus gyrase, respectively. (-)-BO 2367 is a potent antitumor agent .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-121309S1
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     Adriamycin aglycone-13C,d3;  Adriamycinone-13C,d3 
                                                 | 
                                                
                                                    
                                                        Isotope-Labeled Compounds
                                                    
                                                        Endogenous Metabolite
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Doxorubicinone- 13C,d3 (Adriamycin aglycone- 13C,d3) is  13C labeled Doxorubicinone. Doxorubicinone is a metabolite of an anti-cancer chemotherapy agent Doxorubicin . Doxorubicin is a potent human DNA topoisomerase I and topoisomerase II inhibitor with IC50s of 0.8 μM and 2.67 μM, respectively.
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-13551
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     m-AMSA;  acridinyl anisidide 
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                        Autophagy
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Amsacrine (m-AMSA; acridinyl anisidide) is an inhibitor of topoisomerase II, and acts as an antineoplastic agent which can intercalates into the DNA of tumor cells.
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-16518
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     SNS-595 Hydrochloride;  Vosaroxin Hydrochloride;  AG 7352 Hydrochloride 
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                        Apoptosis
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Voreloxin Hydrochloride is a first-in-class topoisomerase II inhibitor that intercalates DNA and induces site-selective DNA DSB, G2 arrest, and apoptosis.
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-16261B
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     (E/Z)-Aldoxorubicin hydrochloride; Doxorubicin(6-maleimidocaproyl)hydrazone hydrochloride 
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                        Drug-Linker Conjugates for ADC
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    MC-DOXHZN ((E/Z)-Aldoxorubicin) hydrochloride is an albumin-binding proagent of Doxorubicin (DNA topoisomerase II inhibitor), with acid-sensitive properties .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-126142
 
                                    - 
                                        
                                    
 
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-17381
 
                                    - 
                                        
                                    
 
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-13551A
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     m-AMSA hydrochloride;  acridinyl anisidide hydrochloride 
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                        Autophagy
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Amsacrine hydrochloride (m-AMSA hydrochloride; acridinyl anisidide hydrochloride) is an inhibitor of topoisomerase II, and acts as an antineoplastic agent which can intercalates into the DNA of tumor cells.
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-13670
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     GI147211;  OSI-211 
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Lurtotecan (GI147211; OSI-211), a semisynthetic Camptothecin analog, is a topoisomerase I inhibitor. Lurtotecan has anticancer effects .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-18258
 
                                    - 
                                        
                                    
 
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-13562A
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     AQ4N dihydrochloride 
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Banoxantrone dihydrochloride is a novel bioreductive agent that can be reduced to a stable, DNA-affinic compound AQ4, which is a potent topoisomerase II inhibitor.
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-16261A
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     (E/Z)-Aldoxorubicin;  Doxorubicin(6-maleimidocaproyl)hydrazone 
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                        Drug-Linker Conjugates for ADC
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    MC-DOXHZN ((E/Z)-Aldoxorubicin) is an albumin-binding proagent of Doxorubicin (DNA topoisomerase II inhibitor), with acid-sensitive properties .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-10581A
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     AM-1155 hydrochloride; BMS-206584 hydrochloride; PD135432 hydrochloride 
                                                 | 
                                                
                                                    
                                                        Bacterial
                                                    
                                                        Topoisomerase
                                                    
                                                        Antibiotic
                                                    
                                                 | 
                                                
                                                    
                                                        Infection
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Gatifloxacin hydrochloride (AM-1155; BMS-206584; PD135432) is a potent fluoroquinolone antibiotic with broad-spectrum antibacterial activity. Gatifloxacin hydrochloride inhibits bacterial type II topoisomerases (IC50=13.8 μg/ml for S. aureus topoisomerase IV) and E. coli DNA gyrase (IC50 = 0.109 μg/ml) . Gatifloxacin hydrochloride can be used to treat bacterial conjunctivitis in vivo.
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-10581B
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     AM-1155 mesylate; BMS-206584 mesylate; PD135432 mesylate 
                                                 | 
                                                
                                                    
                                                        Bacterial
                                                    
                                                        Topoisomerase
                                                    
                                                        Antibiotic
                                                    
                                                 | 
                                                
                                                    
                                                        Infection
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Gatifloxacin mesylate (AM-1155; BMS-206584; PD135432) is a potent fluoroquinolone antibiotic with broad-spectrum antibacterial activity. Gatifloxacin mesylate inhibits bacterial type II topoisomerases (IC50=13.8 μg/ml for S. aureus topoisomerase IV) and E. coli DNA gyrase (IC50 = 0.109 μg/ml) . Gatifloxacin mesylate can be used to treat bacterial conjunctivitis in vivo.
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-15552S
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Microtubule/Tubulin
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Podofilox-d6 is the deuterium labeled Podofilox. Podofilox (Podophyllotoxin) is a potent inhibitor of microtubule assembly and DNA topoisomerase II  .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-168150
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Topoisomerase I/II inhibitor 5 (compund 1) simultaneously inhibits activities of TopoI and II by binding to and stabilizing the G4 structure .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-19637
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    SW044248 is a non-canonical topoisomerase I inhibitor, and selectively toxic for certain non-small cell lung cancer (NSCLC) cell lines.
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-13550
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     NSC 196473;  NSC 290813 
                                                 | 
                                                
                                                    
                                                        DNA/RNA Synthesis
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Ametantrone (NSC 196473) is an antitumor agent that intercalates into DNA and induces topoisomerase II (TOP2)-mediated DNA break .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-10581
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     AM-1155;  BMS-206584;  PD135432 
                                                 | 
                                                
                                                    
                                                        Bacterial
                                                    
                                                        Topoisomerase
                                                    
                                                        Antibiotic
                                                    
                                                 | 
                                                
                                                    
                                                        Infection
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Gatifloxacin (AM-1155; BMS-206584; PD135432) is a potent fluoroquinolone antibiotic with broad-spectrum antibacterial activity. Gatifloxacin inhibits bacterial type II topoisomerases (IC50=13.8 μg/ml for S. aureus topoisomerase IV) and E. coli DNA gyrase (IC50=0.109 μg/ml) . Gatifloxacin can be used to treat bacterial conjunctivitis in vivo.
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-10581C
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     AM-1155 sesquihydrate; BMS-206584 sesquihydrate; PD135432 sesquihydrate 
                                                 | 
                                                
                                                    
                                                        Bacterial
                                                    
                                                        Topoisomerase
                                                    
                                                        Antibiotic
                                                    
                                                 | 
                                                
                                                    
                                                        Infection
                                                    
                                                        Inflammation/Immunology
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Gatifloxacin sesquihydrate (AM-1155; BMS-206584; PD135432) is a potent fluoroquinolone antibiotic with broad-spectrum antibacterial activity. Gatifloxacin sesquihydrate inhibits bacterial type II topoisomerases (IC50=13.8 μg/ml for S. aureus topoisomerase IV) and E. coli DNA gyrase (IC50 = 0.109 μg/ml) . Gatifloxacin sesquihydrate can be used to treat bacterial conjunctivitis in vivo.
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-122575
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        P2X Receptor
                                                    
                                                        Influenza Virus
                                                    
                                                        Topoisomerase
                                                    
                                                        MicroRNA
                                                    
                                                        Apoptosis
                                                    
                                                 | 
                                                
                                                    
                                                        Infection
                                                    
                                                        Neurological Disease
                                                    
                                                        Inflammation/Immunology
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Aurintricarboxylic acid is a nanomolar-potency, allosteric antagonist with selectivity towards αβ-methylene-ATP-sensitive P2X1Rs and P2X3Rs, with IC50s of 8.6 nM and 72.9 nM for rP2X1R and rP2X3R, respectively . Aurintricarboxylic acid is a potent anti-influenza agent by directly inhibiting the neuraminidase . Aurintricarboxylic acid is an inhibitor of topoisomerase II and apoptosis . Aurintricarboxylic acid is a selective inhibitor of the TWEAK-Fn14 signaling pathway . Aurintricarboxylic acid also acts as a cystathionine-lyase (CSE) inhibitor with an IC50 of 0.6 μM . Aurintricarboxylic acid is a modifier of miRNAs that regulate miRNA function, with an IC50 of 0.47 µM .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-15552R
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     Podophyllotoxin (Standard) 
                                                 | 
                                                
                                                    
                                                        Reference Standards
                                                    
                                                        Microtubule/Tubulin
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Podofilox (Standard) is the analytical standard of Podofilox. This product is intended for research and analytical applications. Podofilox (Podophyllotoxin) is a potent inhibitor of microtubule assembly and DNA topoisomerase II.
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-13631
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     DX-8951 
                                                 | 
                                                
                                                    
                                                        ADC Payload
                                                    
                                                        Topoisomerase
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Exatecan (DX-8951) is a DNA topoisomerase I inhibitor, with an IC50 of 2.2 μM (0.975 μg/mL), and can be used in cancer research.
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-116063
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Drug-Linker Conjugates for ADC
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Doxorubicin-SMCC is a agent-linker conjugate for ADC. Doxorubicin-SMCC contains a non-cleavable ADC linker and a DNA topoisomerase II inhibitor Doxorubicin .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-13768AR
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     SKF 104864A hydrochloride (Standard); NSC 609669 hydrochloride (Standard) 
                                                 | 
                                                
                                                    
                                                        Reference Standards
                                                    
                                                        Topoisomerase
                                                    
                                                        Autophagy
                                                    
                                                        Apoptosis
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Topotecan (hydrochloride) (Standard) is the analytical standard of Topotecan (hydrochloride). This product is intended for research and analytical applications. Topotecan Hydrochloride (SKF 104864A Hydrochloride) is a Topoisomerase I inhibitor with potent antineoplastic activities.
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-13566AS
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Belotecan-d7 (hydrochloride) is the deuterium labeled Belotecan hydrochloride. Belotecan hydrochloride (CKD-602 hydrochloride), a Topoisomerase I inhibitor, is a synthetic camptothecin derivative  .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-146816
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                 | 
                                                
                                                    
                                                        Infection
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    NBTIs-IN-6 is a bacterial topoisomerase inhibitor with certain antibacterial activity. Among them, the MIC90 for fluoroquinolone-resistant MRSA was 2 μg/mL .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-143279
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                        Apoptosis
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Topoisomerase II inhibitor 3 (Compound 6 h ) is a acridone derivatives, as well as a Type II DNA topoisomerase (topo II) inhibitor , as a topo IIα/β inhibitor with the value of IC50 is 0.17 μM for topo IIα and the value of IC50 is 0.23 μM for topo IIβ subtypes, caused obvious DNA damage, and induced apoptosis by triggering the loss of mitochondrial membrane potential .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-128959
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Drug-Linker Conjugates for ADC
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    MCC-Modified Daunorubicinol is a drug-Linker conjugates for ADC, which is composed of Modified Daunorubicinol (DNA topoisomerase II inhibitor) and MCC (ADC linker) linked .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-13631A
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     DX8951f 
                                                 | 
                                                
                                                    
                                                        ADC Payload
                                                    
                                                        Topoisomerase
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Exatecan mesylate (DX8951f) is a DNA topoisomerase I inhibitor, with an IC50 of 2.2 μM (0.975 μg/mL). Exatecan mesylate can be used in cancer research.
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-42487
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        ADC Payload
                                                    
                                                        Topoisomerase
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Exatecan Intermediate 1 (compound 6) is an intermediate of Exatecan (HY-13631). Exatecan  is a DNA topoisomerase I inhibitor with anticancer effects   .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-13761R
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     VM26 (Standard) 
                                                 | 
                                                
                                                    
                                                        Reference Standards
                                                    
                                                        Topoisomerase
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Teniposide (Standard) is the analytical standard of Teniposide. This product is intended for research and analytical applications. Teniposide is a podophyllotoxin derivative, acts as a topoisomerase II inhibitor, and used as a chemotherapeutic agent.
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-17577
 
                                    - 
                                        
                                    
 
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-16742R
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     GSK2140944 (Standard) 
                                                 | 
                                                
                                                    
                                                        Reference Standards
                                                    
                                                        Antibiotic
                                                    
                                                        Bacterial
                                                    
                                                        Topoisomerase
                                                    
                                                 | 
                                                
                                                    
                                                        Infection
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Gepotidacin (Standard) is the analytical standard of Gepotidacin. This product is intended for research and analytical applications. Gepotidacin (GSK2140944) is a novel triazaacenaphthylene bacterial type II topoisomerase inhibitor.
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-10581AS
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     AM-1155-d3 hydrochloride; BMS-206584-d3 hydrochloride; PD135432-d3 hydrochloride 
                                                 | 
                                                
                                                    
                                                        Isotope-Labeled Compounds
                                                    
                                                        Bacterial
                                                    
                                                        Topoisomerase
                                                    
                                                        Antibiotic
                                                    
                                                 | 
                                                
                                                    
                                                        Infection
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Gatifloxacin-d3 (hydrochloride) is the deuterium labeled Gatifloxacin (hydrochloride). Gatifloxacin hydrochloride (AM-1155; BMS-206584; PD135432) is a potent fluoroquinolone antibiotic with broad-spectrum antibacterial activity. Gatifloxacin hydrochloride inhibits bacterial type II topoisomerases (IC50=13.8 μg/ml for S. aureus topoisomerase IV) and E. coli DNA gyrase (IC50 = 0.109 μg/ml). Gatifloxacin hydrochloride can be used to treat bacterial conjunctivitis in vivo.
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-N6880
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     (+)-Rabdosiin 
                                                 | 
                                                
                                                    
                                                        Drug Derivative
                                                    
                                                 | 
                                                
                                                    
                                                        Others
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Rabdosiin ((+)-Rabdosiin) is a Caffeic acid (HY-N0172) tetramer. Rabdosiin can be isolated from Macrotomia euchroma  .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-170580
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Topo I/II-IN-1 (compound 7t) is a potent Topo I and Topo II dual inhibitor. Topo I/II-IN-1 exhibits significant cytotoxicity against MCF-7 breast cancer cell line with an IC50 of 7.45 μM .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-15753R
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Ellipticine (Standard) is the analytical standard of Ellipticine. This product is intended for research and analytical applications. Ellipticine (NSC 71795) is a potent antineoplastic agent; inhibits DNA topoisomerase II activities.
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-13745
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     MEN 10755 
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Sabarubicin is a doxorubicin disaccharide analogue with striking antitumor activity. Sabarubicin is more effective than doxorubicin as a topoisomerase II poison and stimulated DNA fragmentation at lower intracellular concentrations.
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-N8745
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Fungal
                                                    
                                                 | 
                                                
                                                    
                                                        Others
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    α-Peltatin is an aryl lignan. α-Peltatin has anticancer and antifungal activity. α-Peltatin inhibits DNA topoisomerase and tubulin polymerization  .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-122139
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Bacterial
                                                    
                                                 | 
                                                
                                                    
                                                        Infection
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Desethylene Ciprofloxacin hydrochloride is a major metabolite of Ciprofloxacin (HY-B0356). Ciprofloxacin is an orally active topoisomerase IV inhibitor. Desethylene Ciprofloxacin hydrochloride has antibacterial activity .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-160806
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                        ADC Payload
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    (5-Cl)-Exatecan (compound 1-5) is a potent DNA topoisomerase inhibitor used in cancer research. (5-Cl)-Exatecan is an ADC Cytotoxin .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-132923
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Bacterial
                                                    
                                                 | 
                                                
                                                    
                                                        Infection
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    NBTIs-IN-4 demonstrates potent antibacterial activity against diverse Gram-positive pathogens, inhibition of both DNA gyrase and topoisomerase IV, a low frequency of resistance.
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-15753AR
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Ellipticine (hydrochloride) (Standard) is the analytical standard of Ellipticine (hydrochloride). This product is intended for research and analytical applications. Ellipticine (NSC 71795) hydrochloride is a potent antineoplastic agent; inhibits DNA topoisomerase II activities.
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-123393
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                 | 
                                                
                                                    
                                                        Others
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    PNU-142586 is the major metabolite of Linezolid (HY-10394). PNU-142586 can inhibit the activity of DNA topoisomerase 2-α (TOP2A) and DNA topoisomerase 2-β (TOP2B). PNU-142586 interferes with DNA replication and transcription by blocking the binding of DNA to TOP2 and inhibiting ATP hydrolysis. PNU-142586 can be used to study Linezolid-induced hematotoxicity and its molecular mechanism .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-10581AR
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     AM-1155 hydrochloride (Standard); BMS-206584 hydrochloride (Standard); PD135432 hydrochloride (Standard) 
                                                 | 
                                                
                                                    
                                                        Reference Standards
                                                    
                                                        Bacterial
                                                    
                                                        Topoisomerase
                                                    
                                                        Antibiotic
                                                    
                                                 | 
                                                
                                                    
                                                        Infection
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Gatifloxacin (hydrochloride) (Standard) is the analytical standard of Gatifloxacin (hydrochloride). This product is intended for research and analytical applications. Gatifloxacin hydrochloride (AM-1155; BMS-206584; PD135432) is a potent fluoroquinolone antibiotic with broad-spectrum antibacterial activity. Gatifloxacin hydrochloride inhibits bacterial type II topoisomerases (IC50=13.8 μg/ml for S. aureus topoisomerase IV) and E. coli DNA gyrase (IC50 = 0.109 μg/ml)[1]. Gatifloxacin hydrochloride can be used to treat bacterial conjunctivitis in vivo.
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-15142A
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     Hydroxydaunorubicin 
                                                 | 
                                                
                                                    
                                                        ADC Payload
                                                    
                                                        Antibiotic
                                                    
                                                        Bacterial
                                                    
                                                        Topoisomerase
                                                    
                                                        AMPK
                                                    
                                                        HIV
                                                    
                                                        Autophagy
                                                    
                                                        Mitophagy
                                                    
                                                        Apoptosis
                                                    
                                                        HBV
                                                    
                                                 | 
                                                
                                                    
                                                        Infection
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Doxorubicin (Hydroxydaunorubicin), a  broad-spectrum anthracycline antibiotic with cytotoxic properties, is an anti-cancer chemotherapy agent. Doxorubicin has fluorescence properties. Doxorubicin inhibits topoisomerase II with an IC50 of 2.67 μM, thus stopping DNA replication. Doxorubicin reduces basal phosphorylation of AMPK and its downstream target acetyl-CoA carboxylase. Doxorubicin induces apoptosis and autophagy  . Doxorubicin inhibits human DNA topoisomerase I with an IC50 of 0.8 μM .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-15142R
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     Hydroxydaunorubicin hydrochloride (Standard); ADR (Standard) 
                                                 | 
                                                
                                                    
                                                        Reference Standards
                                                    
                                                        Topoisomerase
                                                    
                                                        ADC Payload
                                                    
                                                        AMPK
                                                    
                                                        Autophagy
                                                    
                                                        Apoptosis
                                                    
                                                        HIV
                                                    
                                                        HBV
                                                    
                                                        Mitophagy
                                                    
                                                        Antibiotic
                                                    
                                                        Bacterial
                                                    
                                                 | 
                                                
                                                    
                                                        Infection
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Doxorubicin hydrochloride (Standard) is the analytical standard of Doxorubicin hydrochloride. This product is intended for research and analytical applications. Doxorubicin (Hydroxydaunorubicin) hydrochloride, a cytotoxic anthracycline antibiotic, is an anti-cancer chemotherapy agent. Doxorubicin hydrochloride is a potent human DNA topoisomerase I and topoisomerase II inhibitor with IC50s of 0.8 μM and 2.67 μM, respectively. Doxorubicin hydrochloride reduces basal phosphorylation of AMPK and its downstream target acetyl-CoA carboxylase. Doxorubicin hydrochloride induces apoptosis and autophagy   .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-N7066
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Bacterial
                                                    
                                                        Antibiotic
                                                    
                                                 | 
                                                
                                                    
                                                        Infection
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Difloxacin hydrochloride is a broad-spectrum antibacterial agent. Difloxacin hydrochloride inhibits bacterial DNA gyrase and exhibits a concentration-dependant bactericidal effect by interference with the activity of DNA gyrase and topoisomerase IV .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-111630
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    PluriSIn #2 is a selective transcriptional inhibitor of topoisomerase II α (TOP2A). PluriSIn #2 is a compound that selectively eliminates undifferentiated human pluripotent stem cells (hPSCs) .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-120173
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                 | 
                                                
                                                    
                                                        Others
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Ro 47-3359 is a pyrimido[1,6-a]benzimidazole compound with the activity of enhancing eukaryotic topoisomerase II-mediated DNA cleavage and being toxic to Kc cells.
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-16568R
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     (+)-Irinotecan hydrochloride trihydrate (Standard); CPT-11 hydrochloride trihydrate (Standard) 
                                                 | 
                                                
                                                    
                                                        Reference Standards
                                                    
                                                        Topoisomerase
                                                    
                                                        Autophagy
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Irinotecan (hydrochloride trihydrate) (Standard) is the analytical standard of Irinotecan (hydrochloride trihydrate). This product is intended for research and analytical applications. Irinotecan hydrochloride trihydrate ((+)-Irinotecan hydrochloride trihydrate) is a topoisomerase I inhibitor with antitumor activity .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-173001
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    AuL1 is an inhibitor of topoisomerase IIα (Top II) with DNA-intercalating properties. AuL1 is cytotoxic to tumor cells and can be used in the research of anticancer agents .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-N2063
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                 | 
                                                
                                                    
                                                        Others
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    12-Ethyl-9-hydroxycamptothecin is a derivative of Camptothecin. Camptothecin (CPT), a kind of alkaloid, is a DNA topoisomerase I (Topo I) inhibitor with an IC50 of 679 nM .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-13631P
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     DX-8951 mesylate dihydrate 
                                                 | 
                                                
                                                    
                                                        ADC Payload
                                                    
                                                        Topoisomerase
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Exatecan (DX-8951) mesylate dihydrate is a DNA topoisomerase I inhibitor, with an IC50 of 2.2 μM (0.975 μg/mL), and can be used in cancer research   .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-N2331R
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Reference Standards
                                                    
                                                        Topoisomerase
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Proscillaridin A (Standard) is the analytical standard of Proscillaridin A. This product is intended for research and analytical applications. Proscillaridin A is a potent poison of topoisomerase I/II activity with IC50 values of 30 nM and 100 nM, respectively .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-N2198
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                        Apoptosis
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Podocarpusflavone A is a DNA topoisomerase I inhibitor. Podocarpusflavone A has moderated anti-proliferative activity and  induces cell apoptosis in MCF-7. Podocarpusflavone A is developing anti-tumor agents .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-10534
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     SNS-595;  Vosaroxin;  AG 7352 
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                        Apoptosis
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Voreloxin (SNS-595; Vosaroxin; AG 7352) is a first-in-class topoisomerase II inhibitor that intercalates DNA and induces site-selective DNA DSB, G2 arrest, and apoptosis.
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-16562AR
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     (+)-Irinotecan hydrochloride (Standard); CPT-11 hydrochloride (Standard); VAL-413 (Standard) 
                                                 | 
                                                
                                                    
                                                        Reference Standards
                                                    
                                                        Topoisomerase
                                                    
                                                        Autophagy
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Irinotecan (hydrochloride) (Standard) is the analytical standard of Irinotecan (hydrochloride). This product is intended for research and analytical applications. Irinotecan hydrochloride ((+)-Irinotecan hydrochloride) is a topoisomerase I inhibitor mainly used to treat colon cancer and rectal cancer .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-16562AS
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     (+)-Irinotecan-d5 hydrochloride; CPT-11-d5 hydrochloride;  VAL-413-d5 
                                                 | 
                                                
                                                    
                                                        Autophagy
                                                    
                                                        Topoisomerase
                                                    
                                                        Isotope-Labeled Compounds
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Irinotecan-d5 hydrochloride is deuterated labeled Irinotecan hydrochloride (HY-16562A). Irinotecan hydrochloride ((+)-Irinotecan hydrochloride) is a topoisomerase I inhibitor mainly used to treat colon cancer and rectal cancer .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-16472R
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Reference Standards
                                                    
                                                        Antibiotic
                                                    
                                                        Bacterial
                                                    
                                                 | 
                                                
                                                    
                                                        Infection
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Irinotecan (hydrochloride) (Standard) is the analytical standard of Irinotecan (hydrochloride). This product is intended for research and analytical applications. Irinotecan hydrochloride ((+)-Irinotecan hydrochloride) is a topoisomerase I inhibitor mainly used to treat colon cancer and rectal cancer .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-146228
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        HSP
                                                    
                                                        Apoptosis
                                                    
                                                        Topoisomerase
                                                    
                                                        EGFR
                                                    
                                                        VEGFR
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    HSP90-IN-13 (compound 5k) is a highly potent HSP90 pan inhibitor with an IC50 value of 25.07 nM. HSP90-IN-13 has multi-target activity against EGFR, VEGFR-2 and Topoisomerase-2. HSP90-IN-13 causes cell cycle arrest at G2/M phase and induces apoptosis of MCF-7 cells through mitochondrial-mediated pathway .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-161628
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Tapcin is a dual inhibitor for topoisomerase I and topoisomerase II, with IC50 of 203 and 71 nM. Tapcin inhibits proliferations of cancer cells A-375, HeLa, Huh7.5, U2-OS, A549, Caco-2 and HT29, with IC50s of 441, 1.04, 40.5, 0.002, 0.006, 0.287 and 0.842 nM, respectively. Tapcin exhibits antitumor activity in HT29 xenograft model .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-170567
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                        Bacterial
                                                    
                                                        Antibiotic
                                                    
                                                 | 
                                                
                                                    
                                                        Infection
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    DNA gyrase/Topo IV-IN-1 (Compound 27) is an inhibitor of DNA gyrase and topoisomerase IV, exhibiting antibacterial activity. For Escherichia coli and methicillin-resistant Staphylococcus aureus DNA gyrases, DNA gyrase/Topo IV-IN-1 has an IC50 of 11 and 17 nM respectively, and for topoisomerase IV of Escherichia coli and methicillin-resistant Staphylococcus aureus, the IC50 values are 83 and 21 nM respectively. DNA gyrase/Topo IV-IN-1 can be used for research in the field of anti-infection .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-10581R
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     AM-1155 (Standard); BMS-206584 (Standard); PD135432 (Standard) 
                                                 | 
                                                
                                                    
                                                        Reference Standards
                                                    
                                                        Bacterial
                                                    
                                                        Topoisomerase
                                                    
                                                        Antibiotic
                                                    
                                                 | 
                                                
                                                    
                                                        Infection
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Gatifloxacin (Standard) is the analytical standard of Gatifloxacin. This product is intended for research and analytical applications. Gatifloxacin (AM-1155; BMS-206584; PD135432) is a potent fluoroquinolone antibiotic with broad-spectrum antibacterial activity. Gatifloxacin inhibits bacterial type II topoisomerases (IC50=13.8 μg/ml for S. aureus topoisomerase IV) and E. coli DNA gyrase (IC50=0.109 μg/ml) . Gatifloxacin can be used to treat bacterial conjunctivitis in vivo.
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-10581CR
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     AM-1155 sesquihydrate (Standard); BMS-206584 sesquihydrate (Standard); PD135432 sesquihydrate (Standard) 
                                                 | 
                                                
                                                    
                                                        Reference Standards
                                                    
                                                        Bacterial
                                                    
                                                        Topoisomerase
                                                    
                                                        Antibiotic
                                                    
                                                 | 
                                                
                                                    
                                                        Infection
                                                    
                                                        Inflammation/Immunology
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Gatifloxacin (sesquihydrate) (Standard) is the analytical standard of Gatifloxacin (sesquihydrate). This product is intended for research and analytical applications. Gatifloxacin sesquihydrate (AM-1155; BMS-206584; PD135432) is a potent fluoroquinolone antibiotic with broad-spectrum antibacterial activity. Gatifloxacin sesquihydrate inhibits bacterial type II topoisomerases (IC50=13.8 μg/ml for S. aureus topoisomerase IV) and E. coli DNA gyrase (IC50 = 0.109 μg/ml) . Gatifloxacin sesquihydrate can be used to treat bacterial conjunctivitis?in vivo.
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-13562AS
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     AQ4N-d12 dihydrochloride 
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Banoxantrone-d12 (dihydrochloride)  is the deuterium labeled Banoxantrone dihydrochloride. Banoxantrone is a novel bioreductive agent that can be reduced to a stable, DNA-affinic compound AQ4, which is a potent topoisomerase II inhibitor.
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-121866
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Hippeastrine hydrobromide is an active alkaloid that exhibits a good dose-dependent inhibitory effect on topoisomerase I (Top I) with an IC50 of 7.25 μg/mL. Hippeastrine hydrobromide exhibits antiproliferative and anticancer activities.
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-13555
 
                                    - 
                                        
                                    
 
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-123143
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     MLN576 
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    XR11576 (MLN576) is an orally active inhibitor of topoisomerase I and II. XR11576 shows cytotoxicity against human and murine tumor cell lines (IC50: 6-47 nM) .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-13562S
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     AQ4N d12 
                                                 | 
                                                
                                                    
                                                        Isotope-Labeled Compounds
                                                    
                                                        Topoisomerase
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Banoxantrone-d12 is the deuterium labeled banoxantrone. Banoxantrone is a novel bioreductive agent that can be reduced to a stable, DNA-affinic compound AQ4, which is a potent topoisomerase II inhibitor.
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-160807
 
                                    - 
                                        
                                    
 
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-109855
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                        Antibiotic
                                                    
                                                        Bacterial
                                                    
                                                 | 
                                                
                                                    
                                                        Infection
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    CP-67015, a quinolone antibiotic, is a potent topoisomerase II inhibitor. CP-67015 is a positive direct-acting mutagen in mammalian cells with both gene and chromosomal level effects .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-10982R
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Amonafide (Standard) is the analytical standard of Amonafide. This product is intended for research and analytical applications. Amonafide is a topoisomerase II inhibitor and DNA intercalator that induces apoptotic signaling by blocking the binding of Topo II to DNA.
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-18258S
 
                                    - 
                                        
                                    
 
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-100875A
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     CL-216942 dihydrochloride 
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Bisantrene dihydrochloride is a highly effective antitumor agent, it exerts its cytotoxicity by affecting DNA intercalation. Bisantrene dihydrochloride targets eukaryotic type II topoisomerases. Bisantrene dihydrochloride is a substrate of MDR1    .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-13725R
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     THP (Standard) 
                                                 | 
                                                
                                                    
                                                        Reference Standards
                                                    
                                                        Topoisomerase
                                                    
                                                        Autophagy
                                                    
                                                        Bacterial
                                                    
                                                        Antibiotic
                                                    
                                                 | 
                                                
                                                    
                                                        Infection
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Pirarubicin (Standard) is the analytical standard of Pirarubicin. This product is intended for research and analytical applications. Pirarubicin is an anthracycline antibiotics, acts as a topoisomerase II inhibitor, and is a widely used for treatment of various cancers, in particular, solid tumors.
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-145078
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Drug-Linker Conjugates for ADC
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    PNU-EDA-Gly5 is an oligo-glycine linker-payload for ADC synthesis, composed of a DNA topoisomerase I inhibitor PNU-159682 and a linker EDA-Gly5 .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-106662
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     Chloroquinoxaline;  NSC-339004 
                                                 | 
                                                
                                                    
                                                        Molecular Glues
                                                    
                                                        Topoisomerase
                                                    
                                                        Parasite
                                                    
                                                 | 
                                                
                                                    
                                                        Infection
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Chloroquinoxaline sulfonamide (Chloroquinoxaline), a structural analogue of sulfaquinoxaline, is a topoisomerase II alpha/beta poison. Chloroquinoxaline sulfonamide is used to control coccidiosis in poultry, rabbit, sheep, and cattle . Antitumor activity .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-100875
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     CL216942 
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Bisantrene is a highly effective antitumor agent, it exerts its cytotoxicity by affecting DNA intercalation. Bisantrene targets eukaryotic type II topoisomerases. Bisantrene is a substrate of MDR1    .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-U00441
 
                                    - 
                                        
                                            
                                                
                                                    
                                                        
                                                            DPBQ
                                                            
                                                        
                                                        
                                                            
                                                                
                                                                
                                                                
                                                                    1 Publications Verification 
                                                                
                                                             
                                                        
                                                     
                                                    
                                                 | 
                                                
                                                    
                                                        MDM-2/p53
                                                    
                                                        Apoptosis
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    DPBQ activates p53 and triggers apoptosis in a polyploid-specific manner, but does not inhibit topoisomerase or bind DNA. DPBQ elicits expression and phosphorylation of p53 and this effect is specific to tetraploid cells .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-13725AR
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     THP Hydrochloride (Standard) 
                                                 | 
                                                
                                                    
                                                        Reference Standards
                                                    
                                                        Topoisomerase
                                                    
                                                        Autophagy
                                                    
                                                        Bacterial
                                                    
                                                        Antibiotic
                                                    
                                                 | 
                                                
                                                    
                                                        Infection
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Pirarubicin (Hydrochloride) (Standard) is the analytical standard of Pirarubicin (Hydrochloride). This product is intended for research and analytical applications. Pirarubicin Hydrochloride is an anthracycline antibiotics, acts as a topoisomerase II inhibitor, and is a widely used for treatment of various cancers, in particular, solid tumors.
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-B0526S
 
                                    - 
                                        
                                    
 
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-160756A
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Drug-Linker Conjugates for ADC
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Val-Cit-Exatecan TFA is an agent-linker conjugate for ADC. Val-Cit-Exatecan TFA is composed of a DNA topoisomerase I Exatecan (HY-13631) and a cathepsin cleavable ADC linker .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-B0526R
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     R-802 (Standard) 
                                                 | 
                                                
                                                    
                                                        Reference Standards
                                                    
                                                        Bacterial
                                                    
                                                        Topoisomerase
                                                    
                                                        Antibiotic
                                                    
                                                 | 
                                                
                                                    
                                                        Infection
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Flumequine (Standard) is the analytical standard of Flumequine. This product is intended for research and analytical applications. Flumequine (R-802) is a quinolone antibiotic, and acts as a topoisomerase II inhibitor, with an IC50 of 15 μM (3.92 μg/mL).
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-13631D
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     Exatecan derivative for ADC 
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                        ADC Payload
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Dxd (Exatecan derivative for ADC) is a potent DNA topoisomerase I inhibitor, with an IC50 of 0.31 μM, used as a conjugated drug of HER2-targeting ADC (DS-8201a).
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-156848
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Drug-Linker Conjugates for ADC
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Fmoc-GGFG-DXd is a drug-linker conjugate for ADC. Fmoc-GGFG-DXd contains a ADC linker Fmoc-GGFG and a DNA topoisomerase I inhibitor DXd (HY-13631D) .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-118036
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                 | 
                                                
                                                    
                                                        Infection
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    ACT-387042 is a bacterial topoisomerase inhibitor with broad-spectrum activity against Gram-positive and Gram-negative bacteria, including methicillin-resistant Staphylococcus aureus and penicillin- and fluoroquinolone-resistant Streptococcus pneumoniae  .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-10529
 
                                    - 
                                        
                                    
 
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-W015490R
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        DNA/RNA Synthesis
                                                    
                                                        NF-κB
                                                    
                                                        Monoamine Oxidase
                                                    
                                                        TNF Receptor
                                                    
                                                        Bacterial
                                                    
                                                 | 
                                                
                                                    
                                                        Infection
                                                    
                                                        Inflammation/Immunology
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    1,4-Naphthoquinone is an inhibitor with broad-spectrum inhibitory activity targeting DNA polymerase, NF-κB and monoamine oxidase (MAO-A/B), with antibacterial and anti-biofilm efficacy. 1,4-Naphthoquinone is a competitive inhibitor of MAO-B (Ki=1.4 μM) and a non-competitive inhibitor of MAO-A (Ki=7.7 μM). 1,4-Naphthoquinone inhibits DNA polymerase pol α, β, γ, δ, ε, λ with IC50 ranging from 5.57-128 μM. 1,4-Naphthoquinone inhibits tumor cell proliferation, induces apoptosis and necrosis, and has anti-angiogenic and anti-inflammatory activities by inducing oxidative stress, depleting glutathione (GSH), inhibiting DNA polymerase-mediated DNA synthesis and blocking NF-κB nuclear translocation. 1,4-Naphthoquinone can be used in anti-bacterial , anti-tumor and anti-inflammatory studies, including inhibition of melanoma and colon cancer cell growth and endothelial cell function, as well as LPS-induced inflammation models     .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-122550
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Keap1-Nrf2
                                                    
                                                        Topoisomerase
                                                    
                                                        Apoptosis
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Artemisitene, a natural derivative of Artemisinin, is a Nrf2 activator with antioxidant and anticancer activities. Artemisitene activates Nrf2 by decreasing Nrf2 ubiquitination and increasing its stability  .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-W015490
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        DNA/RNA Synthesis
                                                    
                                                        NF-κB
                                                    
                                                        Monoamine Oxidase
                                                    
                                                        TNF Receptor
                                                    
                                                        Bacterial
                                                    
                                                 | 
                                                
                                                    
                                                        Infection
                                                    
                                                        Inflammation/Immunology
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    1,4-Naphthoquinone is an inhibitor with broad-spectrum inhibitory activity targeting DNA polymerase, NF-κB and monoamine oxidase (MAO-A/B), with antibacterial and anti-biofilm efficacy. 1,4-Naphthoquinone is a competitive inhibitor of MAO-B (Ki=1.4 μM) and a non-competitive inhibitor of MAO-A (Ki=7.7 μM). 1,4-Naphthoquinone inhibits DNA polymerase pol α, β, γ, δ, ε, λ with IC50 ranging from 5.57-128 μM. 1,4-Naphthoquinone inhibits tumor cell proliferation, induces apoptosis and necrosis, and has anti-angiogenic and anti-inflammatory activities by inducing oxidative stress, depleting glutathione (GSH), inhibiting DNA polymerase-mediated DNA synthesis and blocking NF-κB nuclear translocation. 1,4-Naphthoquinone can be used in anti-bacterial , anti-tumor and anti-inflammatory studies, including inhibition of melanoma and colon cancer cell growth and endothelial cell function, as well as LPS-induced inflammation models     .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-147729
 
                                    - 
                                        
                                    
 
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-17381R
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     4-Demethoxydaunorubicin hydrochloride (Standard) 
                                                 | 
                                                
                                                    
                                                        Reference Standards
                                                    
                                                        Topoisomerase
                                                    
                                                        Bacterial
                                                    
                                                        Fungal
                                                    
                                                        Autophagy
                                                    
                                                        Antibiotic
                                                    
                                                        DNA/RNA Synthesis
                                                    
                                                        c-Myc
                                                    
                                                 | 
                                                
                                                    
                                                        Infection
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Idarubicin (hydrochloride) (Standard) is the analytical standard of Idarubicin (hydrochloride). This product is intended for research and analytical applications. Idarubicin hydrochloride is an anthracycline antileukemic agent. It inhibits the topoisomerase II interfering with the replication of DNA and RNA transcription. Idarubicin hydrochloride inhibits the growth of bacteria and yeasts.
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-16055
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     AR-67;  DB 67 
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Silatecan (AR-67; DB 67) is a Camptothecin (HY-16560) analogue with improved stability and lipophilicity. Silatecan is an inhibitor for topoisomerase I, that inhibits the DNA replication and transcription, and exhibits antitumor and radiosensitizing activities 
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-13551AR
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                        Autophagy
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Amsacrine (hydrochloride) (Standard) is the analytical standard of Amsacrine (hydrochloride). This product is intended for research and analytical applications. Amsacrine hydrochloride (m-AMSA hydrochloride; acridinyl anisidide hydrochloride) is an inhibitor of topoisomerase II, and acts as an antineoplastic agent which can intercalates into the DNA of tumor cells.
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-13551R
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     m-AMSA (Standard); acridinyl anisidide (Standard) 
                                                 | 
                                                
                                                    
                                                        Reference Standards
                                                    
                                                        Topoisomerase
                                                    
                                                        Autophagy
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Amsacrine (Standard) is the analytical standard of Amsacrine. This product is intended for research and analytical applications. Amsacrine (m-AMSA; acridinyl anisidide) is an inhibitor of topoisomerase II, and acts as an antineoplastic agent which can intercalates into the DNA of tumor cells.
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-13562AR
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Banoxantrone (dihydrochloride) (Standard) is the analytical standard of Banoxantrone (dihydrochloride). This product is intended for research and analytical applications. Banoxantrone dihydrochloride is a novel bioreductive agent that can be reduced to a stable, DNA-affinic compound AQ4, which is a potent topoisomerase II inhibitor.
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-145513
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    CL2-MMT-SN38 is a SN-38 derivative. SN-38, an anticancer agent, is an active metabolite of the Topoisomerase I inhibitor Irinotecan (CPT-11) .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-156402
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    AuM1Gly is a topoisomerase I inhibitor. AuM1Gly affects the growth of MDA-MB-231 breast cancer cells, with IC50?values in the low nanomolar range .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-118726
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Luotonin F is an alkaloid found in the aerial parts of the P. nigellastrum Bunge. Luotonin F shows cytotoxic activity against mouse leukemia P-388 cells by inhibiting human topoisomerase II  .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-18258R
 
                                    - 
                                        
                                    
 
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-13566
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     CKD-602 free base 
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                        Apoptosis
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Belotecan (CKD-602 free base) is a DNA topoisomerase I inhibitor. Belotecan induces cell apoptosis and cell-cycle arrest. Belotecan is a camptothecin analogue with anti-tumor effects, it can be used for the research of cancer .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-19437
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     AT-1727 
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Bimolane (AT-1727), a human topoisomerase II inhibitor, can be used as an anti-neoplastic agent and for the research of psoriasis. Bimolane shows leukemogenic activity and induces multiple types of chromosomal aberrations in human lymphocytes  .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-13631AS1
 
                                    - 
                                        
                                    
 
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-13629
 
                                    - 
                                        
                                    
 
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-13768C
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     SKF 104864A hydrochloride hydrate; NSC 609669 hydrochloride hydrate 
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                        Apoptosis
                                                    
                                                        Autophagy
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Topotecan hydrochloride hydrate is an orally active and potent Topoisomerase I inhibitor. Topotecan hydrochloride hydrate induces cell cycle arrest in G0/G1 and S phases and promotes apoptosis. Topotecan hydrochloride hydrate shows anticancer activity .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-13502S
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     Mitozantrone-d8; NSC 301739-d8 
                                                 | 
                                                
                                                    
                                                        Isotope-Labeled Compounds
                                                    
                                                        Topoisomerase
                                                    
                                                        PKC
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Mitoxantrone-d8 (mitozantrone-d8) is the deuterium labeled Mitoxantrone. Mitoxantrone is a topoisomerase II inhibitor and also inhibits protein kinase C (PKC) activity with an IC50 of 8.5 μM  .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-147408
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     SHR9265 
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                        ADC Payload
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Rezetecán (SHR9265) is a topoisomerase I inhibitor. In addition, Rezetecán can be used to synthesize Trastuzumab rezetecan, an antineoplastic agent. Rezetecán can be used as a cytotoxic payload (ADC Cytotoxin) in antibody-drug conjugates (ADCs)  .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-49556
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    (S)-Benzyl 2-cyclopropyl-2-hydroxyacetate is an intermediate reactant in the synthesis of Camptothecin (HY-16560). Camptothecin is an inhibitor of the DNA topoisomerase Topo I, withIC50=679 nM  .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-N0275R
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    (±)-10-Hydroxycamptothecin (Standard) is the analytical standard of (±)-10-Hydroxycamptothecin. This product is intended for research and analytical applications. (±)-10-Hydroxycamptothecin is an indole alkaloid that inhibits the activity of topoisomerase I and has a broad spectrum of anticancer activity.
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-116529
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Others
                                                    
                                                 | 
                                                
                                                    
                                                        Others
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Lamellarin E is a biologically active marine alkaloid, while the Lamellarin series of alkaloids show potential cytotoxicity, topoisomerase I inhibition, protein kinase inhibition, multidrug resistance reversal, and anti-HIV-1 activity .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-159935
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                        Apoptosis
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Top1-IN-2 (Compound 1a) is a topoisomerase 1 (Top1) inhibitor. Top1-IN-2 inhibits P-gp resistant tumor cells growth and  induces cell apoptosis .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-148668A
 
                                    - 
                                        
                                    
 
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-13631R
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     DX-8951 (Standard) 
                                                 | 
                                                
                                                    
                                                        ADC Payload
                                                    
                                                        Reference Standards
                                                    
                                                        Topoisomerase
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Exatecan (Standard) is the analytical standard of Exatecan. This product is intended for research and analytical applications. Exatecan (DX-8951) is a DNA topoisomerase I inhibitor, with an IC50 of 2.2 μM (0.975 μg/mL), and can be used in cancer research.
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-153013
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Drug-Linker Conjugates for ADC
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    SN38-COOH is used for the synthesis of antibody-drug conjugates (ADCs). SN-38 is an active metabolite of the Topoisomerase I inhibitor Irinotecan. SN-38 inhibits DNA and RNA synthesis  .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-125580
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Makaluvamine A is a member of Makaluvamines. Makaluvamines can be isolated from Fijian sponges of the genus Zyzzya, and possess inhibitory activity toward topoisomerase II along with cytotoxic activity against HCT-116 human colon cancer cells .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-111320
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Bacterial
                                                    
                                                        Antibiotic
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Chrysomycin B is an antibiotic isolated from a strain of Streptomyces. Chrysomycin B causes DNA damage in the human lung adenocarcinoma A549 cell line and inhibits topoisomerase II. Chrysomycin B suppresses the growth of transplantable tumors in mice.
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-160788
 
                                    - 
                                        
                                    
 
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-164647
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Drug-Linker Conjugates for ADC
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Val-Ala-PABC-N(Mesylpropane)-Exatecan is an agent-linker conjugate for ADC. Val-Ala-PABC-N(Mesylpropane)-Exatecan is a Exatecan (a DNA topoisomerase I inhibitor) d with cleavable Val-Ala-PABC-N(Mesylpropane) linker .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-108352
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     VCE 004 
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    HU 331 (HU 331) is a highly specific Topoisomerase II inhibitor with anticancer activity. HU 331 has shown promising inhibitory effects on human cancer cell lines in vitro and human tumor xenografts in nude mice in vivo .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-13744
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     RFS 2000;  9-Nitrocamptothecin 
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Rubitecan (RFS 2000), a Camptothecin derivative, is an orally active topoisomerase I inhibitor with broad antitumor activity, and induces protein-linked DNA single-strand breaks, thereby blocking DNA and RNA synthesis in dividing cells   .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-48878
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        ADC Payload
                                                    
                                                        Topoisomerase
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Exatecan analog 36 is a analog of Exatecan (HY-13631). Exatecan (DX-8951) is a common toxin component in ADC preparation (ADC Cytotoxin) and an inhibitor of DNA topoisomerase I (IC50=2.2 μM) .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-13631AG
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     DX8951f 
                                                 | 
                                                
                                                    
                                                        ADC Payload
                                                    
                                                        Topoisomerase
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Exatecan mesylate (DX8951f ) GMP is a GMP-class Exatecan (HY-13631). Exatecan is a DNA topoisomerase I inhibitor, with an IC50 of 2.2 μM (0.975 μg/mL), and can be used in cancer research   .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-N6011
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                        Apoptosis
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    9-Methoxycamptothecin (MCPT), isolated from Camptotheca acuminata, has antitumor activities through topoisomerase inhibition. 9-Methoxycamptothecin (MCPT) induces strong G2/M arrest and apoptosis in cancer  .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-114983
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     (S)-9-Allyl-10-Hydroxycamptothecin 
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Chimmitecan ((S)-9-Allyl-10-Hydroxycamptothecin), a novel 9-small-alkyl-substituted lipophilic Camptothecin (HY-16560), is a potent inhibitor of topoisomerase I. Chimmitecan exhibits anticancer activity .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-49861
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        ADC Payload
                                                    
                                                        Topoisomerase
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Exatecan intermediate 11 is an intermediate for the synthesis of Exatecan (HY-13631). Exatecan (DX-8951) is a common toxin component in ADC preparation (ADC Cytotoxin) and an inhibitor of DNA topoisomerase I (IC50=2.2 μM) .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-43565B
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        ADC Payload
                                                    
                                                        Topoisomerase
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Exatecan intermediate 10 is an intermediate in the synthesis of Exatecan (HY-13631).Exatecan (DX-8951) is a DNA topoisomerase I inhibitor with an IC50 of 2 .2 μM (0 .975 μg/mL) for use in cancer research .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-400316
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        ADC Payload
                                                    
                                                        Topoisomerase
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Exatecan intermediate 8 is an intermediate for the synthesis of Exatecan (HY-13631). Exatecan (DX-8951) is a common toxin component in ADC preparation (ADC Cytotoxin) and an inhibitor of DNA topoisomerase I (IC50=2.2 μM) .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-158137
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Drug-Linker Conjugates for ADC
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Val-Cit-PAB-DEA-Dxd (compound 81) is a Drug-Linker Conjugates for ADC, which is composed of a linker and a toxic molecule Dxd (DNA topoisomerase I inhibitor). Val-Cit-PAB-DEA-Dxd can be used for ADC synthesis .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-P3371
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     DS-7300a;  MABX-9001a 
                                                 | 
                                                
                                                    
                                                        Antibody-Drug Conjugates (ADCs)
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Ifinatamab deruxtecan (DS-7300a) is an ADC that binds an anti-B7-H3 antibody to the DNA topoisomerase I inhibitory anti-tumor drug DXd. Ifinatamab deruxtecan has antitumor activity .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-43565
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        ADC Payload
                                                    
                                                        Topoisomerase
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Exatecan intermediate 9 is an intermediate for the synthesis of Exatecan (HY-13631). Exatecan (DX-8951) is a common toxin component in ADC preparation (ADC Cytotoxin) and an inhibitor of DNA topoisomerase I (IC50=2.2 μM) .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-164836
 
                                    - 
                                        
                                    
 
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-108969
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     NSC 366140;  PD 115934 
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                        Apoptosis
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Pyrazoloacridine (NSC 366140), an intercalating agent with anti-cancer activity, inhibits the activity of topoisomerases 1 and 2. Pyrazoloacridine (NSC 366140) exhibits an IC50 of 1.25 μM in K562 myeloid leukemia cells for 24 h treatment  .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-17577R
 
                                    - 
                                        
                                    
 
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-13631DS
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     Exatecan-d5 derivative for ADC 
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                        ADC Payload
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Dxd-d5 is a deuterium labeled Dxd. Dxd is a potent DNA topoisomerase I inhibitor, with an IC50 of 0.31 μM, used as a conjugated drug of HER2-targeting ADC (DS-8201a)  .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-159966
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                        HDAC
                                                    
                                                        Reactive Oxygen Species (ROS)
                                                    
                                                        Apoptosis
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Top/HDAC-IN-3 (Compound 31) is an orally active dual inhibitor of Topoisomerase and HDAC. Top/HDAC-IN-3 increases reactive oxygen species (ROS) levels, leading to DNA damage, thereby inhibiting cancer cell colony formation and migration, inducing cancer cell Apoptosis, and causing cell cycle arrest. In the NSCLC model, Top/HDAC-IN-3 exhibited significant antitumor effects, with a tumor growth inhibition (TGI) of 77.5% at 100 mg/kg, surpassing the efficacy of the HDAC inhibitor SAHA (HY-10221) and the combination of SAHA (HY-10221) with the topoisomerase inhibitor Irinotecan (HY-16562) .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-126373
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     SN-38G 
                                                 | 
                                                
                                                    
                                                        Drug Metabolite
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    SN-38 glucuronide is an inactive metabolite of the anticancer active molecule Irinotecan (HY-16562) and has toxic effects on the gastrointestinal tract. Irinotecan is a topoisomerase I inhibitor which can be used for researching colon and rectal cancer   .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-161937
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                        Bacterial
                                                    
                                                 | 
                                                
                                                    
                                                        Infection
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Antibacterial agent 236 (Compound 4l) is an orally active inhibitor for DNA gyrase and topoisomerase IV (IC50 is 3.2 and 300 nM in Staphylococcus aureus), and exhibits board-spectrum antibacterial activity. Antibacterial agent 236 exhibits good pharmacokinetic properties in mice .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-N7066R
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Reference Standards
                                                    
                                                        Bacterial
                                                    
                                                        Antibiotic
                                                    
                                                 | 
                                                
                                                    
                                                        Infection
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Difloxacin (hydrochloride) (Standard) is the analytical standard of Difloxacin (hydrochloride). This product is intended for research and analytical applications. Difloxacin hydrochloride is a broad-spectrum antibacterial agent. Difloxacin hydrochloride inhibits bacterial DNA gyrase and exhibits a concentration-dependant bactericidal effect by interference with the activity of DNA gyrase and topoisomerase IV .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-13630
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     BMY-40481 
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                        Bacterial
                                                    
                                                        Autophagy
                                                    
                                                        Apoptosis
                                                    
                                                 | 
                                                
                                                    
                                                        Infection
                                                    
                                                        Neurological Disease
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Etoposide phosphate (BMY-40481) is a potent anti-cancer chemotherapy agent and a selective topoisomerase II inhibitor to prevent re-ligation of DNA strands. Etoposide phosphate is the phosphate ester proagent of etoposide and is considered as active equivalent to Etoposide. Etoposide phosphate induces cell cycle arrest, apoptosis, and autophagy.
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-13768
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     SKF 104864A;  NSC 609669 
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                        Autophagy
                                                    
                                                        Apoptosis
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Topotecan (SKF 104864A; NSC 609669) is an orally active and potent Topoisomerase I inhibitor. Topotecan induces cell cycle arrest in G0/G1 and S phases and promotes apoptosis. Topotecan shows anticancer activity .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-N0716B
 
                                    - 
                                        
                                    
 
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-18626
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    NK 314 is an inhibitor for topoisomerase IIα, which generates the break of DNA double-strand. NK 314 arrests the cell cycle at G2 phase in human acute myeloid leukemia cells, inhibits the proliferation of CEM with IC90 of 55 nM .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-135845
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     CH0793011 
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    TP3011 (CH0793011) is an active metabolite of CH-0793076 and is a potent topoisomerase I inhibitor equipotent as SN38 . TP3011 is against cancer cell lines growth with IC50s at the range sub-nanomolar in vitro .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-156755
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Drug-Linker Conjugates for ADC
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Propargyl-PEG4-GGFG-DXd is a drug-linker conjugate for ADC. Propargyl-PEG4-GGFG-DXd contains a ADC linker and a DNA topoisomerase I inhibitor DXd (HY-13631D) .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-N11536
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                        Apoptosis
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    erythro-Austrobailignan-6 is an orally active anti-cancer agent. erythro-Austrobailignan-6 inhibits DNA topoisomerase I and II activity. erythro-Austrobailignan-6 induces cell apoptosis and increases phosphorylation of p38 and JNK  .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-153031
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     Val-Cit-PAB-DX8951 
                                                 | 
                                                
                                                    
                                                        Drug-Linker Conjugates for ADC
                                                    
                                                        Topoisomerase
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Val-Cit-PAB-Exatecan (Val-Cit-PAB-DX8951) is a agent-linker conjugate for ADC. Val-Cit-PAB-Exatecan is composed of a DNA topoisomerase I DX-8951 (HY-13631) and a cathepsin cleavable ADC linker .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-131057
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Drug-Linker Conjugates for ADC
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Mc-VC-PAB-SN38 consists a cleavable ADC linker (Mc-VC-PAB) and a DNA topoisomerase I inhibitor (SN38). Mc-VC-PAB-SN38 can be used in the synthesis of antibody-drug conjugates (ADCs) .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-122139R
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Bacterial
                                                    
                                                        Reference Standards
                                                    
                                                 | 
                                                
                                                    
                                                        Infection
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Desethylene Ciprofloxacin (hydrochloride) (Standard) is the analytical standard of Desethylene Ciprofloxacin (hydrochloride). This product is intended for research and analytical applications. Desethylene Ciprofloxacin hydrochloride is a major metabolite of Ciprofloxacin (HY-B0356). Ciprofloxacin is an orally active topoisomerase IV inhibitor. Desethylene Ciprofloxacin hydrochloride has antibacterial activity .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-13550A
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     NSC 196473 acetate; NSC 290813 acetate 
                                                 | 
                                                
                                                    
                                                        DNA/RNA Synthesis
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Ametantrone acetate (NSC 196473 acetate) is an antineoplastic drug with topoisomerase II inhibitory activity. Ametantrone acetate causes covalent cross-linking of DNA. The pharmacokinetic profile of Ametantrone acetate has been confirmed in clinical trials, and its elimination pathway in the body indicates the existence of a major metabolic pathway .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-10919
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                        Mitosis
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    C-1311 shows to inhibit the catalytic activity of DNA topoisomerase II in vitro and in tumour cells. C-1311 prolongs G2 arrest followed by G2 to M transit and cell death during mitosis in the process of mitotic catastrophe .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-105387
 
                                    - 
                                        
                                    
 
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-42487R
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        ADC Payload
                                                    
                                                        Topoisomerase
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Exatecan Intermediate 1 (Standard) is the analytical standard of Exatecan Intermediate 1. This product is intended for research and analytical applications. Exatecan Intermediate 1 (compound 6) is an intermediate of Exatecan (HY-13631). Exatecan  is a DNA topoisomerase I inhibitor with anticancer effects   .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-B0398
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Bacterial
                                                    
                                                        Antibiotic
                                                    
                                                        Topoisomerase
                                                    
                                                 | 
                                                
                                                    
                                                        Infection
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Nalidixic acid, a quinolone antibiotic, is effective against both gram-positive and gram-negative bacteria. Nalidixic acid acts in a bacteriostatic manner in lower concentrations and is bactericidal in higher concentrations. Nalidixic acid inhibits a subunit of DNA gyrase and topoisomerase IV and reversibly blocks DNA replication in susceptible bacteria .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-N2306A
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     Aclarubicin hydrochloride 
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                        DNA/RNA Synthesis
                                                    
                                                        Proteasome
                                                    
                                                        Antibiotic
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Aclacinomycin A (Aclarubicin) hydrochloride is an orally active and potent anthracycline antitumor antibiotic. Aclacinomycin A hydrochloride is an inhibitor of topoisomerase I and II. Aclacinomycin A hydrochloride inhibits synthesis of nucleic acid, especially RNA. Aclacinomycin A hydrochloride might inhibit the 26S protease complex as well as the ubiquitin-ATP-dependent proteolysis   .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-164835
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     SMP-54418 
                                                 | 
                                                
                                                    
                                                        Drug-Linker Conjugates for ADC
                                                    
                                                        Microtubule/Tubulin
                                                    
                                                        Topoisomerase
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    VcMMAE-Deruxtecan (SMP-54418) is a Drug-Linker Conjugates for ADC, which is composed of a linker and a toxic molecule MMAE (HY-15162) (Microtubule inhibitor) and Exatecan (HY-13631) (DNA topoisomerase I inhibitor). VcMMAE-Deruxtecan can be used for ADC synthesis.
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-16261
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     INNO-206;  DOXO-EMCH 
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                        ADC Payload
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Aldoxorubicin (INNO-206) is an albumin-binding proagent of Doxorubicin (DNA topoisomerase II inhibitor), which is released from albumin under acidic conditions. Aldoxorubicin (INNO-206) has potent antitumor activities in various cancer cell lines and in murine tumor models.
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-122481
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                        Apoptosis
                                                    
                                                        Bcl-2 Family
                                                    
                                                        Cytochrome P450
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Thaspine acetate, an alkaloid, is a topoisomerase I and II inhibitor. Thaspine acetate induces cancer cell apoptosis. Thaspine acetate induces Bak and Bax activation, mitochondrial cytochrome c release and mitochondrial membrane permeabilization. Thaspine acetate can be isoalted from the cortex of the South American tree Croton lechleri .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-143692
 
                                    - 
                                        
                                    
 
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-16261C
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     INNO-206 hydrochloride; DOXO-EMCH hydrochloride 
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                        ADC Payload
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Aldoxorubicin (INNO-206) hydrochloride is an albumin-binding proagent of Doxorubicin (DNA topoisomerase II inhibitor), which is released from albumin under acidic conditions. Aldoxorubicin hydrochloride (INNO-206) has potent antitumor activities in various cancer cell lines and in murine tumor models.
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-A0210
 
                                    - 
                                        
                                    
 
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-N2306
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     Aclarubicin 
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                        DNA/RNA Synthesis
                                                    
                                                        Proteasome
                                                    
                                                        Antibiotic
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Aclacinomycin A (Aclarubicin) is an orally active and potent anthracycline antitumor antibiotic. Aclacinomycin A is an inhibitor of topoisomerase I and II. Aclacinomycin A inhibits synthesis of nucleic acid, especially RNA. Aclacinomycin A might inhibit the 26S protease complex as well as the ubiquitin-ATP-dependent proteolysis   .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-171931
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Drug-Linker Conjugates for ADC
                                                    
                                                        Topoisomerase
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Aminocaproyl-Val-Cit-PABC-Exatecan is a drug-linker conjugate for ADC, consiting of a cleavable linker (Aminocaproyl-Val-Cit-PABC) and Exatecan (HY-13631) (topoisomerase I inhibitor). Aminocaproyl-Val-Cit-PABC-Exatecan can be used for ADC molecues synthesis .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-114668
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     Camptothecin-20-O-propionate 
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Camptothecin-20(S)-O-propionate (CZ48), the C20-propionate ester of CPT, is a highly effective anticancer agent. Camptothecin-20(S)-O-propionate (CZ48) is a topoisomerase-Ι inhibitor   .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-B0398A
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Bacterial
                                                    
                                                        Antibiotic
                                                    
                                                        Topoisomerase
                                                    
                                                 | 
                                                
                                                    
                                                        Infection
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Nalidixic acid sodium salt, a quinolone antibiotic, is effective against both gram-positive and gram-negative bacteria. Nalidixic acid acts in a bacteriostatic manner in lower concentrations and is bactericidal in higher concentrations. Nalidixic acid inhibits a subunit of DNA gyrase and topoisomerase IV and reversibly blocks DNA replication in susceptible bacteria  .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-13624A
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     4'-Epidoxorubicin hydrochloride 
                                                 | 
                                                
                                                    
                                                        DNA/RNA Synthesis
                                                    
                                                        Topoisomerase
                                                    
                                                        Apoptosis
                                                    
                                                        Antibiotic
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Epirubicin hydrochloride (4'-Epidoxorubicin hydrochloride), a semisynthetic L-arabino derivative of doxorubicin, has an antineoplastic agent by inhibiting Topoisomerase . Epirubicin hydrochloride inhibits DNA and RNA synthesis. Epirubicin hydrochloride is a Forkhead box protein p3 (Foxp3) inhibitor and inhibits regulatory T cell activity .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-145929
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     MC-Val-Cit-PAB-DX8951 
                                                 | 
                                                
                                                    
                                                        Drug-Linker Conjugates for ADC
                                                    
                                                        Topoisomerase
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    MC-Val-Cit-PAB-Exatecan (MC-Val-Cit-PAB-DX8951) is a agent-linker conjugate for ADC. MC-Val-Cit-PAB-Exatecan is composed of a DNA topoisomerase I DX-8951 (HY-13631) and a cathepsin cleavable ADC linker.
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-17647
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     ETX0914;  AZD0914 
                                                 | 
                                                
                                                    
                                                        DNA/RNA Synthesis
                                                    
                                                        Bacterial
                                                    
                                                        Antibiotic
                                                    
                                                 | 
                                                
                                                    
                                                        Infection
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Zoliflodacin (ETX0914;AZD0914) is a novel spiropyrimidinetrione bacterial DNA gyrase/topoisomerase inhibitor. Zoliflodacin has potent in vitro antibacterial activity against Gram-positive and Gram-negative organisms, including S. aureus with the MIC90 of 0.25 μg/mL.
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-114668A
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     Camptothecin-20-O-propionate hydrate 
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Camptothecin-20(S)-O-propionate (Camptothecin-20-O-propionate) hydrate, the C20-propionate ester of CPT, is a highly effective anticancer agent. Camptothecin-20(S)-O-propionate hydrate is a topoisomerase-Ι inhibitor  .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-100875R
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     CL216942 (Standard) 
                                                 | 
                                                
                                                    
                                                        Reference Standards
                                                    
                                                        Topoisomerase
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Bisantrene (Standard) is the analytical standard of Bisantrene. This product is intended for research and analytical applications. Bisantrene is a highly effective antitumor agent, it exerts its cytotoxicity by affecting DNA intercalation. Bisantrene targets eukaryotic type II topoisomerases. Bisantrene is a substrate of MDR1    .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-153031A
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     Val-Cit-PAB-DX8951 TFA 
                                                 | 
                                                
                                                    
                                                        Drug-Linker Conjugates for ADC
                                                    
                                                        Topoisomerase
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Val-Cit-PAB-Exatecan (Val-Cit-PAB-DX8951) TFA is a agent-linker conjugate for ADC. Val-Cit-PAB-Exatecan TFA is composed of a DNA topoisomerase I DX-8951 (HY-13631) and a cathepsin cleavable ADC linker .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-13631M
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Drug-Linker Conjugates for ADC
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Gly-Gly-Phe-Gly-NH-O-CO-Exatecan is a Drug-Linker Conjugates for ADC, consiting of an ADC linker and Exatecan (HY-13631) (topoisomerase I inhibitor). Gly-Gly-Phe-Gly-NH-O-CO-Exatecan can be used for ADC molecues synthesis.
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-13624
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     4'-Epidoxorubicin 
                                                 | 
                                                
                                                    
                                                        DNA/RNA Synthesis
                                                    
                                                        Topoisomerase
                                                    
                                                        Apoptosis
                                                    
                                                        Antibiotic
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Epirubicin (4'-Epidoxorubicin), a semisynthetic L-arabino derivative of doxorubicin, has an antineoplastic agent by inhibiting Topoisomerase . Epirubicin inhibits DNA and RNA synthesis. Epirubicin is a Forkhead box protein p3 (Foxp3) inhibitor and inhibits regulatory T cell activity .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-18351A
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     LMP-400 hydrochloride; NSC-724998 hydrochloride 
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                 | 
                                                
                                                    
                                                        Infection
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Indotecan hydrochloride, an indenoisoquinoline derivative, is a potent Topoisomerase I inhibitor, with IC50s of 300, 1200, 560 nM for P388, HCT116, MCF-7 cell lines, respectively. Indotecan hydrochloride prevents the relaxation of supercoiled DNA and can be used for the research of visceral leishmaniasis  .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-148668
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     SHR-A1811 Drug-linker 
                                                 | 
                                                
                                                    
                                                        Drug-Linker Conjugates for ADC
                                                    
                                                        Topoisomerase
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    MC-Gly-Gly-Phe-Gly-(R)-Cyclopropane-Exatecan (SHR-A1811 Drug-linker) is a agent-linker conjugates for ADC, consisting Exatecan (HY-13631). Exatecan is a DNA Topoisomerase I inhibitor (IC50=2.2 μM) .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-148819A
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        ADC Payload
                                                    
                                                        Topoisomerase
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    NH2-bicyclo[1.1.1]pentane-7-MAD-MDCPT (compound I) hydrochloride is a topoisomerase I inhibitor, which can be delivered to cells through conjugated antibody targeting, and has good ADC activity in vivo and in vitro .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-13562
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     AQ4N 
                                                 | 
                                                
                                                    
                                                        NO Synthase
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Banoxantrone (AQ4N), as a prototype hypoxia selective cytotoxin, can be reduced to AQ4, a potent topoisomerase II inhibitor. Banoxantrone selectively kills hypoxic cells via an iNOS-dependent mechanism. Banoxantrone shows a potent cytotoxicity and hypoxia-selective effect enhanced by radiation  .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-10529R
 
                                    - 
                                        
                                    
 
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-125331
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                        ADC Payload
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    DRF-1042 is an orally active derivative of Camptothecin. DRF-1042 acts to inhibit DNA topoisomerase I. DRF-1042 shows good anticancer activity against a panel of human cancer cell lines including multi-agent resistance (MDR) phenotype  .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-13630A
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     BMY-40481 disodium 
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                        Autophagy
                                                    
                                                        Apoptosis
                                                    
                                                 | 
                                                
                                                    
                                                        Neurological Disease
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Etoposide phosphate disodium (BMY-40481 disodium) is a potent anti-cancer chemotherapy agent and a selective topoisomerase II inhibitor to prevent re-ligation of DNA strands. Etoposide phosphate disodium is the phosphate ester proagent of etoposide and is considered as active equivalent to Etoposide. Etoposide phosphate disodium induces cell cycle arrest, apoptosis, and autophagy.
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-161813
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Bacterial
                                                    
                                                        Fungal
                                                    
                                                        Topoisomerase
                                                    
                                                 | 
                                                
                                                    
                                                        Infection
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Antibacterial agent 229 (compound 8a) is a potent antibacterial agent. Antibacterial agent 229 shows antibacterial and antifungal abilities. Antibacterial agent 229 disrupts the integrity of the bacterial membrane, intercalates into DNA. Antibacterial agent 229 inhibits topoisomerase IV with an IC50 value of 10.88 µM .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-155034
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                        GLUT
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Antitumor agent-102 (compound 10) is a conjugate of Topoisomerase I inhibitor SN38 and glucose transporter inhibitor, targeting to colorectal cancer. Antitumor agent-102 induces higher concentrations of free SN38 in tumor tissues than Irinotecan (HY-16562) .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-148819
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        ADC Payload
                                                    
                                                        Topoisomerase
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    NH2-bicyclo[1.1.1]pentane-7-MAD-MDCPT (compound I) is a topoisomerase I inhibitor, which can be delivered to cells through conjugated antibody targeting, and has good ADC activity in vivo and in vitro .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-171931A
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Drug-Linker Conjugates for ADC
                                                    
                                                        Topoisomerase
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Aminocaproyl-Val-Cit-PABC-Exatecan TFA is a drug-linker conjugate for ADC, consiting of a cleavable linker (Aminocaproyl-Val-Cit-PABC) and Exatecan (HY-13631) (topoisomerase I inhibitor). Aminocaproyl-Val-Cit-PABC-Exatecan TFA can be used for ADC molecues synthesis .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-13631AS
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     DX8951f-d5; Deuterated labeled Exatecan mesylate 
                                                 | 
                                                
                                                    
                                                        Isotope-Labeled Compounds
                                                    
                                                        ADC Payload
                                                    
                                                        Topoisomerase
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Exatecan-d5 (DX8951f-d5) mesylate is deuterium labeled Exatecan mesylate (HY-13631A). Exatecan mesylate is a DNA topoisomerase I inhibitor, with an IC50 of 2.2 μM (0.975 μg/mL). Exatecan mesylate can be used in cancer research .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-146094
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Antitumor agent-63 (Compound 40), a 20 (S)-O-linked camptothecin (CPT) glycoconjugate, is an antitumor agent without toxicity towards normal cells. Antitumor agent-63 shows high stability and very weak direct topoisomerase I (Topo I) inhibition .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-43565C
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Drug Intermediate
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    (1S,9R)-Ac-Exatecan is an intermediate for the synthesis of Exatecan (HY-13631). Exatecan (DX-8951) is a common toxin component in ADC preparation (ADC Cytotoxin) and an inhibitor of DNA topoisomerase I (IC50=2.2 μM) .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-13704
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     7-Ethyl-10-hydroxycamptothecin 
                                                 | 
                                                
                                                    
                                                        Drug Metabolite
                                                    
                                                        Topoisomerase
                                                    
                                                        ADC Payload
                                                    
                                                        Autophagy
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    SN-38 is an active metabolite of the Topoisomerase I inhibitor Irinotecan. SN-38 inhibits DNA and RNA synthesis with IC50s of 0.077 and 1.3 μM, respectively. SN-38 is a payload of sacituzumab govitecan (HY -132254)     .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-119827
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     F 860191 
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Moflomycin (F 860191) is a compound with strong anti-leukemic activity and low mutagenicity. Moflomycin has an antiproliferative effect on the leukemic cell line HL60 in vitro (IC50=2.9 nM) . Moflomycin enhances topoisomerase II-induced DNA breaks and free radical production .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-100620
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     APC 
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                        Cholinesterase (ChE)
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    RPR121056 (APC) is a metabolite of Irinotecan (CPT-11), which is generated by CYP3A4. Irinotecan (CPT-11) is an antineoplastic agent that inhibits topoisomerase type I, causing cell death, and is widely used in the treatment of colorectal cancer. Irinotecan also directly inhibits AChE .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-106662R
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Molecular Glues
                                                    
                                                        Topoisomerase
                                                    
                                                        Parasite
                                                    
                                                 | 
                                                
                                                    
                                                        Infection
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Chloroquinoxaline sulfonamide (Standard) is the analytical standard of Chloroquinoxaline sulfonamide. This product is intended for research and analytical applications. Chloroquinoxaline sulfonamide (Chloroquinoxaline), a structural analogue of sulfaquinoxaline, is a topoisomerase II alpha/beta poison. Chloroquinoxaline sulfonamide is used to control coccidiosis in poultry, rabbit, sheep, and cattle . Antitumor activity .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-156686
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        ADC Payload
                                                    
                                                        Topoisomerase
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    NH2-methylpropanamide-Exatecan TFA is a methylpropanamide-modified Exatecan (HY-13631), which is the common ADC Cytotoxin used in the synthesis of ADC. Exatecan is a DNA topoisomerase I inhibitor, with an IC50 of 2.2 μM (0.975 μg/mL), and can be used in cancer research .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-147095
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Drug-Linker Conjugates for ADC
                                                    
                                                        Topoisomerase
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Val-Ala-PABC-Exatecan is a Drug-Linker Conjugates for ADC, consiting of a cleavable Tesirine linker (Val-Ala-PABC) and Exatecan (HY-13631) (topoisomerase I inhibitor). Val-Ala-PABC-Exatecan can be used for ADC molecues synthesis, such as Mal-PEGn-amide-va-Exatecan .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-147095A
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Drug-Linker Conjugates for ADC
                                                    
                                                        Topoisomerase
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Val-Ala-PABC-Exatecan trifluoroacetate is a Drug-Linker Conjugates for ADC, consiting of a cleavable Tesirine linker (Val-Ala-PABC) and Exatecan (topoisomerase I inhibitor, HY-13631). Val-Ala-PABC-Exatecan trifluoroacetate can be used for ADC molecues synthesis, such as Mal-PEGn-amide-va-Exatecan .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-B0330A
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     Levofloxacin hemihydrate 
                                                 | 
                                                
                                                    
                                                        Bacterial
                                                    
                                                        Antibiotic
                                                    
                                                        Topoisomerase
                                                    
                                                        DNA/RNA Synthesis
                                                    
                                                        Orthopoxvirus
                                                    
                                                 | 
                                                
                                                    
                                                        Infection
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Levofloxacin hydrate (Levofloxacin hemihydrate) is an orally active antibiotic and is active against both Gram-positive and Gram-negative bacteria. Levofloxacin hydrate inhibits the DNA gyrase and topoisomerase IV.  Levofloxacin hydrate can be used for chronic periodontitis, airway inflammation and BK Viremia research. Levofloxacin hydrate shows anti-orthopoxvirus activity    .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-44369
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        ADC Payload
                                                    
                                                        Topoisomerase
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Exatecan Intermediate 6 is the intermediate of Exatecan (HY-13631) And Exatecan (DX-8951) is a DNA topoisomerase I inhibitor with an IC50 value of 2.2 μM (0.975 μg/mL) that can be used in cancer research. Exatecan Intermediate 6 can be used to synthesize Antibody-Drug Conjugates (ADCs).
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-107096
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     TP3076 
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    CH-0793076 (TP3076), a hexacyclic camptothecin analog, is active drug and major metabolite of TP300. CH-0793076 inhibits DNA topoisomerase I with an IC50 of 2.3 μM. CH-0793076 is efficacious against cells expressing BCRP (breast cancer resistance protein) .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-18351
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     LMP-400;  NSC-724998 
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                 | 
                                                
                                                    
                                                        Infection
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Indotecan (LMP-400), an indenoisoquinoline derivative, is a potent Topoisomerase I inhibitor, with IC50s of 300, 1200, 560 nM for P388, HCT116, MCF-7 cell lines, respectively. Indotecan prevents the relaxation of supercoiled DNA and can be used for the research of visceral leishmaniasis  .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-43564
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        ADC Payload
                                                    
                                                        Topoisomerase
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Exatecan Intermediate 5 is the intermediate of Exatecan (HY-13631) And Exatecan (DX-8951) is a DNA topoisomerase I inhibitor with an IC50 value of 2.2 μM (0.975 μg/mL) that can be used in cancer research. Exatecan Intermediate 5 can be used to synthesize Antibody-Drug Conjugates (ADCs).
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-13631F
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Drug-Linker Conjugates for ADC
                                                    
                                                        Topoisomerase
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Gly-Gly-Phe-Gly-NH-O-CO-Exatecan, as a drug-linker conjugate composed of linker Gly-Gly-Phe-Gly-NH-O-CO and Exatecan, can be used to prepare antibody conjugate drugs. Exatecan is a DNA topoisomerase I inhibitor that can be used in cancer research  .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-10982A
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     AS1413 dihydrochloride 
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                 | 
                                                
                                                    
                                                        Others
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Amonafide dihydrochloride (AS1413 dihydrochloride) is a topoisomerase II (Topo II) inhibitor and DNA intercalator with activity in inducing apoptotic signaling. Amonafide dihydrochloride can inhibit the binding of Topo II to DNA, thereby preventing the synthesis of DNA and RNA. Amonafide dihydrochloride maintains cytotoxic activity in the presence of P-glycoprotein-mediated multidrug resistance (MDR) .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-13566R
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                        Apoptosis
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Belotecan (Standard) is the analytical standard of Belotecan. This product is intended for research and analytical applications. Belotecan (CKD-602 free base) is a DNA topoisomerase I inhibitor. Belotecan induces cell apoptosis and cell-cycle arrest. Belotecan is a camptothecin analogue with anti-tumor effects, it can be used for the research of cancer .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-46081
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        ADC Payload
                                                    
                                                        Topoisomerase
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Exatecan Intermediate 3 is the intermediate of Exatecan (HY-13631) And Exatecan (DX-8951) is a DNA topoisomerase I inhibitor with an IC50 value of 2.2 μM (0.975 μg/mL) that can be used in cancer research. Exatecan Intermediate 3 can be used to synthesize Antibody-Drug Conjugates (ADCs).
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-141436
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     Sucrose octasulfate potassium 
                                                 | 
                                                
                                                    
                                                        Biochemical Assay Reagents
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Sucrosofate (Sucrose octasulfate) potassium is a sucrose acid that can be used to prepare liposomes to deliver Irinotecan (HY-16562). Irinotecan is an inhibitor of topoisomerase Topo I and is commonly used in colon and rectal cancer research. Sucrosofate nanoliposome preparation loaded with Irinotecan, also known as PEP02 or MM-398  .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-17381A
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     4-Demethoxydaunorubicin 
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                        Bacterial
                                                    
                                                        Fungal
                                                    
                                                        Autophagy
                                                    
                                                        c-Myc
                                                    
                                                        DNA/RNA Synthesis
                                                    
                                                        Antibiotic
                                                    
                                                 | 
                                                
                                                    
                                                        Infection
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Idarubicin is an orally active and potent anthracycline antileukemic agent. Idarubicin inhibits the topoisomerase II interfering with the replication of DNA and RNA transcription. Idarubicin shows induction of DNA damage. Idarubicin inhibits DNA synthesis and of c-myc expression. Idarubicin inhibits the growth of bacteria and yeasts     .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-13629R
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     VP-16 (Standard); VP-16-213 (Standard) 
                                                 | 
                                                
                                                    
                                                        Reference Standards
                                                    
                                                        Topoisomerase
                                                    
                                                        Autophagy
                                                    
                                                        Mitophagy
                                                    
                                                        Bacterial
                                                    
                                                        Apoptosis
                                                    
                                                        Antibiotic
                                                    
                                                 | 
                                                
                                                    
                                                        Infection
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Etoposide (Standard) is the analytical standard of Etoposide. This product is intended for research and analytical applications. Etoposide (VP-16; VP-16-213) is an anti-cancer chemotherapy agent. Etoposide inhibits topoisomerase II, thus stopping DNA replication. Etoposide induces cell cycle arrest, apoptosis and autophagy .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-160649
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Drug-Linker Conjugates for ADC
                                                    
                                                        Topoisomerase
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    MC-Gly-Gly-Phe-Gly-GABA-Exatecan is an agent linker conjugate for ADC, with an inhibitor for Topoisomerase Exatecan (HY-13631) with IC50 of 22 μM. MC-Gly-Gly-Phe-Gly-GABA-Exatecan targets various antibodies, exhibits cytotoxic and antitumor efficacy in vitro and in vivo  .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-13555R
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Indoleamine 2,3-Dioxygenase (IDO)
                                                    
                                                        Topoisomerase
                                                    
                                                        Autophagy
                                                    
                                                        Apoptosis
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    β-Lapachone (Standard) is the analytical standard of β-Lapachone. This product is intended for research and analytical applications. β-Lapachone (ARQ-501;NSC-26326) is a naturally occurring O-naphthoquinone, acts as a topoisomerase I inhibitor, and induces apoptosis by inhibiting cell cycle progression.
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-16700
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        ADC Payload
                                                    
                                                        Topoisomerase
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    PNU-159682, a metabolite of the anthracycline Nemorubicin, is a highly potent DNA topoisomerase II inhibitor with excellent cytotoxicity. PNU-159682 acts as a more potent and tolerated ADC cytotoxin than Doxorubicin for ADC synthesis. PNU-159682 can be used in EDV-nanocell technology to overcome agent resistance.
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-W338859
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Bacterial
                                                    
                                                        Topoisomerase
                                                    
                                                        Antibiotic
                                                    
                                                 | 
                                                
                                                    
                                                        Infection
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Levofloxacin mesylate is an orally active antibiotic and is active against both Gram-positive and Gram-negative bacteria. Levofloxacin mesylate  inhibits the DNA gyrase and topoisomerase IV. Levofloxacin mesylate can be used for chronic periodontitis, airway inflammation and BK Viremia research. Levofloxacin mesylate shows anti-orthopoxvirus activity     .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-147270
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Drug-Linker Conjugates for ADC
                                                    
                                                        Topoisomerase
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    MC-VA-PAB-Exatecan is a agent-linker conjugate for ADC. MC-VA-PAB-Exatecan contains the ADC linker (peptide MC-VA-PAB) and a DNA topoisomerase I inhibitor Exatecan (HY-13631). MC-VA-PAB-Exatecan synthesized ADC shows good antitumor activity .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-45157
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        ADC Payload
                                                    
                                                        Topoisomerase
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Exatecan Intermediate 7 is the intermediate of Exatecan (HY-13631) And Exatecan (DX-8951) is a DNA topoisomerase I inhibitor with an IC50 value of 2.2 μM (0.975 μg/mL) that can be used in cancer research. Exatecan Intermediate 7 can be used to synthesize Antibody-Drug Conjugates (ADCs).
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-B0330
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     (-)-Ofloxacin 
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                        DNA/RNA Synthesis
                                                    
                                                        Antibiotic
                                                    
                                                        Bacterial
                                                    
                                                        Orthopoxvirus
                                                    
                                                 | 
                                                
                                                    
                                                        Infection
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Levofloxacin ((-)-Ofloxacin) is an orally active antibiotic and is active against both Gram-positive and Gram-negative bacteria. Levofloxacin inhibits the DNA gyrase and topoisomerase IV.  Levofloxacin can be used for chronic periodontitis, airway inflammation and BK Viremia research. Levofloxacin shows anti-orthopoxvirus activity     .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-N5038
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                 | 
                                                
                                                    
                                                        Cardiovascular Disease
                                                    
                                                        Neurological Disease
                                                    
                                                        Metabolic Disease
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Mauritianin is an orally active kaempferol glycoside. Mauritianin can be isolated from the flowers and leaves of Acalypha indica. Mauritianin is a topoisomerase I inhibitor. Mauritianin has hepatoprotective, neuroprotective, and renoprotective activities. Mauritianin increases vascular tone when used in combination with Alcesefoliside (HY-N5049)    .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-126373S1
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     SN-38G-13C6 
                                                 | 
                                                
                                                    
                                                        Isotope-Labeled Compounds
                                                    
                                                 | 
                                                
                                                    
                                                        Others
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    SN-38 glucuronide- 13C6 is the  13C labeled SN-38 glucuronide (HY-126373) . SN-38 glucuronide is an inactive metabolite of the cancer agent Irinotecan. Irinotecan is a topoisomerase I inhibitor which can be used for researching colon and rectal cancer .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-149925
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Bacterial
                                                    
                                                        DNA/RNA Synthesis
                                                    
                                                        Topoisomerase
                                                    
                                                 | 
                                                
                                                    
                                                        Infection
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Antibacterial agent 138 is a benzothiazole inhibitor of bacterial DNA gyrase and topoisomerase IV. Antibacterial agent 138 exhibits favorable solubility and plasma protein binding. Antibacterial agent 138 has antibacterial activity against Gram-positive and Gram-negative strains. Antibacterial agent 138 is a dual GyrB and ParE inhibitor .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-B0330C
 
                                    - 
                                        
                                    
 
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-109785A
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Bacterial
                                                    
                                                 | 
                                                
                                                    
                                                        Infection
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    (R)-Gyramide A hydrochloride is a bacterial DNA gyrase inhibitor that disrupts supercoiling activity with an IC50 value of 3.3 µM. (R)-Gyramide A hydrochloride demonstrates antibacterial activity against E. coli, P. aeruginosa, and S. enterica (MICs of 10-80 µM). (R)-Gyramide A hydrochloride does not affect the closely related enzyme topoisomerase IV.
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-D0216
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Others
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Salicylaldoxime is an organic compound, that has been used as a reagent for the gravimetric determination and separation of Cooper, Nickel, Palladium, Lead, Bismuth and Zine. The copper complex of Salicylaldoxime has anticancer activity  .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-B0356B
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     Bay-09867 hydrochloride monohydrate 
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                        Apoptosis
                                                    
                                                        Antibiotic
                                                    
                                                        Bacterial
                                                    
                                                        Mitochondrial Metabolism
                                                    
                                                        Reactive Oxygen Species (ROS)
                                                    
                                                 | 
                                                
                                                    
                                                        Infection
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Ciprofloxacin (Bay-09867) hydrochloride monohydrate is a potent, orally active topoisomerase IV inhibitor. Ciprofloxacin hydrochloride monohydrate induces mitochondrial DNA and nuclear DNA damage and lead to mitochondrial dysfunction, ROS production. Ciprofloxacin hydrochloride monohydrate has anti-proliferative activity and induces apoptosis. Ciprofloxacin hydrochloride monohydrate is a fluoroquinolone antibiotic, exhibiting potent antibacterial activity    .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-108969R
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                        Apoptosis
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Pyrazoloacridine (Standard) is the analytical standard of Pyrazoloacridine. This product is intended for research and analytical applications. Pyrazoloacridine (NSC 366140), an intercalating agent with anti-cancer activity, inhibits the activity of topoisomerases 1 and 2. Pyrazoloacridine (NSC 366140) exhibits an IC50 of 1.25 μM in K562 myeloid leukemia cells for 24 h treatment  .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-W010800
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                        DNA/RNA Synthesis
                                                    
                                                        Apoptosis
                                                    
                                                        Necroptosis
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Cholesteryl hemisuccinate is a with hepatoprotective an anticancer activity. Cholesteryl hemisuccinate inhibits Acetaminophen (AAP, HY-66005) hepatotoxicity, and prevents AAP-induced hepatic apoptosis and necrosis. Cholesteryl hemisuccinate inhibits DNA polymerase and DNA topoisomerase to inhibit DNA replication and repair and cell division. Thus, Cholesteryl hemisuccinate inhibits tumor growth  .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-P10765
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Peptide-Drug Conjugates (PDCs)
                                                    
                                                        Topoisomerase
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    DTS-108 is a prodrug of SN38 (HY-13704) (a Topoisomerase I inhibitor). DTS-108 is a conjugate generated by linking SN38 to a human oligopeptide via an esterase sensitive cross-linker. DTS-108 exhibits anti-tumor activity against colorectal, lung, and mammary cancer  .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-14780
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     NXL 101 
                                                 | 
                                                
                                                    
                                                        Antibiotic
                                                    
                                                        Topoisomerase
                                                    
                                                        DNA/RNA Synthesis
                                                    
                                                        Bacterial
                                                    
                                                 | 
                                                
                                                    
                                                        Infection
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Viquidacin (NXL 101) is an antibiotic with inhibitory activity against topoisomerase IV and DNA gyrase. Viquidacin exhibits antibacterial activity against gram positive bacterial by inhibiting the supercoiling, decatenation and relaxation in strains Staphylococcus aureus and Escherichia coli in micromolar levels. Viquidacin inhibits S. aureus wildtype and mutants with MIC of 2-128 mg/L .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-13629S1
 
                                    - 
                                        
                                    
 
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-B0536A
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     AM 1091 hydrochloride; CI 960 hydrochloride; PD127391 hydrochloride 
                                                 | 
                                                
                                                    
                                                        Bacterial
                                                    
                                                        Antibiotic
                                                    
                                                 | 
                                                
                                                    
                                                        Infection
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Clinafloxacin hydrochloride (AM 1091 hydrochloride) is a potent and broad-spectrum fluoroquinolone antibiotic, has inhibitory activity against gram-positive, gram-negative bacterias, and anaerobic pathogens in vitro . Clinafloxacin hydrochloride is against DNA gyrase and topoisomerase IV of S. aureus with IC50 values of 0.92 µg/ml and 1.62 µg/ml, respectively .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-B0536
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     AM-1091;  CI-960;  PD 127391 
                                                 | 
                                                
                                                    
                                                        Bacterial
                                                    
                                                        Antibiotic
                                                    
                                                 | 
                                                
                                                    
                                                        Infection
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Clinafloxacin (AM 1091) is a potent and broad-spectrum fluoroquinolone antibiotic, has inhibitory activity against gram-positive, gram-negative bacterias, and anaerobic pathogens in vitro . Clinafloxacin is against DNA gyrase and topoisomerase IV of?S. aureus with IC50 values of 0.92 μg/ml and 1.62 μg/ml, respectively .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-168285
 
                                    - 
                                        
                                    
 
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-13629S
 
                                    - 
                                        
                                    
 
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-101647
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     RP 60475 
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Intoplicine (RP 60475), an antitumor derivative in the 7H-benzo[e]pyrido[4,3-b]indole series, is a DNA topoisomerase I and II inhibitor. Intoplicine strongly binds DNA (KA = 2 x 10 5 /M) and thereby increases the length of linear DNA  .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-107096B
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     TP3076 TFA 
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    CH-0793076 (TP3076) TFA, a hexacyclic camptothecin analog, is active drug and major metabolite of TP300. CH-0793076 TFA inhibits DNA topoisomerase I with an IC50 of 2.3 μM. CH-0793076 TFA is efficacious against cells expressing BCRP (breast cancer resistance protein) .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-159483
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                        Autophagy
                                                    
                                                        Glutathione Peroxidase
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    SelB-1 serves as a dual inhibitor for Topoisomerase I/II. SelB-1 possesses anticancer activity and can be utilized in the research of prostate cancer and colon cancer. Furthermore, SelB-1 is also capable of inducing autophagy gene expression and lipid peroxidation, while simultaneously reducing the level of GSH .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-B1099
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        DNA/RNA Synthesis
                                                    
                                                        Topoisomerase
                                                    
                                                        Parasite
                                                    
                                                 | 
                                                
                                                    
                                                        Infection
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Hycanthone is a thioxanthenone DNA intercalator and inhibits RNA synthesis as well as the DNA topoisomerases I and II. Hycanthone inhibits nucleic acid biosynthesis and inhibits apurinic endonuclease-1 (APE1) by direct protein binding with a KD of 10 nM. Hycanthone is a bioactive metabolite of Lucanthone (HY-B2098) and has anti-schistosomal agent .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-B0356
 
                                    - 
                                        
                                    
 
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-B0395E
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     (1S,2R,7S)-DU-6859a;  DU-6856 
                                                 | 
                                                
                                                    
                                                        Antibiotic
                                                    
                                                        Bacterial
                                                    
                                                        Topoisomerase
                                                    
                                                 | 
                                                
                                                    
                                                        Infection
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    (1S,2R,7S)-Sitafloxacin (DU-6856) is an enantiomer of Sitafloxacin (HY-B0395). (1S,2R,7S)-Sitafloxacin is a topoisomerase inhibitor. (1S,2R,7S)-Sitafloxacin is an antibiotic. (1S,2R,7S)-Sitafloxacin has inhibitory activity against Escherichia coli DNA gyrase (IC50 0.18 μg/mL) and Staphylococcus aureus topoisomerase IV. (1S,2R,7S)-Sitafloxacin has antibacterial activity and can be used in the study of various bacterial infections .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-B0398S
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Isotope-Labeled Compounds
                                                    
                                                        Bacterial
                                                    
                                                        Antibiotic
                                                    
                                                        Topoisomerase
                                                    
                                                 | 
                                                
                                                    
                                                        Infection
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Nalidixic Acid-d5 is the deuterium labeled Nalidixic acid. Nalidixic acid, a quinolone antibiotic, is effective against both gram-positive and gram-negative bacteria. Nalidixic acid acts in a bacteriostatic manner in lower concentrations and is bactericidal in higher concentrations. Nalidixic acid inhibits a subunit of DNA gyrase and topoisomerase IV and reversibly blocks DNA replication in susceptible bacteria .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-W744739
 
                                    - 
                                        
                                    
 
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-147307
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Drug-Linker Conjugates for ADC
                                                    
                                                        Topoisomerase
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    MC-Gly-Gly-Phe-Gly-Cyclobutanecarboxylic-Exatecan is a agent-linker conjugate for ADC, contains the ADC linker (MC-Gly-Gly-Phe-Gly-Cyclobutanecarboxylic acid) and a DNA topoisomerase I inhibitor Exatecan (HY-13631). MC-Gly-Gly-Phe-Gly-Cyclobutanecarboxylic-Exatecan synthesized ADC can be used in study of cancer .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-114233
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     MC-GGFG-DX8951 
                                                 | 
                                                
                                                    
                                                        Drug-Linker Conjugates for ADC
                                                    
                                                        Topoisomerase
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    MC-GGFG-Exatecan (MC-GGFG-DX8951) is a agent-linker conjugate for ADC. MC-GGFG-Exatecan is a DX8951 (a DNA topoisomerase I inhibitor) derivative with protease cleavable MC-GGFG linker. MC-GGFG-Exatecan shows antitumor activity and can be used to prepare DX8951 antibody conjugate (ADC) .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-13620
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     LU 79553 
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Elinafide is an anticancer agent with a naphthalimide structure that targets DNA. Elinafide interferes with cell metabolism by inserting a planar ring into the DNA double helix and interacting with enzymes through its side chain.LU-79553 is a DNA-binding topoisomerase II inhibitor. The IC50 value of Elinafide for HT-29 cells is 0.014 μM  .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-P99813
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     HER3-DXd;  U3-1402 
                                                 | 
                                                
                                                    
                                                        Antibody-Drug Conjugates (ADCs)
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Patritumab deruxtecan (HER3-DXd) is an antibody-drug conjugate (ADC) consisting of a fully human anti-HER3 IgG1 monoclonal antibody Patritumab (HY-P99275) attached to a topoisomerase I inhibitor payload via a tetrapeptide-based cleavable linker. Patritumab deruxtecan shows anticancer activity .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-122532
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Histone Methyltransferase
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Fagaronine chloride is an alkaloid with inhibitory activity against reverse transcriptase and topoisomerase I. Fagaronine chloride can effectively inhibit the reverse transcriptase of RSii tumor virus at a concentration of 6-60 μg/mL. Fagaronine chloride rapidly blocks the synthesis of DNA polymerase by interacting with the template primer. Fagaronine chloride has shown anti-tumor potential, especially in the study of retroviral infection .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-123786
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Apoptosis
                                                    
                                                        Caspase
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    NSC745887 (compound 25) is an inhibitor that targets DNA topoisomerase cleavage, activates the caspase-8/9-caspase-3-poly (ADP-ribose) polymerase cascade, and induces apoptosis in cancer cells. NSC745887 enhances γH2AX expression and causes DNA fragmentation leading to DNA damage  .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-13630R
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     BMY-40481 (Standard) 
                                                 | 
                                                
                                                    
                                                        Reference Standards
                                                    
                                                        Topoisomerase
                                                    
                                                        Bacterial
                                                    
                                                        Autophagy
                                                    
                                                        Apoptosis
                                                    
                                                 | 
                                                
                                                    
                                                        Infection
                                                    
                                                        Neurological Disease
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Etoposide phosphate (Standard) is the analytical standard of Etoposide phosphate. This product is intended for research and analytical applications. Etoposide phosphate (BMY-40481) is a potent anti-cancer chemotherapy agent and a selective topoisomerase II inhibitor to prevent re-ligation of DNA strands. Etoposide phosphate is the phosphate ester proagent of etoposide and is considered as active equivalent to Etoposide. Etoposide phosphate induces cell cycle arrest, apoptosis, and autophagy.
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-N0716
 
                                    - 
                                        
                                    
 
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-101647A
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     RP 60475 dimesylate 
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Intoplicine (RP 60475) dimesylate, an antitumor derivative in the 7H-benzo[e]pyrido[4,3-b]indole series, is a DNA topoisomerase I and II inhibitor. Intoplicine dimesylate strongly binds DNA (KA = 2 x 10 5 /M) and thereby increases the length of linear DNA  .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-136170
 
                                    - 
                                        
                                            
                                                
                                                    
                                                        
                                                            MC-SN38
                                                            
                                                        
                                                        
                                                            
                                                                
                                                                
                                                                
                                                                    2 Publications Verification 
                                                                
                                                             
                                                        
                                                     
                                                    
                                                 | 
                                                
                                                    
                                                        Drug-Linker Conjugates for ADC
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    MC-SN38 is a agent-linker conjugate composed of a potent microtubule-disrupting agent SN38 and a non-cleavable MC linker to make antibody agent conjugate (ADC). SN-38, an active metabolite of the Topoisomerase I inhibitor Irinotecan, inhibits DNA synthesis and causes frequent DNA single-strand breaks  .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-171580
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Drug-Linker Conjugates for ADC
                                                    
                                                        Topoisomerase
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Mc-PEG4-Val-Ala-PAB-Exatecan is a Drug-linker conjugate for ADC. Mc-PEG4-Val-Ala-PAB-Exatecan contains the ADC linker (Mc-PEG4-Val-Ala-PAB) and a DNA topoisomerase I inhibitor Exatecan (HY-13631) .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-B0398R
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Reference Standards
                                                    
                                                        Bacterial
                                                    
                                                        Antibiotic
                                                    
                                                        Topoisomerase
                                                    
                                                 | 
                                                
                                                    
                                                        Infection
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Nalidixic acid (Standard) is the analytical standard of Nalidixic acid. This product is intended for research and analytical applications. Nalidixic acid, a quinolone antibiotic, is effective against both gram-positive and gram-negative bacteria. Nalidixic acid acts in a bacteriostatic manner in lower concentrations and is bactericidal in higher concentrations. Nalidixic acid inhibits a subunit of DNA gyrase and topoisomerase IV and reversibly blocks DNA replication in susceptible bacteria .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-N0716BR
 
                                    - 
                                        
                                    
 
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-79490
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        ADC Payload
                                                    
                                                        Topoisomerase
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Ac-Exatecan is acetylation-modified Exatecan (HY-13631). Exatecan is a common toxin component in ADC preparation (ADC cytotoxin) and an inhibitor of DNA topoisomerase I (IC50 = 2.2 μM). Exatecan has antitumor activity. Exatecan can be used as a payload for ADC. Exatecan is effective against P-glycoprotein mediated multi-drug resistant cells  .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-N2306R
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     Aclarubicin (Standard) 
                                                 | 
                                                
                                                    
                                                        Reference Standards
                                                    
                                                        Topoisomerase
                                                    
                                                        DNA/RNA Synthesis
                                                    
                                                        Proteasome
                                                    
                                                        Antibiotic
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Aclacinomycin A (Standard) is the analytical standard of Aclacinomycin A. This product is intended for research and analytical applications. Aclacinomycin A (Aclarubicin) is an orally active and potent anthracycline antitumor antibiotic. Aclacinomycin A is an inhibitor of topoisomerase I and II. Aclacinomycin A inhibits synthesis of nucleic acid, especially RNA. Aclacinomycin A might inhibit the 26S protease complex as well as the ubiquitin-ATP-dependent proteolysis   .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-174800
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    ARN21929 is a Topoisomerase II inhibitor with an IC50 of 4.5 μM. ARN21929 exhibits excellent kinetic and thermodynamic solubility as well as metabolic stability. However, ARN21929 shows poor antiproliferative activity against A549, DU145, MCF7, HeLa, and A375 cells. ARN21929 can be used in the study of cancer .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-W046353
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     o-Methoxycinnamaldehyde 
                                                 | 
                                                
                                                    
                                                        Apoptosis
                                                    
                                                        NF-κB
                                                    
                                                        Topoisomerase
                                                    
                                                        Mitochondrial Metabolism
                                                    
                                                        Caspase
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    2-Methoxycinnamaldehyde (o-Methoxycinnamaldehyde) is a natural compound that can be isolated from Cinnamomum cassia. 2-Methoxycinnamaldehyde inhibits topoisomerase-I/II and NF-κB signaling pathway, causes mitochondrial dysfunction, induces lysosomal vesiculation, thereby leading to DNA damage and cell apoptosis. 2-Methoxycinnamaldehyde exhibits antitumor effects   .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-116926
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Antibiotic
                                                    
                                                        Bacterial
                                                    
                                                        DNA/RNA Synthesis
                                                    
                                                        Topoisomerase
                                                    
                                                        Apoptosis
                                                    
                                                 | 
                                                
                                                    
                                                        Infection
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Deoxynybomycin is an antibiotic, that can be isolated from Streptomyces, and antibacterial activity against Staphylococcus aureus. Deoxynybomycin is the inhibitor for DNA gyrase and Topoisomerase I. Deoxynybomycin induces expression of p21/WAF1, exhibits cytotoxicity and induces apoptosis in cancer cells Saos-2, TMK-1, and THP-1  .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-13624AR
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     4'-Epidoxorubicin hydrochloride (Standard) 
                                                 | 
                                                
                                                    
                                                        Reference Standards
                                                    
                                                        DNA/RNA Synthesis
                                                    
                                                        Topoisomerase
                                                    
                                                        Apoptosis
                                                    
                                                        Antibiotic
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Epirubicin (hydrochloride) (Standard) is the analytical standard of Epirubicin (hydrochloride). This product is intended for research and analytical applications. Epirubicin hydrochloride (4'-Epidoxorubicin hydrochloride), a semisynthetic L-arabino derivative of doxorubicin, has an antineoplastic agent by inhibiting Topoisomerase . Epirubicin hydrochloride inhibits DNA and RNA synthesis. Epirubicin hydrochloride is a Forkhead box protein p3 (Foxp3) inhibitor and inhibits regulatory T cell activity .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-W040298
 
                                    - 
                                        
                                    
 
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-13704S
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     NK012-d3 
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                        ADC Payload
                                                    
                                                        Autophagy
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    SN-38-d3 is the deuterium labeled SN-38. SN-38 (NK012) is an active metabolite of the Topoisomerase I inhibitor Irinotecan. SN-38 (NK012) inhibits DNA and RNA synthesis with IC50s of 0.077 and 1.3 μM, respectively    .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-13631I
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     (1S,9R)-DX8951f 
                                                 | 
                                                
                                                    
                                                        ADC Payload
                                                    
                                                        Topoisomerase
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    (1S,9R)-Exatecan mesylate ((1S,9R)-DX8951f) is an isomer of Exatecan mesylate (HY-13631A). Exatecan mesylate (DX8951f) is an inhibitor of DNA topoisomerase I with an IC50 of 2.2 μM (0.975 μg/mL) and can be used in cancer research .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-B0356A
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     Bay-09867 monohydrochloride 
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                        Apoptosis
                                                    
                                                        Antibiotic
                                                    
                                                        Bacterial
                                                    
                                                        Mitochondrial Metabolism
                                                    
                                                        Reactive Oxygen Species (ROS)
                                                    
                                                 | 
                                                
                                                    
                                                        Infection
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Ciprofloxacin (Bay-09867) monohydrochloride is a potent, orally active topoisomerase IV inhibitor. Ciprofloxacin monohydrochloride induces mitochondrial DNA and nuclear DNA damage and lead to mitochondrial dysfunction, ROS production. Ciprofloxacin monohydrochloride has anti-proliferative activity and induces apoptosis. Ciprofloxacin monohydrochloride is a fluoroquinolone antibiotic, exhibiting potent antibacterial activity    .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-17028
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Bacterial
                                                    
                                                        Antibiotic
                                                    
                                                        DNA/RNA Synthesis
                                                    
                                                        Topoisomerase
                                                    
                                                 | 
                                                
                                                    
                                                        Infection
                                                    
                                                        Inflammation/Immunology
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Besifloxacin Hydrochloride is a fourth generation fluoroquinolone antibiotic. Besifloxacin Hydrochloride is a DNA gyrase and topoisomerase IV inhibitor. Besifloxacin Hydrochloride has broad-spectrum antibacterial activity, it is effective against Gram-negative and Gram-positive aerobic and anaerobic strains and reduces the incidence of drug resistance. Besifloxacin Hydrochloride has anti-inflammatory activity. Besifloxacin Hydrochloride can be used in bacterial conjunctivitis research    .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-106410A
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     DW-224a 
                                                 | 
                                                
                                                    
                                                        Bacterial
                                                    
                                                        Topoisomerase
                                                    
                                                        Antibiotic
                                                    
                                                 | 
                                                
                                                    
                                                        Infection
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Zabofloxacin hydrochloride (DW-224a) is a potent and seletive inhibitor of the bacterial type II and IV topoisomerases. Zabofloxacin hydrochloride has excellent activity against gram-positive pathogens including Steptococcus aureus, Streptococcus pyogenes and S.pneumonia. Zabofloxacin hydrochloride is a novel fluoronaphthyridone quinolone that is considered as an alternative antibiotic for treatment of quinolone-susceptible (QSSP) and quinolone-resistant gonorrhea (QRSP) .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-118899
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Endogenous Metabolite
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    XR5944 is an anti-tumor compound with DNA-targeting activity. As a topoisomerase inhibitor, XR5944 can effectively inhibit the activities of topoisomerase I and II. XR5944 shows excellent anti-tumor activity against human and mouse tumor cells in vitro and in vivo. XR5944 exhibits significant potency in multiple cell lines, with IC50 values of 0.04-0.4 nM. XR5944 is not affected by atypical drug resistance in cells and remains significantly active even in cells overexpressing P-glycoprotein or multidrug resistance-related proteins. XR5944 showed anti-tumor efficacy in human tumor models of H69 small cell lung cancer and HT29 colon cancer, inducing tumor regression in most animals in the HT29 model. XR5944 can be used to study biological processes related to colon and lung cancer .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-P99843
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        TROP2
                                                    
                                                        ADC Antibody
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Datopotamab (CDP7657) is a humanized anti trophoblast cell surface antigen 2 (TROP2) antibody. Datopotamab can generate antibody drug conjugates (ADC) (HY-141598) with DNA topoisomerase I inhibitor Deruxtecan (HY-13631E). Datopotamab can be used in the study of triple negative breast cancer and non-small cell lung cancer .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-W010800A
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     Cholesterol hydrogen succinate Tris salt;  CHS-Tris 
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                        DNA/RNA Synthesis
                                                    
                                                        Apoptosis
                                                    
                                                        Necroptosis
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Cholesterol hemisuccinate Tris salt (CHS-Tris) is a with hepatoprotective an anticancer activity. Cholesterol hemisuccinate Tris salt  inhibits Acetaminophen (AAP, HY-66005) hepatotoxicity, and prevents AAP-induced hepatic apoptosis and necrosis. Cholesterol hemisuccinate Tris salt inhibits DNA polymerase and DNA topoisomerase to inhibit DNA replication and repair and cell division. Thus, Cholesterol hemisuccinate Tris salt inhibits tumor growth  .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-161970
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                        Apoptosis
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    XSJ05 is a camptothecin (CPT) derivative that can inhibit topoisomerase I (Topo I) to exert anti-cancer activity. XSJ05 can trigger DNA double-strand breaks, leading to DNA damage. XSJ05 can inhibit the growth of colorectal cancer (CRC), arrest the cell cycle in G2/M phase, and induce apoptosis .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-145397S
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Isotope-Labeled Compounds
                                                    
                                                        Topoisomerase
                                                    
                                                        ADC Payload
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    (4-NH2)-Exatecan-d5 is a deuterated labeled (4-NH2)-Exatecan . (4-NH2)-Exatecan (compound A), a topoisomerase inhibitor, is a derivative of Exatecan. (4-NH2)-Exatecan can be used in the synthesis of antibody-drug conjugates (ADCs) .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-148696A
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        ADC Payload
                                                    
                                                        Topoisomerase
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Gly-Cyclopropane-Exatecan involves in the synthesis of anti-B7-H4 ADC, containing Exatecan (HY-13631), a DNA Topoisomerase I inhibitor. Gly-Cyclopropane-Exatecan participated in the formation of the ADC hu2F7-Exatecan (compound 34), which showed antitumor activity in vivo and in vitro .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-W653919
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Isotope-Labeled Compounds
                                                    
                                                        Drug Metabolite
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    SN-38 glucuronide-d3 is deuterium labeled SN-38 glucuronide. SN-38 glucuronide is an inactive metabolite of the anticancer active molecule Irinotecan (HY-16562) and has toxic effects on the gastrointestinal tract. Irinotecan is a topoisomerase I inhibitor which can be used for researching colon and rectal cancer    .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-164429
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Integrin
                                                    
                                                        Elastase
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    VIP236 is a small-molecule-drug conjugates (SMDCs) consisting of an αvβ3 integrin binder linked to an optimized Camptothecin (HY-16560) topoisomerase I (TOP1) inhibitor payload. VIP236 exerts anticancer activity by targeting αvβ3 integrins, and it can release payload upon cleavage by neutrophil elastase in the tumor microenvironment .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-120638
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    BMS-250749 is a topoisomerase I (Top I) inhibitor of the fluoroglycosyl-3,9-difluoroindolecarbazole class. BMS-250749 exhibits potent cytotoxicity and selectivity, and shows curative antitumor activity against Lewis lung cancer. BMS-250749 exhibits broad-spectrum antitumor activity superior to CPT-11 in certain preclinical xenograft models. .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-13062A
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     Daunomycin;  RP 13057;  Rubidomycin 
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                        DNA/RNA Synthesis
                                                    
                                                        ADC Payload
                                                    
                                                        Autophagy
                                                    
                                                        Bacterial
                                                    
                                                        Antibiotic
                                                    
                                                        Apoptosis
                                                    
                                                 | 
                                                
                                                    
                                                        Infection
                                                    
                                                        Neurological Disease
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Daunorubicin (Daunomycin) is a topoisomerase II inhibitor with potent anti-tumor activity. Daunorubicin inhibits DNA and RNA synthesis. Daunorubicin is a cytotoxin that inhibits cancer cell viability and induces apoptosis and necrosis. Daunorubicin is also an anthracycline antibiotic. Daunorubicin can be used in the research of infection and variety of cancers, including leukemia, non-Hodgkin lymphomas, Ewing's sarcoma, Wilms' tumor    .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-B0330D
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     Dextrofloxacin 
                                                 | 
                                                
                                                    
                                                        Bacterial
                                                    
                                                        Antibiotic
                                                    
                                                 | 
                                                
                                                    
                                                        Infection
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    (R)-Ofloxacin is the dextrorotatory enantiomer of Ofloxacin (HY-B0125) and is an orally effective fluoroquinolone antibiotic. (R)-Ofloxacin can inhibit the activity of bacterial DNA topoisomerase II, interfere with bacterial DNA replication and repair, and exert a bactericidal effect. (R)-Ofloxacin has a broad-spectrum antibacterial activity and has inhibitory effects on both Gram-negative and Gram-positive bacteria  .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-13062
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     Daunomycin hydrochloride; RP 13057 hydrochloride; Rubidomycin hydrochloride 
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                        DNA/RNA Synthesis
                                                    
                                                        ADC Payload
                                                    
                                                        Bacterial
                                                    
                                                        Autophagy
                                                    
                                                        Apoptosis
                                                    
                                                        Antibiotic
                                                    
                                                 | 
                                                
                                                    
                                                        Infection
                                                    
                                                        Neurological Disease
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Daunorubicin (Daunomycin) hydrochloride is a topoisomerase II inhibitor with potent anti-tumor activity. Daunorubicin hydrochloride inhibits DNA and RNA synthesis. Daunorubicin hydrochloride is a cytotoxin that inhibits cancer cell viability and induces apoptosis and necrosis. Daunorubicin hydrochloride is also an anthracycline antibiotic. Daunorubicin hydrochloride can be used in the research of infection and variety of cancers, including leukemia, non-Hodgkin lymphomas, Ewing's sarcoma, Wilms' tumor    .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-106410
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     DW-224a Free base 
                                                 | 
                                                
                                                    
                                                        Bacterial
                                                    
                                                        Topoisomerase
                                                    
                                                        Antibiotic
                                                    
                                                 | 
                                                
                                                    
                                                        Infection
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Zabofloxacin (DW-224a Free base) is a potent and seletive inhibitor of the bacterial type II and IV topoisomerases. Zabofloxacin has excellent activity against gram-positive pathogens including Steptococcus aureus, Streptococcus pyogenes and S.pneumonia. Zabofloxacin is a novel fluoronaphthyridone quinolone that is considered as an alternative antibiotic for treatment of quinolone-susceptible (QSSP) and quinolone-resistant gonorrhea (QRSP) .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-150045
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                        Bacterial
                                                    
                                                 | 
                                                
                                                    
                                                        Infection
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    TP0480066 is a selective topoisomerase II inhibitor with IC50s of 1.10 and 62.89 nM for DNA gyrase and topo IV, respectively. TP0480066 shows good activity of againsting various bacterial species including drug-resistant strains. TP0480066 also exhibits potent inhibitory activity to N. gonorrhoeae, can be used in study of gonorrhea  .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-13631J
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     (1R,9R)-DX8951f 
                                                 | 
                                                
                                                    
                                                        ADC Payload
                                                    
                                                        Topoisomerase
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    (1R,9R)-Exatecan mesylate((1R,9R)-DX8951f) is an isomer of Exatecan mesylate (HY-13631A). Exatecan mesylate (DX8951f) is an inhibitor of DNA topoisomerase I with an IC50 of 2.2 μM (0.975 μg/mL) and can be used in cancer research .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-174151
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                        Apoptosis
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    XSJ110 is a potent irreversible topoisomerase I (Topo I) inhibitor with an IC50 value of 0.133 μM. XSJ110 blocks DNA topoisomerization, induces DNA double-strand breaks, and triggers cell cycle arrest at G0/G1 phase, inducing tumor cell apoptosis. XSJ110 is promising for research of ampullary carcinoma (AC) .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-B0330AR
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     Levofloxacin hemihydrate (Standard) 
                                                 | 
                                                
                                                    
                                                        Reference Standards
                                                    
                                                        Bacterial
                                                    
                                                        Antibiotic
                                                    
                                                        Topoisomerase
                                                    
                                                        DNA/RNA Synthesis
                                                    
                                                        Orthopoxvirus
                                                    
                                                 | 
                                                
                                                    
                                                        Infection
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Levofloxacin (hydrate) (Standard) is the analytical standard of Levofloxacin (hydrate). This product is intended for research and analytical applications. Levofloxacin hydrate (Levofloxacin hemihydrate) is an orally active antibiotic and is active against both Gram-positive and Gram-negative bacteria. Levofloxacin hydrate inhibits the DNA gyrase and topoisomerase IV. Levofloxacin hydrate can be used for chronic periodontitis, airway inflammation and BK Viremia research. Levofloxacin hydrate shows anti-orthopoxvirus activity    .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-N8248A
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    (-)-Eleutherin is a pyranonaphthoquinone derivative that exhibits cytotoxic activity by inhibiting DNA topoisomerase II. (-)-Eleutherin has been shown to have promising potential as a medicinal compound due to its association with naphthoquinones. (-)-Eleutherin demonstrates significant DNA fragmentation rates, indicating its strong cytotoxic effects on cells. Additionally, (-)-Eleutherin possesses higher antioxidant potential compared to control samples, contributing to its therapeutic efficacy.
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-B0330R
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     (-)-Ofloxacin (Standard) 
                                                 | 
                                                
                                                    
                                                        Antibiotic
                                                    
                                                        DNA/RNA Synthesis
                                                    
                                                        Orthopoxvirus
                                                    
                                                        Topoisomerase
                                                    
                                                        Bacterial
                                                    
                                                        Reference Standards
                                                    
                                                 | 
                                                
                                                    
                                                        Infection
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Levofloxacin (Standard) is the analytical standard of Levofloxacin. This product is intended for research and analytical applications. Levofloxacin ((-)-Ofloxacin) is an orally active antibiotic and is active against both Gram-positive and Gram-negative bacteria. Levofloxacin inhibits the DNA gyrase and topoisomerase IV.  Levofloxacin can be used for chronic periodontitis, airway inflammation and BK Viremia research. Levofloxacin shows anti-orthopoxvirus activity     .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-141436R
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     Sucrose octasulfate potassium (Standard) 
                                                 | 
                                                
                                                    
                                                        Biochemical Assay Reagents
                                                    
                                                        Reference Standards
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Sucrosofate (potassium) (Standard) is the analytical standard of Sucrosofate (potassium). This product is intended for research and analytical applications. Sucrosofate (Sucrose octasulfate) potassium is a sucrose acid that can be used to prepare liposomes to deliver Irinotecan (HY-16562). Irinotecan is an inhibitor of topoisomerase Topo I and is commonly used in colon and rectal cancer research. Sucrosofate nanoliposome preparation loaded with Irinotecan, also known as PEP02 or MM-398  .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-17028A
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Bacterial
                                                    
                                                        Antibiotic
                                                    
                                                        DNA/RNA Synthesis
                                                    
                                                        Topoisomerase
                                                    
                                                 | 
                                                
                                                    
                                                        Infection
                                                    
                                                        Inflammation/Immunology
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    (Rac)-Besifloxacin Hydrochloride is a fourth generation fluoroquinolone antibiotic. (Rac)-Besifloxacin Hydrochloride is a DNA gyrase and topoisomerase IV inhibitor. (Rac)-Besifloxacin Hydrochloride has broad-spectrum antibacterial activity, it is effective against Gram-negative and Gram-positive aerobic and anaerobic strains and reduces the incidence of drug resistance. (Rac)-Besifloxacin Hydrochloride has anti-inflammatory activity. Besifloxacin Hydrochloride can be used in bacterial conjunctivitis research    .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-132561S
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Isotope-Labeled Compounds
                                                    
                                                        Topoisomerase
                                                    
                                                        Cholinesterase (ChE)
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    RPR121056-d3 is the deuterium labeled RPR121056. RPR121056 is a metabolite of Irinotecan (HY-16562), which is generated by CYP3A4. Irinotecan (CPT-11) is an antineoplastic agent that inhibits topoisomerase type I, causing cell death, and is widely used in the treatment of colorectal cancer. Irinotecan also directly inhibits AChE  .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-N0095
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     10-HCPT;  10-Hydroxycamptothecin 
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                        Apoptosis
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    (S)-10-Hydroxycamptothecin (10-HCPT;10-Hydroxycamptothecin) is a DNA topoisomerase I inhibitor of isolated from the Chinese plant Camptotheca accuminata.  (S)-10-Hydroxycamptothecin exhibits a remarkable apoptosis-inducing effect. (S)-10-Hydroxycamptothecin has the potential for hepatoma, gastric carcinoma, colon cancer and leukaemia treatment    .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-100620R
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     APC (Standard) 
                                                 | 
                                                
                                                    
                                                        Drug Metabolite
                                                    
                                                        Reference Standards
                                                    
                                                        Topoisomerase
                                                    
                                                        Cholinesterase (ChE)
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    RPR121056 (Standard) is the analytical standard of RPR121056. This product is intended for research and analytical applications. RPR121056 (APC) is a metabolite of Irinotecan (CPT-11), which is generated by CYP3A4. Irinotecan (CPT-11) is an antineoplastic agent that inhibits topoisomerase type I, causing cell death, and is widely used in the treatment of colorectal cancer. Irinotecan also directly inhibits AChE[1].
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-16700G
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        ADC Payload
                                                    
                                                        Topoisomerase
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    PNU-159682 GMP is a GMP grade PNU-159682 (HY-16700). PNU-159682, a metabolite of the anthracycline Nemorubicin, is a highly potent DNA topoisomerase II inhibitor with excellent cytotoxicity. PNU-159682 acts as a more potent and tolerated ADC cytotoxin than Doxorubicin for ADC synthesis. PNU-159682 can be used in EDV-nanocell technology to overcome agent resistance.
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-17028R
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Reference Standards
                                                    
                                                        Bacterial
                                                    
                                                        Antibiotic
                                                    
                                                        DNA/RNA Synthesis
                                                    
                                                        Topoisomerase
                                                    
                                                 | 
                                                
                                                    
                                                        Infection
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Besifloxacin (Hydrochloride) (Standard) is a fourth generation fluoroquinolone antibiotic. Besifloxacin Hydrochloride (Standard) is a DNA gyrase and topoisomerase IV inhibitor. Besifloxacin Hydrochloride (Standard) has broad-spectrum antibacterial activity, it is effective against Gram-negative and Gram-positive aerobic and anaerobic strains and reduces the incidence of drug resistance. Besifloxacin Hydrochloride (Standard) has anti-inflammatory activity. Besifloxacin Hydrochloride (Standard) can be used in bacterial conjunctivitis research    .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-B1099R
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        DNA/RNA Synthesis
                                                    
                                                        Topoisomerase
                                                    
                                                        Parasite
                                                    
                                                 | 
                                                
                                                    
                                                        Infection
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Hycanthone (Standard) is the analytical standard of Hycanthone. This product is intended for research and analytical applications. Hycanthone is a thioxanthenone DNA intercalator and inhibits RNA synthesis as well as the DNA topoisomerases I and II. Hycanthone inhibits nucleic acid biosynthesis and inhibits apurinic endonuclease-1 (APE1) by direct protein binding with a KD of 10 nM. Hycanthone is a bioactive metabolite of Lucanthone (HY-B2098) and has anti-schistosomal agent .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-B0356R
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     Bay-09867 (Standard) 
                                                 | 
                                                
                                                    
                                                        Reference Standards
                                                    
                                                        Topoisomerase
                                                    
                                                        Apoptosis
                                                    
                                                        Antibiotic
                                                    
                                                        Bacterial
                                                    
                                                        Mitochondrial Metabolism
                                                    
                                                        Reactive Oxygen Species (ROS)
                                                    
                                                 | 
                                                
                                                    
                                                        Infection
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Ciprofloxacin (Standard) is the analytical standard of Ciprofloxacin. This product is intended for research and analytical applications. Ciprofloxacin (Bay-09867) is a potent, orally active topoisomerase IV inhibitor. Ciprofloxacin induces mitochondrial DNA and nuclear DNA damage and lead to mitochondrial dysfunction, ROS production. Ciprofloxacin has anti-proliferative activity and induces apoptosis. Ciprofloxacin is a fluoroquinolone antibiotic, exhibiting potent antibacterial activity    .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-B0536R
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     AM-1091 (Standard); CI-960 (Standard); PD 127391 (Standard) 
                                                 | 
                                                
                                                    
                                                        Reference Standards
                                                    
                                                        Bacterial
                                                    
                                                        Antibiotic
                                                    
                                                 | 
                                                
                                                    
                                                        Infection
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Clinafloxacin (Standard) is the analytical standard of Clinafloxacin. This product is intended for research and analytical applications. Clinafloxacin (AM 1091) is a potent and broad-spectrum fluoroquinolone antibiotic, has inhibitory activity against gram-positive, gram-negative bacterias, and anaerobic pathogens in vitro . Clinafloxacin is against DNA gyrase and topoisomerase IV of S. aureus with IC50 values of 0.92 µg/ml and 1.62 µg/ml, respectively .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-158109
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Antibody-Drug Conjugates (ADCs)
                                                    
                                                        CD2
                                                    
                                                        Topoisomerase
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    M3554 is an anti-GD2 antibody-drug conjugate (ADC) based on the humanized anti-GD2 antibody. M3554 consists of the humanized monoclonal antibody Dinutuximab (HY-P9933) linked to a topoisomerase 1 inhibitor Exatecan (HY-13631) via a cleavable β-glucuronide linker. M3554 can be used for the study of neuroblastoma, osteosarcoma or glioma .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-13704R
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     7-Ethyl-10-hydroxycamptothecin (Standard) 
                                                 | 
                                                
                                                    
                                                        Drug Metabolite
                                                    
                                                        Reference Standards
                                                    
                                                        Topoisomerase
                                                    
                                                        ADC Payload
                                                    
                                                        Autophagy
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    SN-38 (Standard) is the analytical standard of SN-38. This product is intended for research and analytical applications. SN-38 is an active metabolite of the Topoisomerase I inhibitor Irinotecan. SN-38 inhibits DNA and RNA synthesis with IC50s of 0.077 and 1.3 μM, respectively. SN-38 is a payload of sacituzumab govitecan (HY -132254)     .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-B0067B
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     (R)-SM-5887 
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    (R)-Amrubicin ((R)-SM-5887) is an anthracycline that effectively treats lung cancer by intercalating into DNA and inhibiting topoisomerase II activity, which consequently hampers DNA replication as well as RNA and protein synthesis, leading to cell growth inhibition and apoptosis. This compound exhibits superior anti-tumor efficacy compared to traditional anthracycline drugs while lacking the cumulative cardiac toxicity typically associated with this drug class.
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-B0356BR
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     Bay-09867 hydrochloride monohydrate (Standard) 
                                                 | 
                                                
                                                    
                                                        Reference Standards
                                                    
                                                        Topoisomerase
                                                    
                                                        Apoptosis
                                                    
                                                        Antibiotic
                                                    
                                                        Bacterial
                                                    
                                                        Mitochondrial Metabolism
                                                    
                                                        Reactive Oxygen Species (ROS)
                                                    
                                                 | 
                                                
                                                    
                                                        Infection
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Ciprofloxacin (hydrochloride monohydrate) (Standard) is the analytical standard of Ciprofloxacin (hydrochloride monohydrate). This product is intended for research and analytical applications. Ciprofloxacin (Bay-09867) hydrochloride monohydrate is a potent, orally active topoisomerase IV inhibitor. Ciprofloxacin hydrochloride monohydrate induces mitochondrial DNA and nuclear DNA damage and lead to mitochondrial dysfunction, ROS production. Ciprofloxacin hydrochloride monohydrate has anti-proliferative activity and induces apoptosis. Ciprofloxacin hydrochloride monohydrate is a fluoroquinolone antibiotic, exhibiting potent antibacterial activity    .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-150571
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                        c-Myc
                                                    
                                                        Apoptosis
                                                    
                                                        ROS Kinase
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Anticancer agent 76 (Compound CT2-3) is an anticancer agent. Anticancer agent 76 significantly inhibits the proliferation of human NSCLC cells, induces cell cycle arrest, causes ROS generation and induces cell apoptosis .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-B0330BS1
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     (-)-Ofloxacin-d3 hydrochloride 
                                                 | 
                                                
                                                    
                                                        Isotope-Labeled Compounds
                                                    
                                                        Antibiotic
                                                    
                                                        Bacterial
                                                    
                                                        Topoisomerase
                                                    
                                                        DNA/RNA Synthesis
                                                    
                                                        Orthopoxvirus
                                                    
                                                 | 
                                                
                                                    
                                                        Infection
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Levofloxacin-d3 ((-)-Ofloxacin-d3) hydrochlorideis deuterium labeled Levofloxacin (hydrochloride). Levofloxacin ((-)-Ofloxacin) hydrochloride is an orally active antibiotic and is active against both Gram-positive and Gram-negative bacteria. Levofloxacin hydrochloride inhibits the DNA gyrase and topoisomerase IV.  Levofloxacin hydrochloride can be used for chronic periodontitis, airway inflammation and BK Viremia research.  Levofloxacin hydrochloride shows anti-orthopoxvirus activity      .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-13721
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     Idronoxil;  Dehydroequol;  Haginin E 
                                                 | 
                                                
                                                    
                                                        Caspase
                                                    
                                                        Apoptosis
                                                    
                                                        Topoisomerase
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Phenoxodiol (Idronoxil), a synthetic analog of Genestein, activates the mitochondrial caspase system, inhibits XIAP (an apoptosis inhibitor), and sensitizes the cancer cells to Fas-mediated apoptosis. Phenoxodiol also inhibits DNA topoisomerase II by stabilizing the cleavable complex. Phenoxodiol induces cell cycle arrest in the G1/S phase of the cell cycle and upregulates p21 WAF1 via a p53 independent manner  .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-171138
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     SET0568 
                                                 | 
                                                
                                                    
                                                        Drug-Linker Conjugates for ADC
                                                    
                                                        Topoisomerase
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Mal-VC-PAB-DMEA-PNU-159682 is a agent-linker conjugate for ADC with potent antitumor activity by using the anti-topoisomerase II agent, PNU-159682, linked via the lysosomally cleavable dipeptide, Mc-VC-PAB. Mal-VC-PAB-DMEA-PNU-159682 can be used in the synthesis of Anti-CD22-NMS249 (HY-164761) .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-B1050
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     SB-265805S;  LB-20304a 
                                                 | 
                                                
                                                    
                                                        Bacterial
                                                    
                                                        Antibiotic
                                                    
                                                        DNA/RNA Synthesis
                                                    
                                                        Topoisomerase
                                                    
                                                 | 
                                                
                                                    
                                                        Infection
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Gemifloxacin mesylate (SB-265805S; LB-20304a) is an orally active broad-spectrum quinolone antibacterial antibiotic. Gemifloxacin mesylate inhibits DNA synthesis by inhibiting DNA gyrase and Topoisomerase IV activities. Gemifloxacin mesylate has potent antibacterial activities against gram-positive bacteria in vitro efficacy study, particularly Streptococci and Staphylococci. Gemifloxacin mesylate has been used in the research of respiratory tract infections   .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-128942
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Drug-Linker Conjugates for ADC
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    MAC glucuronide α-hydroxy lactone-linked SN-38 (Topoisomerase I inhibitor) is a stabilized lactone MAC glucuronide α-hydroxy lactone-linked SN-38 agent linker. MAC glucuronide α-hydroxy lactone-linked SN-38 is cytotoxic across L540cy cells and Ramos cells with IC50 values of 99 and 105 ng/mL, respectively .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-171124
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     AZD9592 
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                        DNA/RNA Synthesis
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Tilatamig samrotecan (AZD9592) is an antibody-drug conjugate (ADC) used to deliver topoisomerase I inhibitors (TOP1i), targeting the epidermal growth factor receptor (EGFR) and c-MET, with anti-tumor activity. Tilatamig samrotecan (AZD9592) can induce DNA double-strand breaks, increase the expression of pRAD50 and γH2AX, and inhibit the growth of non-small cell lung cancer  .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-W744243
 
                                    - 
                                        
                                    
 
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-108876
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     Daunomycin(citrate); RP 13057(citrate); Rubidomycin(citrate) 
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                        DNA/RNA Synthesis
                                                    
                                                        ADC Payload
                                                    
                                                        Autophagy
                                                    
                                                        Bacterial
                                                    
                                                        Antibiotic
                                                    
                                                        Apoptosis
                                                    
                                                 | 
                                                
                                                    
                                                        Infection
                                                    
                                                        Neurological Disease
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Daunorubicin (Daunomycin) citrate is a topoisomerase II inhibitor with potent anti-tumor activity. Daunorubicin citrate inhibits DNA and RNA synthesis. Daunorubicin citrate is a cytotoxin that inhibits cancer cell viability and induces apoptosis and necrosis. Daunorubicin citrate is also an anthracycline antibiotic. Daunorubicin citrate can be used in the research of infection and variety of cancers, including leukemia, non-Hodgkin lymphomas, Ewing's sarcoma, Wilms' tumor    .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-143278
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                        FLT3
                                                    
                                                        Apoptosis
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    FLT3-IN-13 (compound 20) is a potent and effective antileukemic topoisomerase II and FLT3 dual inhibitor with IC50 values of 2.26 μM and 2.26 μM, respectively. FLT3-IN-13 arrests cell cycle at G2/M phase and induce apoptosis. FLT3-IN-13 has anticytotoxic activity, particularly against leukemia .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-W744235
 
                                    - 
                                        
                                    
 
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-N6769
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     Monorden 
                                                 | 
                                                
                                                    
                                                        HSP
                                                    
                                                        Bacterial
                                                    
                                                        Antibiotic
                                                    
                                                        Parasite
                                                    
                                                 | 
                                                
                                                    
                                                        Infection
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Radicicol is an inhibitor of Hsp90 with an IC50 value < 1 μM, and leads to proteasomal degradation . Radicicol exhibits inhibition on PDK with IC50s of 230 μM (PDK1) and 400 μM (PDK3). Radicicol is an antifungal and antimalarial antibiotic, impairs mitochondrial replication by targeting P. falciparum topoisomerase VIB . Radicicol is also an inhibitor of fat mass and obesity-associated protein (FTO), with an IC50 value of 16.04 μM .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-13502B
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     Mitozantrone diacetate; NSC 301739 diacetate 
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                        PKC
                                                    
                                                        Orthopoxvirus
                                                    
                                                        Apoptosis
                                                    
                                                        Endogenous Metabolite
                                                    
                                                 | 
                                                
                                                    
                                                        Infection
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Mitoxantrone diacetate is a potent topoisomerase II inhibitor. Mitoxantrone diacetate also inhibits protein kinase C (PKC) activity with an IC50 of 8.5 μM. Mitoxantrone diacetate induces apoptosis of B-CLL (B-chronic lymphocytic leukaemia) cells. Mitoxantrone diacetate shows antitumor activity    . Mitoxantrone diacetate also has anti-orthopoxvirus activity with EC50s of 0.25 μM and and 0.8 μM for cowpox and monkeypox, respectively .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-173639
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Antibody-Drug Conjugates (ADCs)
                                                    
                                                        Topoisomerase
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    AZD0516 is a first-in-class antibody-drug conjugate (ADC) targeting six-transmembrane epithelial antigen of the prostate-2 (STEAP2). The anti-STEAP2 monoclonal antibody (mAb) is conjugated via interchain cysteines to a maleimide-reactive, β-glucuronidase-cleavable linker (HY-173635) bearing the topoisomerase 1 inhibitor, Exatecan (HY-13631). AZD0516 can be used for the study of prostate cancer .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-13502
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     Mitozantrone;  NSC 301739 
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                        PKC
                                                    
                                                        Orthopoxvirus
                                                    
                                                        Apoptosis
                                                    
                                                        Endogenous Metabolite
                                                    
                                                 | 
                                                
                                                    
                                                        Infection
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Mitoxantrone is a potent topoisomerase II inhibitor. Mitoxantrone also inhibits protein kinase C (PKC) activity with an IC50 of 8.5 μM. Mitoxantrone induces apoptosis of B-CLL (B-chronic lymphocytic leukaemia) cells. Mitoxantrone shows antitumor activity    . Mitoxantrone also has anti-orthopoxvirus activity with EC50s of 0.25 μM and and 0.8 μM for cowpox and monkeypox, respectively .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-W010800R
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Reference Standards
                                                    
                                                        Topoisomerase
                                                    
                                                        DNA/RNA Synthesis
                                                    
                                                        Apoptosis
                                                    
                                                        Necroptosis
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Cholesteryl hemisuccinate (Standard) is the analytical standard of Cholesteryl hemisuccinate. This product is intended for research and analytical applications. Cholesteryl hemisuccinate is a with hepatoprotective an anticancer activity. Cholesteryl hemisuccinate inhibits Acetaminophen (AAP, HY-66005) hepatotoxicity, and prevents AAP-induced hepatic apoptosis and necrosis. Cholesteryl hemisuccinate inhibits DNA polymerase and DNA topoisomerase to inhibit DNA replication and repair and cell division. Thus, Cholesteryl hemisuccinate inhibits tumor growth[1][2].
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-101959
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     AG213 
                                                 | 
                                                
                                                    
                                                        EGFR
                                                    
                                                        Topoisomerase
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Tyrphostin AG213 (AG213) is an inhibitor of epidermal growth factor receptor (EGFR) protein tyrosine kinase (IC50=0.85 μM). Tyrphostin AG213 inhibits tyrosine kinase activity IC50=2.4 μM) and topoisomerase II (IC100=50 μM). Tyrphostin AG213 can induce nonapoptotic cell programmed death in tumor cells   .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-13768S1
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Isotope-Labeled Compounds
                                                    
                                                        Topoisomerase
                                                    
                                                        Autophagy
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Topotecan-d6 is the deuterium labeled Topotecan. Topotecan (SKF 104864A; NSC 609669) is a Topoisomerase I inhibitor. The IC50 values of Topotecan at 24 h are 2.73±0.25 μM of U251 cells, 2.95±0.23 μM of U87 cells, 5.46±0.41 μM of GSCs-U251 and 5.95 μM of GSCs-U87  .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-B0356S2
 
                                    - 
                                        
                                    
 
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-13502A
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     Mitozantrone dihydrochloride; NSC 301739 dihydrochloride 
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                        PKC
                                                    
                                                        Orthopoxvirus
                                                    
                                                        Apoptosis
                                                    
                                                        Endogenous Metabolite
                                                    
                                                 | 
                                                
                                                    
                                                        Infection
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Mitoxantrone dihydrochloride is a potent topoisomerase II inhibitor. Mitoxantrone dihydrochloride also inhibits protein kinase C (PKC) activity with an IC50 of 8.5 μM. Mitoxantrone dihydrochloride induces apoptosis of B-CLL (B-chronic lymphocytic leukaemia) cells. Mitoxantrone dihydrochloride shows antitumor activity    . Mitoxantrone dihydrochloride also has anti-orthopoxvirus activity with EC50s of 0.25 μM and and 0.8 μM for cowpox and monkeypox, respectively .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-13768S
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     SKF 104864A-d5;  NSC 609669-d5 
                                                 | 
                                                
                                                    
                                                        Isotope-Labeled Compounds
                                                    
                                                        Topoisomerase
                                                    
                                                        Autophagy
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Topotecan-d5 is the deuterium labeled Topotecan. Topotecan (SKF 104864A; NSC 609669) is a Topoisomerase I inhibitor. The IC50 values of Topotecan at 24 h are 2.73±0.25 μM of U251 cells, 2.95±0.23 μM of U87 cells, 5.46±0.41 μM of GSCs-U251 and 5.95±0.24 μM of GSCs-U87  .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-161501
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        GLUT
                                                    
                                                        Topoisomerase
                                                    
                                                        Apoptosis
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    3-Fluoro-evodiamine glucose (Compound 8) is an evodiamine-glucose conjugate. 3-Fluoro-evodiamine glucose activates the expression of glucose transporter 1 (GLUT1), and inhibits topoisomerase I/II. 3-Fluoro-evodiamine glucose induces apoptosis and arrests the cell cycle at G2/M phase. 3-Fluoro-evodiamine glucose exhibits antitumor efficacy in vivo and in vitro, without significant toxicity .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-134723
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Drug-Linker Conjugates for ADC
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    DBCO-PEG4-GGFG-Dxd is a agent-linker conjugate for ADC with potent antitumor activity by using Dxd (a DNA topoisomerase I inhibitor), linked via the cleavable ADC linker DBCO-PEG4-GGFG . DBCO-PEG4-GGFG-Dxd is a click chemistry reagent, it contains a DBCO group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-164762
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     SHR-A1811 
                                                 | 
                                                
                                                    
                                                        Antibody-Drug Conjugates (ADCs)
                                                    
                                                        EGFR
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Trastuzumab rezetecan (SHR-A1811) is a HER2-targeting antibody-drug conjugate (ADC). Trastuzumab rezetecan is composed of a humanized anti-HER2 antibody (HY-P9907), a cleavable linker MC-Gly-Gly-Phe-Gly (HY-44246), and a topoisomerase I inhibitor payload Rezetecán (HY-147408). Trastuzumab rezetecan can be used for research in HER2-positive breast cancer .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-156376
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Cuproptosis
                                                    
                                                        Apoptosis
                                                    
                                                        Topoisomerase
                                                    
                                                        Reactive Oxygen Species (ROS)
                                                    
                                                 | 
                                                
                                                    
                                                        Inflammation/Immunology
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Cu(II)-Elesclomol is a complex formed by Elesclomol (HY-12040) and Cu 2+ (copper ions). Cu(II)-Elesclomol is also a weak inhibitor of DNA topoisomerase I. Cu(II)-Elesclomol exerts anticancer effects by inducing oxidative stress and DNA damage through copper chelation. Cu(II)-Elesclomol can inhibit tumor cell proliferation and induce cell cycle arrest and apoptosis. Cu(II)-Elesclomol can be used in the study of cancer  .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-128943
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Drug-Linker Conjugates for ADC
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    MAC glucuronide phenol-linked SN-38 is a pH-susceptible lactone MAC glucuronide phenol-linked SN-38 (DNA topoisomerase I inhibitor) agent linker. MAC glucuronide phenol-linked SN-38 is cytotoxic across L540cy cells and Ramos cells with IC50 values of 113 and 67 ng/mL, respectively.Albumin-coupled MAC glucosidol-linked SN-38 shows good stability in mouse plasma  .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-B0330DS
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Isotope-Labeled Compounds
                                                    
                                                        Bacterial
                                                    
                                                        Antibiotic
                                                    
                                                 | 
                                                
                                                    
                                                        Infection
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    (R)-Ofloxacin-d3 is the deuterium labeled (R)-Ofloxacin. (R)-Ofloxacin is the dextrorotatory enantiomer of Ofloxacin (HY-B0125) and is an orally effective fluoroquinolone antibiotic. (R)-Ofloxacin can inhibit the activity of bacterial DNA topoisomerase II, interfere with bacterial DNA replication and repair, and exert a bactericidal effect. (R)-Ofloxacin has a broad-spectrum antibacterial activity and has inhibitory effects on both Gram-negative and Gram-positive bacteria   .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-W040298R
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     Bay-09867 lactate (Standard) 
                                                 | 
                                                
                                                    
                                                        Reference Standards
                                                    
                                                        Topoisomerase
                                                    
                                                        Apoptosis
                                                    
                                                        Antibiotic
                                                    
                                                        Bacterial
                                                    
                                                        Mitochondrial Metabolism
                                                    
                                                        Reactive Oxygen Species (ROS)
                                                    
                                                 | 
                                                
                                                    
                                                        Infection
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Ciprofloxacin (lactate) (Standard) is the analytical standard of Ciprofloxacin (lactate). This product is intended for research and analytical applications. Ciprofloxacin (Bay-09867) lactate is a potent, orally active topoisomerase IV inhibitor. Ciprofloxacin lactate induces mitochondrial DNA and nuclear DNA damage and lead to mitochondrial dysfunction, ROS production. Ciprofloxacin lactate has anti-proliferative activity and induces apoptosis. Ciprofloxacin lactate is a fluoroquinolone antibiotic, exhibiting potent antibacterial activity   [4].
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-B0455
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     SC47111A hydrochloride; NY-198 hydrochloride 
                                                 | 
                                                
                                                    
                                                        Antibiotic
                                                    
                                                        Bacterial
                                                    
                                                        Topoisomerase
                                                    
                                                        Reactive Oxygen Species (ROS)
                                                    
                                                        Apoptosis
                                                    
                                                 | 
                                                
                                                    
                                                        Infection
                                                    
                                                        Endocrinology
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Lomefloxacin hydrochloride (NY-198 hydrochloride) is an orally active difluoroquinolone antibiotic. Lomefloxacin hydrochloride prevents DNA supercoiling and replication by inhibiting bacterial topoisomerase II. Lomefloxacin hydrochloride induces ROS production and Apoptosis. Lomefloxacin hydrochloride has broad-spectrum bactericidal activity against Gram-positive and Gram-negative bacteria. Lomefloxacin hydrochloride has anticancer effects against melanoma. Lomefloxacin hydrochloride can be used in the study of systemic bacterial infections (such as Salmonella typhimurium infections), skin and melanoma       .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-16560S
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     Campathecin-d5; (S)-(+)-Camptothecin-d5; CPT-d5 
                                                 | 
                                                
                                                    
                                                        Isotope-Labeled Compounds
                                                    
                                                        Topoisomerase
                                                    
                                                        ADC Payload
                                                    
                                                        MicroRNA
                                                    
                                                        Influenza Virus
                                                    
                                                        Apoptosis
                                                    
                                                        Fungal
                                                    
                                                        Antibiotic
                                                    
                                                 | 
                                                
                                                    
                                                        Infection
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Camptothecin-d5 is the deuterium labeled Camptothecin. Camptothecin (CPT), a kind of alkaloid, is a DNA topoisomerase I (Topo I) inhibitor with an IC50 of 679 nM . Camptothecin (CPT) exhibits powerful antineoplastic activity against colorectal, breast, lung and ovarian cancers, modulates hypoxia-inducible factor-1α (HIF-1α) activity by changing microRNAs (miRNA) expression patterns in human cancer cells  .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-B0356AR
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     Bay-09867 monohydrochloride (Standard) 
                                                 | 
                                                
                                                    
                                                        Reference Standards
                                                    
                                                        Topoisomerase
                                                    
                                                        Apoptosis
                                                    
                                                        Antibiotic
                                                    
                                                        Bacterial
                                                    
                                                        Mitochondrial Metabolism
                                                    
                                                        Reactive Oxygen Species (ROS)
                                                    
                                                 | 
                                                
                                                    
                                                        Infection
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Ciprofloxacin (monohydrochloride) (Standard) is the analytical standard of Ciprofloxacin (monohydrochloride). This product is intended for research and analytical applications. Ciprofloxacin (Bay-09867) monohydrochloride is a potent, orally active topoisomerase IV inhibitor. Ciprofloxacin monohydrochloride induces mitochondrial DNA and nuclear DNA damage and lead to mitochondrial dysfunction, ROS production. Ciprofloxacin monohydrochloride has anti-proliferative activity and induces apoptosis. Ciprofloxacin monohydrochloride is a fluoroquinolone antibiotic, exhibiting potent antibacterial activity   [4].
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-B0395DS
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     (1R,2S,7R)-DU6859a-d4 hydrochloride 
                                                 | 
                                                
                                                    
                                                        Antibiotic
                                                    
                                                        Bacterial
                                                    
                                                        Isotope-Labeled Compounds
                                                    
                                                 | 
                                                
                                                    
                                                        Others
                                                    
                                                 | 
                                            
                                            
                                                
                                                    (1R,2S,7R)-Sitafloxacin-d4 hydrochloride is deuterium labeled  (1R,2S,7R)-Sitafloxacin hydrochloride (HY-B0395D).  (R)-Sitafloxacin (DU-6857), a stereoisomer of Sitafloxacin (DU-6859a), is also an inhibitor of topoisomerases, with an IC50 of 0.18 μg/mL of DNA gyrase . 
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-W046353R
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     o-Methoxycinnamaldehyde (Standard) 
                                                 | 
                                                
                                                    
                                                        Reference Standards
                                                    
                                                        Apoptosis
                                                    
                                                        NF-κB
                                                    
                                                        Mitochondrial Metabolism
                                                    
                                                        Caspase
                                                    
                                                        Topoisomerase
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    2-Methoxycinnamaldehyde (Standard) is the analytical standard of 2-Methoxycinnamaldehyde. This product is intended for research and analytical applications. 2-Methoxycinnamaldehyde (o-Methoxycinnamaldehyde) is a natural compound that can be isolated from Cinnamomum cassia. 2-Methoxycinnamaldehyde inhibits topoisomerase-I/II and NF-κB signaling pathway, causes mitochondrial dysfunction, induces lysosomal vesiculation, thereby leading to DNA damage and cell apoptosis. 2-Methoxycinnamaldehyde exhibits antitumor effects   .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-W654130
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     Daunomycin-13C,d3; RP 13057-13C,d3; Rubidomycin-13C,d3 
                                                 | 
                                                
                                                    
                                                        Isotope-Labeled Compounds
                                                    
                                                        Bacterial
                                                    
                                                        ADC Payload
                                                    
                                                        Apoptosis
                                                    
                                                        Antibiotic
                                                    
                                                        Topoisomerase
                                                    
                                                        Autophagy
                                                    
                                                        DNA/RNA Synthesis
                                                    
                                                 | 
                                                
                                                    
                                                        Infection
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Daunorubicin- 13C,d3 is  13C and deuterium labeled Daunorubicin. Daunorubicin (Daunomycin) is a topoisomerase II inhibitor with potent anti-tumor activity. Daunorubicin inhibits DNA and RNA synthesis. Daunorubicin is a cytotoxin that inhibits cancer cell viability and induces apoptosis and necrosis. Daunorubicin is also an anthracycline antibiotic. Daunorubicin can be used in the research of infection and variety of cancers, including leukemia, non-Hodgkin lymphomas, Ewing's sarcoma, Wilms' tumor   .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-13062R
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     Daunomycin hydrochloride (Standard); RP 13057 hydrochloride (Standard); Rubidomycin hydrochloride (Standard) 
                                                 | 
                                                
                                                    
                                                        Reference Standards
                                                    
                                                        Topoisomerase
                                                    
                                                        DNA/RNA Synthesis
                                                    
                                                        ADC Payload
                                                    
                                                        Bacterial
                                                    
                                                        Autophagy
                                                    
                                                        Apoptosis
                                                    
                                                        Antibiotic
                                                    
                                                 | 
                                                
                                                    
                                                        Infection
                                                    
                                                        Neurological Disease
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Daunorubicin (hydrochloride) (Standard) is the analytical standard of Daunorubicin (hydrochloride). This product is intended for research and analytical applications. Daunorubicin (Daunomycin) hydrochloride is a topoisomerase II inhibitor with potent anti-tumor activity. Daunorubicin hydrochloride inhibits DNA and RNA synthesis. Daunorubicin hydrochloride is a cytotoxin that inhibits cancer cell viability and induces apoptosis and necrosis. Daunorubicin hydrochloride is also an anthracycline antibiotic. Daunorubicin hydrochloride can be used in the research of infection and variety of cancers, including leukemia, non-Hodgkin lymphomas, Ewing's sarcoma, Wilms' tumor    .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-163099
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Drug-Linker Conjugates for ADC
                                                    
                                                        Topoisomerase
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    P5(PEG24)-VC-PAB-Exatecan (LP5) is a drug-linker conjugate composed of a potent a DNA Topoisomerase I inhibitor Exatecan (HY-13631) and a linker P5(PEG24)-VC-PAB to make antibody agent conjugate (ADC). P5(PEG24)-VC-PAB-Exatecan can be used for the research of tumor .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-173625
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Drug-Linker Conjugates for ADC
                                                    
                                                        Topoisomerase
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    P5(PEG12)-VC-PAB-Exatecan (LP3) is a drug-linker conjugate composed of a potent a DNA Topoisomerase I inhibitor Exatecan (HY-13631) and a linker P5(PEG24)-VC-PAB to make antibody agent conjugate (ADC). P5(PEG12)-VC-PAB-Exatecan can be used for the research of tumor .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-N6865
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Cholinesterase (ChE)
                                                    
                                                        Topoisomerase
                                                    
                                                        Reactive Oxygen Species (ROS)
                                                    
                                                        Beta-secretase
                                                    
                                                        Apoptosis
                                                    
                                                 | 
                                                
                                                    
                                                        Neurological Disease
                                                    
                                                        Metabolic Disease
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Groenlandicine, a protoberberine alkaloid, is a cholinesterase inhibitor (AChE (IC50 = 0.54 μM), BChE (IC50 = 3.32 μM)). Groenlandicine non-competitively inhibits BACE1 (IC50 = 19.68 μM, Ki = 21.2) and inhibits RLAR (IC50 = 140.1 μM), HRAR (IC50 = 154.2 μM), and total ROS generation (IC50 = 51.78 μM) in vitro. Groenlandicine suppresses osteosarcoma cell proliferation while promoting apoptosis. Groenlandicine inhibits the tumor growth when combined with Cisplatin (HY-17394). Groenlandicine can be used for the study on osteosarcoma, Alzheimer's disease and diabetes mellitus      .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-B1050R
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     SB-265805S (Standard); LB-20304a (Standard) 
                                                 | 
                                                
                                                    
                                                        Reference Standards
                                                    
                                                        Bacterial
                                                    
                                                        Antibiotic
                                                    
                                                        DNA/RNA Synthesis
                                                    
                                                        Topoisomerase
                                                    
                                                 | 
                                                
                                                    
                                                        Infection
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Gemifloxacin (mesylate) (Standard) is the analytical standard of Gemifloxacin (mesylate). This product is intended for research and analytical applications. Gemifloxacin mesylate (SB-265805S; LB-20304a) is an orally active broad-spectrum quinolone antibacterial antibiotic. Gemifloxacin mesylate inhibits DNA synthesis by inhibiting DNA gyrase and Topoisomerase IV activities. Gemifloxacin mesylate has potent antibacterial activities against gram-positive bacteria in vitro efficacy study, particularly Streptococci and Staphylococci. Gemifloxacin mesylate has been used in the research of respiratory tract infections   .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-13721R
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Caspase
                                                    
                                                        Apoptosis
                                                    
                                                        Topoisomerase
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Phenoxodiol (Standard) is the analytical standard of Phenoxodiol. This product is intended for research and analytical applications. Phenoxodiol (Idronoxil), a synthetic analog of Genestein, activates the mitochondrial caspase system, inhibits XIAP (an apoptosis inhibitor), and sensitizes the cancer cells to Fas-mediated apoptosis. Phenoxodiol also inhibits DNA topoisomerase II by stabilizing the cleavable complex. Phenoxodiol induces cell cycle arrest in the G1/S phase of the cell cycle and upregulates p21WAF1 via a p53 independent manner  .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-169299
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        PARP
                                                    
                                                        Topoisomerase
                                                    
                                                        Apoptosis
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    TOPOI/PARP-1-IN-2 (compound 6c) is a dual PARP-1 and topoisomerase 1 (TOPO-1) inhibitor with IC50s of 32.2 nM and 46.2 nM, respectively. TOPOI/PARP-1-IN-2 shows a selectivity for PARP-1 over PARP-2. TOPOI/PARP-1-IN-2 disrupts the cell cycle at the S phase and induces apoptosis in NCI-60 cancer cell lines .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-N0095S
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     10-HCPT-d5;  10-Hydroxycamptothecin-d5 
                                                 | 
                                                
                                                    
                                                        Isotope-Labeled Compounds
                                                    
                                                        Apoptosis
                                                    
                                                        Topoisomerase
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    (S)-10-Hydroxycamptothecin-d5 (10-HCPT-d5) is the deuterium labeled (S)-10-Hydroxycamptothecin. (S)-10-Hydroxycamptothecin (10-HCPT) is a DNA topoisomerase I inhibitor. (S)-10-Hydroxycamptothecin exhibits a remarkable apoptosis-inducing effect. (S)-10-Hydroxycamptothecin has the potential for hepatoma, gastric carcinoma, colon cancer and leukaemia research    .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-N0498
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Parasite
                                                    
                                                        Apoptosis
                                                    
                                                        STAT
                                                    
                                                        Topoisomerase
                                                    
                                                        ERK
                                                    
                                                        FAK
                                                    
                                                        p38 MAPK
                                                    
                                                        NF-κB
                                                    
                                                 | 
                                                
                                                    
                                                        Inflammation/Immunology
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Nitidine chloride, a potential anti-malarial lead compound derived from Zanthoxylum nitidum (Roxb) DC, exerts potent anticancer activity through diverse pathways, including inducing apoptosis, inhibiting STAT3 signaling cascade, DNA topoisomerase 1 and 2A, ERK and c-Src/FAK associated signaling pathway, also has anti-inflammatory activity. Nitidine chloride inhibits LPS-induced inflammatory cytokines production via MAPK and NF-kB pathway     .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-162472
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        ATM/ATR
                                                    
                                                        DNA-PK
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    XRD-0394 is a potent and orally active dual ATM and DNA-PKcs inhibitor with IC50s of 0.39 nM and 0.89 nM, respectively. XRD-0394 shows selectivity over other PIKK and PI3K family members. XRD-0394 significantly enhances tumor cell killing in vitro and in vivo under therapeutic ionizing radiation conditions. XRD-0394 can potentiate the effects of PARP and topoisomerase I inhibitors in vitro .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-B0330DR
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     Dextrofloxacin (Standard) 
                                                 | 
                                                
                                                    
                                                        Reference Standards
                                                    
                                                        Bacterial
                                                    
                                                        Antibiotic
                                                    
                                                 | 
                                                
                                                    
                                                        Infection
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    (R)-Ofloxacin (Standard) is the analytical standard of (R)-Ofloxacin (HY-B0330D). (R)-Ofloxacin is the dextrorotatory enantiomer of Ofloxacin (HY-B0125) and is an orally effective fluoroquinolone antibiotic. (R)-Ofloxacin can inhibit the activity of bacterial DNA topoisomerase II, interfere with bacterial DNA replication and repair, and exert a bactericidal effect. (R)-Ofloxacin has a broad-spectrum antibacterial activity and has inhibitory effects on both Gram-negative and Gram-positive bacteria  .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-A0170
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Bacterial
                                                    
                                                        Topoisomerase
                                                    
                                                        Antibiotic
                                                    
                                                 | 
                                                
                                                    
                                                        Infection
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Trovafloxacin is a broad-spectrum quinolone antibiotic with potent activity against Gram-positive, Gram-negative and anaerobic organisms. Trovafloxacin blocks the DNA gyrase and topoisomerase IV activity. Trovafloxacin is also a potent, selective and orally active pannexin 1 channel (PANX1) inhibitor with an IC50 of 4 μM for PANX1 inward current. Trovafloxacin does not inhibit connexin 43 gap junction or PANX2. Trovafloxacin leads to dysregulated fragmentation of apoptotic cells by inhibiting PANX1   .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-16560R
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     Campathecin (Standard); (S)-(+)-Camptothecin (Standard); CPT (Standard) 
                                                 | 
                                                
                                                    
                                                        Reference Standards
                                                    
                                                        Topoisomerase
                                                    
                                                        ADC Payload
                                                    
                                                        MicroRNA
                                                    
                                                        Influenza Virus
                                                    
                                                        Apoptosis
                                                    
                                                        Fungal
                                                    
                                                        Antibiotic
                                                    
                                                 | 
                                                
                                                    
                                                        Infection
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Camptothecin (Standard) (Campathecin (Standard)) is the analytical standard of Camptothecin (HY-16560). This product is intended for research and analytical applications. Camptothecin (CPT), a kind of alkaloid, is a DNA topoisomerase I (Topo I) inhibitor with an IC50 of 679 nM. Camptothecin (CPT) exhibits powerful antineoplastic activity against colorectal, breast, lung and ovarian cancers, modulates hypoxia-inducible factor-1α (HIF-1α) activity by changing microRNAs (miRNA) expression patterns in human cancer cells.
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-103399
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Bacterial
                                                    
                                                        Topoisomerase
                                                    
                                                        Antibiotic
                                                    
                                                 | 
                                                
                                                    
                                                        Infection
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Trovafloxacin mesylate is a broad-spectrum quinolone antibiotic with potent activity against Gram-positive, Gram-negative and anaerobic organisms. Trovafloxacin mesylate blocks the DNA gyrase and topoisomerase IV activity. Trovafloxacin mesylate is also a potent, selective and orally active pannexin 1 channel (PANX1) inhibitor with an IC50 of 4 μM for PANX1 inward current. Trovafloxacin mesylate does not inhibit connexin 43 gap junction or PANX2. Trovafloxacin mesylate leads to dysregulated fragmentation of apoptotic cells by inhibiting PANX1   .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-17460A
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     BMS284756 Mesylate hydrate 
                                                 | 
                                                
                                                    
                                                        Bacterial
                                                    
                                                        Topoisomerase
                                                    
                                                        DNA/RNA Synthesis
                                                    
                                                        Antibiotic
                                                    
                                                 | 
                                                
                                                    
                                                        Infection
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Garenoxacin (BMS284756) Mesylate hydrate is an orally active quinolone antibiotic and has a broad spectrum of activity against a wide array of gram-positive and gram-negative bacteria, anaerobes, and fastidious organisms .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-17460AR
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     BMS284756 Mesylate hydrate (Standard) 
                                                 | 
                                                
                                                    
                                                        Reference Standards
                                                    
                                                        Bacterial
                                                    
                                                        Topoisomerase
                                                    
                                                        DNA/RNA Synthesis
                                                    
                                                        Antibiotic
                                                    
                                                 | 
                                                
                                                    
                                                        Infection
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    ACHE-IN-38 (hydrochloride) (Standard) is the analytical standard of ACHE-IN-38 (hydrochloride). This product is intended for research and analytical applications. ACHE-IN-38 hydrochloride (Compound 13b) inhibits the metabolic breakdown of the neurotransmitter acetylcholine (ACh) by the enzyme acetylcholinesterase (AChE) and hence alleviates memory deficits in patients with Alzheimer’s Disease by potentiating cholinergic transmission .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-17460R
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     BMS284756 (Standard) 
                                                 | 
                                                
                                                    
                                                        Reference Standards
                                                    
                                                        Bacterial
                                                    
                                                        Topoisomerase
                                                    
                                                        DNA/RNA Synthesis
                                                    
                                                        Antibiotic
                                                    
                                                 | 
                                                
                                                    
                                                        Infection
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Garenoxacin (Standard) is the analytical standard of Garenoxacin. This product is intended for research and analytical applications. Garenoxacin (BMS284756) is an orally active quinolone antibiotic and has a broad spectrum of activity against a wide array of gram-positive and gram-negative bacteria, anaerobes, and fastidious organisms .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-17460
 
                                    - 
                                        
                                    
 
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-13502AR
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     Mitozantrone dihydrochloride (Standard); NSC 301739 dihydrochloride (Standard) 
                                                 | 
                                                
                                                    
                                                        Reference Standards
                                                    
                                                        Topoisomerase
                                                    
                                                        PKC
                                                    
                                                        Orthopoxvirus
                                                    
                                                        Apoptosis
                                                    
                                                        Endogenous Metabolite
                                                    
                                                 | 
                                                
                                                    
                                                        Infection
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Mitoxantrone (dihydrochloride) (Standard) is the analytical standard of Mitoxantrone (dihydrochloride). This product is intended for research and analytical applications. Mitoxantrone dihydrochloride is a potent topoisomerase II inhibitor. Mitoxantrone dihydrochloride also inhibits protein kinase C (PKC) activity with an IC50 of 8.5 μM. Mitoxantrone dihydrochloride induces apoptosis of B-CLL (B-chronic lymphocytic leukaemia) cells. Mitoxantrone dihydrochloride shows antitumor activity    . Mitoxantrone dihydrochloride also has anti-orthopoxvirus activity with EC50s of 0.25 μM and and 0.8 μM for cowpox and monkeypox, respectively .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-B0506
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     OPC7251 
                                                 | 
                                                
                                                    
                                                        Bacterial
                                                    
                                                        Antibiotic
                                                    
                                                        DNA/RNA Synthesis
                                                    
                                                        Interleukin Related
                                                    
                                                 | 
                                                
                                                    
                                                        Infection
                                                    
                                                        Inflammation/Immunology
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Nadifloxacin (OPC7251) is a broad-spectrum quinolone antibiotic. Nadifloxacin inhibits bacterial DNA gyrase and topoisomerase IV, interfering with DNA replication. It also suppresses the production of proinflammatory cytokines (such as IL-1α, IL-6, and IL-8). Nadifloxacin exhibits antibacterial activity against various pathogens, including Propionibacterium acnes and Staphylococcus aureus. Nadifloxacin also exhibits anti-inflammatory activity. Nadifloxacin can be used in the research of skin infections such as acne vulgaris, folliculitis, and impetigo     .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-120750
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Endogenous Metabolite
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    A 62176 hydrochloride is a compound that targets DNA topoisomerase II and has the activity of inhibiting purine synthesis in cancer cells. A 62176 hydrochloride interferes with c-MYC mRNA expression by interacting with G-quadruplex. The main mechanism of action of A 62176 hydrochloride is by displacing nucleosomes from the quadruplex of non-template strand rDNA, resulting in rapid redistribution of nucleosomes. The application potential of A 62176 hydrochloride is that it causes DNA damage and relies on BRCA1/2-mediated homologous recombination and DNA-PK-mediated non-homologous end-joining pathways to repair the damage .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-138298
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     DS-8201 (solution); DS-8201a (solution) 
                                                 | 
                                                
                                                    
                                                        Antibody-Drug Conjugates (ADCs)
                                                    
                                                        EGFR
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Trastuzumab deruxtecan (T-DXd; DS-8201a) (solution) is an anti-human epidermal growth factor receptor 2 (HER2) antibody-drug conjugate (ADC). Trastuzumab deruxtecan is composed of a humanized anti-HER2 antibody, an enzymatically cleavable peptide-linker, a topoisomerase I inhibitor (a toxin component of Dxd), and the drug-linker conjugate for ADC is Deruxtecan (HY-13631E). Trastuzumab deruxtecan can be used for the research of HER2-positive breast cancer and gastric cancer  .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-N0498R
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Reference Standards
                                                    
                                                        Parasite
                                                    
                                                        Apoptosis
                                                    
                                                        STAT
                                                    
                                                        Topoisomerase
                                                    
                                                        ERK
                                                    
                                                        FAK
                                                    
                                                        p38 MAPK
                                                    
                                                        NF-κB
                                                    
                                                 | 
                                                
                                                    
                                                        Inflammation/Immunology
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Nitidine (chloride) (Standard) is the analytical standard of Nitidine (chloride). This product is intended for research and analytical applications. Nitidine chloride, a potential anti-malarial lead compound derived from Zanthoxylum nitidum (Roxb) DC, exerts potent anticancer activity through diverse pathways, including inducing apoptosis, inhibiting STAT3 signaling cascade, DNA topoisomerase 1 and 2A, ERK and c-Src/FAK associated signaling pathway. Nitidine chloride inhibits LPS-induced inflammatory cytokines production via MAPK and NF-kB pathway      .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-N2150
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        HDAC
                                                    
                                                        DNA Methyltransferase
                                                    
                                                        DNA/RNA Synthesis
                                                    
                                                        Bacterial
                                                    
                                                        Aminopeptidase
                                                    
                                                        Farnesyl Transferase
                                                    
                                                        PPAR
                                                    
                                                        Apoptosis
                                                    
                                                 | 
                                                
                                                    
                                                        Infection
                                                    
                                                        Inflammation/Immunology
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Psammaplin A is a marine metabolite. Psammaplin A is a selective HDAC1 (IC50: 45 nM), DNA methyltransferases (IC50: 18.6 nM) and aminopeptidase N (APN) (IC50: 18 μM) inhibitor. Psammaplin A also inhibits DNA topoisomerase and farnesyl protein transferase. Psammaplin A is a PPARγ activator and induces apoptosis. Psammaplin A has antitumor and anti-inflammatory activities. Psammaplin A has antibacterial activity against Gram-positive bacteria and inhibits DNA synthesis and DNA gyrase activity. Psammaplin A inhibits angiogenesis        .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-13502AS
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     Mitozantrone-d8(dihydrochloride); NSC 301739-d8 dihydrochloride 
                                                 | 
                                                
                                                    
                                                        Endogenous Metabolite
                                                    
                                                        PKC
                                                    
                                                        Apoptosis
                                                    
                                                        Topoisomerase
                                                    
                                                        Orthopoxvirus
                                                    
                                                        Isotope-Labeled Compounds
                                                    
                                                 | 
                                                
                                                    
                                                        Infection
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Mitoxantrone-d8 dihydrochloride is deuterated labeled Mitoxantrone dihydrochloride (HY-13502A). Mitoxantrone dihydrochloride is a potent topoisomerase II inhibitor. Mitoxantrone dihydrochloride also inhibits protein kinase C (PKC) activity with an IC50 of 8.5 μM. Mitoxantrone dihydrochloride induces apoptosis of B-CLL (B-chronic lymphocytic leukaemia) cells. Mitoxantrone dihydrochloride shows antitumor activity    . Mitoxantrone dihydrochloride also has anti-orthopoxvirus activity with EC50s of 0.25 μM and and 0.8 μM for cowpox and monkeypox, respectively .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-138298A
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     DS-8201;  DS-8201a 
                                                 | 
                                                
                                                    
                                                        Antibody-Drug Conjugates (ADCs)
                                                    
                                                        EGFR
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Trastuzumab deruxtecan (DS-8201a) is an anti-human epidermal growth factor receptor 2 (HER2) antibody-drug conjugate (ADC). Trastuzumab deruxtecan is composed of a humanized anti-HER2 antibody, an enzymatically cleavable peptide-linker, a topoisomerase I inhibitor (a toxin component of Dxd), and the drug-linker conjugate for ADC is Deruxtecan (HY-13631E). Trastuzumab deruxtecan can be used for the research of HER2-positive breast cancer and gastric cancer  .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-13502AS1
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     Mitozantrone-d8 hydrochloride; NSC 301739-d8 hydrochloride 
                                                 | 
                                                
                                                    
                                                        Isotope-Labeled Compounds
                                                    
                                                        Endogenous Metabolite
                                                    
                                                        Apoptosis
                                                    
                                                        Orthopoxvirus
                                                    
                                                        PKC
                                                    
                                                        Topoisomerase
                                                    
                                                 | 
                                                
                                                    
                                                        Infection
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Mitoxantrone-d8 (hydrochloride) (Mitozantrone-d8 (hydrochloride)) is deuterium labeled Mitoxantrone (dihydrochloride). Mitoxantrone dihydrochloride is a potent topoisomerase II inhibitor. Mitoxantrone dihydrochloride also inhibits protein kinase C (PKC) activity with an IC50 of 8.5 μM. Mitoxantrone dihydrochloride induces apoptosis of B-CLL (B-chronic lymphocytic leukaemia) cells. Mitoxantrone dihydrochloride shows antitumor activity    . Mitoxantrone dihydrochloride also has anti-orthopoxvirus activity with EC50s of 0.25 μM and and 0.8 μM for cowpox and monkeypox, respectively .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-156513
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     7-Hydroxyethyl carbamate-(10Me-11F-Camptothecin) 
                                                 | 
                                                
                                                    
                                                        ADC Payload
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    ZD06519 (7-Hydroxyethyl carbamate-(10Me-11F-Camptothecin)) is a camptothecin (HY-16560) analogue and a topoisomerase I inhibitor. ZD06519 is an ADC cytotoxin with a strong bystander effect, inhibiting a variety of malignancies such as HER2-positive and FRα-overexpressing tumors. ZD06519 inhibits DNA cleavage, relaxation, and reconnection processes, inducing tumor cell death. ZD06519 can be used for ADC synthesis and cancer research  .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-13502R
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     Mitozantrone (Standard); NSC 301739 (Standard) 
                                                 | 
                                                
                                                    
                                                        Reference Standards
                                                    
                                                        Topoisomerase
                                                    
                                                        PKC
                                                    
                                                        Orthopoxvirus
                                                    
                                                        Apoptosis
                                                    
                                                        Endogenous Metabolite
                                                    
                                                 | 
                                                
                                                    
                                                        Infection
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Mitoxantrone (Standard) is the analytical standard of Mitoxantrone. This product is intended for research and analytical applications. Mitoxantrone is a potent topoisomerase II inhibitor. Mitoxantrone also inhibits protein kinase C (PKC) activity with an IC50 of 8.5 μM. Mitoxantrone induces apoptosis of B-CLL (B-chronic lymphocytic leukaemia) cells. Mitoxantrone shows antitumor activity    . Mitoxantrone also has anti-orthopoxvirus activity with EC50s of 0.25 μM and and 0.8 μM for cowpox and monkeypox, respectively .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-173192
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Bacterial
                                                    
                                                 | 
                                                
                                                    
                                                        Infection
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Antibacterial agent 272 (Compound Z22) is a potential antimicrobial agent targeting DNA and the DNA-topoisomerase II (DNA-Topo II) complex, exhibiting MIC values of 1 μg/mL against Staphylococcus aureus 25923 and 29213, 2 μg/mL against Staphylococcus epidermidis 12228, 2-4 μg/mL against Enterococcus faecalis, and 4 μg/mL against Pseudomonas aeruginosa 9027 and 27853, demonstrating potent antibacterial activity. This compound functions by intercalating with DNA base pairs to disrupt normal bacterial DNA function, making it suitable for research on bacterial infectious diseases .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-B0147A
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     Pefloxacinium mesylate 
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                        DNA/RNA Synthesis
                                                    
                                                        Antibiotic
                                                    
                                                        Bacterial
                                                    
                                                        Parasite
                                                    
                                                 | 
                                                
                                                    
                                                        Infection
                                                    
                                                        Inflammation/Immunology
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Pefloxacin (Pefloxacinium) mesylate is a broad spectrum antibiotic. Pefloxacin blocks DNA replication by inhibiting DNA gyrase. Pefloxacin mesylate inhibits DNA relaxation catalyzed by topoisomerase I with an IC50 of 45 μg/mL. Pefloxacin mesylate exhibits antibacterial activity against Escherichia coli, Pseudomonas aeruginosa, and Bacteroides fragilis with MIC90s of 0.12, 4, and 16 mg/L, respectively. Pefloxacin mesylate has anti-Plasmodium yoelii infection activity. Pefloxacin mesylate increase UVA-induced edema and immunesuppression. Pefloxacin mesylate can be used for infection studies         .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-B0147
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     Pefloxacinium 
                                                 | 
                                                
                                                    
                                                        Antibiotic
                                                    
                                                        Bacterial
                                                    
                                                        Parasite
                                                    
                                                        DNA/RNA Synthesis
                                                    
                                                        Topoisomerase
                                                    
                                                 | 
                                                
                                                    
                                                        Infection
                                                    
                                                        Inflammation/Immunology
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Pefloxacin (Pefloxacinium) is a broad spectrum antibiotic. Pefloxacin blocks DNA replication by inhibiting DNA gyrase. Pefloxacin inhibits DNA relaxation catalyzed by topoisomerase I with an IC50 of 45 μg/mL. Pefloxacin exhibits antibacterial activity against Escherichia coli, Pseudomonas aeruginosa, and Bacteroides fragilis with MIC90s of 0.12, 4, and 16 mg/L, respectively. Pefloxacin has anti-Plasmodium yoelii infection activity. Pefloxacin increase UVA-induced edema and immunesuppression. Pefloxacin can be used for infection studies         .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-N0095R
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     10-HCPT (Standard); 10-Hydroxycamptothecin (Standard) 
                                                 | 
                                                
                                                    
                                                        Reference Standards
                                                    
                                                        Topoisomerase
                                                    
                                                        Apoptosis
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    (S)-10-Hydroxycamptothecin (Standard) is the analytical standard of (S)-10-Hydroxycamptothecin. This product is intended for research and analytical applications. (S)-10-Hydroxycamptothecin (10-HCPT;10-Hydroxycamptothecin) is a DNA topoisomerase I inhibitor of isolated from the Chinese plant Camptotheca accuminata. (S)-10-Hydroxycamptothecin exhibits a remarkable apoptosis-inducing effect. (S)-10-Hydroxycamptothecin has the potential for hepatoma, gastric carcinoma, colon cancer and leukaemia treatment    .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-146138
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        EGFR
                                                    
                                                        VEGFR
                                                    
                                                        Casein Kinase
                                                    
                                                        Topoisomerase
                                                    
                                                        Microtubule/Tubulin
                                                    
                                                        Apoptosis
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    EGFR-IN-57 (Compound 25a) is a potent, orally active EGFR-TK inhibitor with an IC50 of 0.054 µM. EGFR-IN-57 also inhibits VEGFR-2, CK2α, topoisomerase IIβ and tubulin polymerization with IC50 values of 0.087, 0.171, 0.13 and 3.61 µM, respectively. EGFR-IN-57 induces cell cycle arrest at G2/M and pre-G1 phases. EGFR-IN-57 induces cancer cell apoptosis .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-A0170R
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Reference Standards
                                                    
                                                        Bacterial
                                                    
                                                        Topoisomerase
                                                    
                                                        Antibiotic
                                                    
                                                 | 
                                                
                                                    
                                                        Infection
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Trovafloxacin (Standard) is the analytical standard of Trovafloxacin. This product is intended for research and analytical applications. Trovafloxacin is a broad-spectrum quinolone antibiotic with potent activity against Gram-positive, Gram-negative and anaerobic organisms. Trovafloxacin blocks the DNA gyrase and topoisomerase IV activity. Trovafloxacin is also a potent, selective and orally active pannexin 1 channel (PANX1) inhibitor with an IC50 of 4 μM for PANX1 inward current. Trovafloxacin does not inhibit connexin 43 gap junction or PANX2. Trovafloxacin leads to dysregulated fragmentation of apoptotic cells by inhibiting PANX1   .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-B0330B
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     (-)-Ofloxacin hydrochloride 
                                                 | 
                                                
                                                    
                                                        Antibiotic
                                                    
                                                        Bacterial
                                                    
                                                        DNA/RNA Synthesis
                                                    
                                                        Topoisomerase
                                                    
                                                        Orthopoxvirus
                                                    
                                                        Apoptosis
                                                    
                                                 | 
                                                
                                                    
                                                        Infection
                                                    
                                                        Neurological Disease
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Levofloxacin hydrochloride is an orally active antibiotic. Levofloxacin inhibits DNA gyrase and topoisomerase IV activity, inducing Apoptosis. Levofloxacin hydrochloride has antibacterial activity against both Gram-positive and Gram-negative bacteria. Levofloxacin hydrochloride exhibits anticancer activity against lung cancer. Levofloxacin hydrochloride has anti-acnegenic, anxiogenic, and analgesic effects. Levofloxacin hydrochloride shortens sleep duration in mice. Levofloxacin hydrochloride can be used in the research of infectious diseases (such as tuberculosis, chronic periodontitis, bacterial infections associated with stable COPD, and BK viremia) and lung cancer          .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-B0268S2
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Isotope-Labeled Compounds
                                                    
                                                        Antibiotic
                                                    
                                                        MicroRNA
                                                    
                                                        DNA/RNA Synthesis
                                                    
                                                        Bacterial
                                                    
                                                 | 
                                                
                                                    
                                                        Infection
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Enoxacin-d8 (hydrate) is deuterium labeled Enoxacin. Enoxacin (AT 2266), a fluoroquinolone, interferes with DNA replication and inhibits bacterial DNA gyrase (IC50=126 μg/ml) and topoisomerase IV (IC50=26.5 μg/ml). Enoxacin is a miRNA processing activator and enhances siRNA-mediated mRNA degradation and promotes the biogenesis of endogenous miRNAs. Enoxacin has potent activities against gram-positive and -negative bacteria. Enoxacin is a cancer-specific growth inhibitor that acts by enhancing TAR RNA-binding protein 2 (TRBP)-mediated microRNA processing     .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-N0311
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Aldose Reductase
                                                    
                                                        Topoisomerase
                                                    
                                                        SOD
                                                    
                                                        p38 MAPK
                                                    
                                                 | 
                                                
                                                    
                                                        Neurological Disease
                                                    
                                                        Inflammation/Immunology
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Emodin-8-glucoside is an anthraquinone derivative that can be isolated from Aloe vera. Emodin-8-glucoside is the inhibitor for MAPK with an inhibition constant of 430.14 pM. Emodin-8-glucoside exhibits moderate inhibitory activity against rat lens aldose reductase (ALAR) and topoisomerases II with IC50s of 14.4 μM and 66 μM. Emodin-8-glucoside exhibits antioxidant, anti-inflammatory and anti-fibrotic activities. Emodin-8-glucoside can cross the blood brain barrier     .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-171684
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Antibody-Drug Conjugates (ADCs)
                                                    
                                                        CCR
                                                    
                                                        Topoisomerase
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Anti-CCL2 (Carlumab)-MC-Vc-PAB-SN38 is an antibody-drug conjugate (ADC) consisting of the humanized anti-CCL2 (chemokine ligand 2) antibody Carlumab (HY-P99188) conjugated to the linker Mc-VC-PAB  and the topoisomerase I inhibitor SN38 (HY-13704). The ADC toxic molecule and linker part are Mc-VC-PAB-SN38 (HY-131057). Anti-CCL2 (Carlumab)-MC-Vc-PAB-SN38 can be used in cancer research  .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-B0455R
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     SC47111A hydrochloride (Standard); NY-198 hydrochloride (Standard) 
                                                 | 
                                                
                                                    
                                                        Reference Standards
                                                    
                                                        Bacterial
                                                    
                                                        Antibiotic
                                                    
                                                        Topoisomerase
                                                    
                                                        Reactive Oxygen Species (ROS)
                                                    
                                                        Apoptosis
                                                    
                                                 | 
                                                
                                                    
                                                        Infection
                                                    
                                                        Endocrinology
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Lomefloxacin (hydrochloride) (Standard) is the analytical standard of Lomefloxacin hydrochloride (HY-B0455). This product is intended for research and analytical applications. Lomefloxacin hydrochloride (NY-198 hydrochloride) is an orally active difluoroquinolone antibiotic. Lomefloxacin hydrochloride prevents DNA supercoiling and replication by inhibiting bacterial topoisomerase II. Lomefloxacin hydrochloride induces ROS production and Apoptosis. Lomefloxacin hydrochloride has broad-spectrum bactericidal activity against Gram-positive and Gram-negative bacteria. Lomefloxacin hydrochloride has anticancer effects against melanoma. Lomefloxacin hydrochloride can be used in the study of systemic bacterial infections (such as Salmonella typhimurium infections), skin and melanoma       .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-B0268S1
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Isotope-Labeled Compounds
                                                    
                                                        Bacterial
                                                    
                                                        DNA/RNA Synthesis
                                                    
                                                        MicroRNA
                                                    
                                                        Antibiotic
                                                    
                                                 | 
                                                
                                                    
                                                        Infection
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Enoxacin-d8 (hydrochloride) is deuterium labeled Enoxacin. Enoxacin (AT 2266), a fluoroquinolone, interferes with DNA replication and inhibits bacterial DNA gyrase (IC50=126 μg/ml) and topoisomerase IV (IC50=26.5 μg/ml). Enoxacin is a miRNA processing activator and enhances siRNA-mediated mRNA degradation and promotes the biogenesis of endogenous miRNAs. Enoxacin has potent activities against gram-positive and -negative bacteria. Enoxacin is a cancer-specific growth inhibitor that acts by enhancing TAR RNA-binding protein 2 (TRBP)-mediated microRNA processing    .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-106031
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    F-14512 is a targeted cytotoxic compound that utilizes the polyamine transport system (PTS) to selectively deliver polyamine-containing drugs to cancer cells. F-14512 combines an epipodophyllotoxin core that targets topoisomerase II with a spermine group that acts as a cell delivery vehicle, with improved selectivity for tumor cells. F-14512 exhibits significant cytotoxicity against cells with high PTS activity and demonstrates high potency in multiple human cell lines (median IC50=0.18 μM). In the MX1 breast tumor xenograft model, F-14512 exhibits potent antitumor activity .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-155073
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Microtubule/Tubulin
                                                    
                                                        Apoptosis
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Tubulin inhibitor 35 (compound 6b) is a dual inhibitor of topoisomerase I (IC50=~50 μM) and tubulin polymerization (IC50=5.69 μM). Tubulin inhibitor 35 inhibits migration and invasion of MGC-803 and RKO cell lines,and induces apoptosis via arresting cell cycle at G2/M phase. Tubulin inhibitor 35 exhibis potent efficacy in gastrointestinal tumor inhibiton (inhibits MGC-803 (IC50=0.09 μM) and RKO (IC50=0.2 μM) cell lines) .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-B0147B
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     Pefloxacinium mesylate dihydrate 
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                        DNA/RNA Synthesis
                                                    
                                                        Antibiotic
                                                    
                                                        Bacterial
                                                    
                                                        Parasite
                                                    
                                                 | 
                                                
                                                    
                                                        Infection
                                                    
                                                        Inflammation/Immunology
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Pefloxacin (Pefloxacinium) mesylate dihydrate is a broad spectrum antibiotic. Pefloxacin mesylate dihydrate blocks DNA replication by inhibiting DNA gyrase. Pefloxacin mesylate dihydrate inhibits DNA relaxation catalyzed by topoisomerase I with an IC50 of 45 μg/mL. Pefloxacin mesylate dihydrate exhibits antibacterial activity against Escherichia coli, Pseudomonas aeruginosa, and Bacteroides fragilis with MIC90s of 0.12, 4, and 16 mg/L, respectively. Pefloxacin mesylate dihydrate has anti-Plasmodium yoelii infection activity. Pefloxacin mesylate dihydrate increase UVA-induced edema and immunesuppression. Pefloxacin mesylate dihydrate can be used for infection studies         .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-161997
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Microtubule/Tubulin
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    hTopo-II/tubulin-IN-1 (compound 5L) is a hTopo-II/tubulin inhibitor. hTopo-II/tubulin-IN-1 inhibits cell migration and can be used in anti-cancer research .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-171738
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Antibody-Drug Conjugates (ADCs)
                                                    
                                                        Topoisomerase
                                                    
                                                        Sodium Channel
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Anti-SLC34A2 (Lifastuzumab)-MC-Vc-PAB-SN38 is an antibody-drug conjugate (ADC) consisting of the humanized anti-SLC34A2 (sodium-dependent phosphate transporter 2) antibody Lifastuzumab (HY-P99970) conjugated to the linker Mc-VC-PAB and the topoisomerase I inhibitor SN38 (HY-13704). The ADC toxic molecule and linker part are Mc-VC-PAB-SN38 (HY-131057). Anti-SLC34A2 (Lifastuzumab)-MC-Vc-PAB-SN38 can be used in cancer research  .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-B0506R
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     OPC7251 (Standard) 
                                                 | 
                                                
                                                    
                                                        Reference Standards
                                                    
                                                        Bacterial
                                                    
                                                        Antibiotic
                                                    
                                                        DNA/RNA Synthesis
                                                    
                                                        Interleukin Related
                                                    
                                                 | 
                                                
                                                    
                                                        Infection
                                                    
                                                        Inflammation/Immunology
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Nadifloxacin (Standard) is the analytical standard of Nadifloxacin (HY-B0506). This product is intended for research and analytical applications. Nadifloxacin (OPC7251) is a broad-spectrum quinolone antibiotic. Nadifloxacin inhibits bacterial DNA gyrase and topoisomerase IV, interfering with DNA replication. It also suppresses the production of proinflammatory cytokines (such as IL-1α, IL-6, and IL-8). Nadifloxacin exhibits antibacterial activity against various pathogens, including Propionibacterium acnes and Staphylococcus aureus. Nadifloxacin also exhibits anti-inflammatory activity. Nadifloxacin can be used in the research of skin infections such as acne vulgaris, folliculitis, and impetigo     .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-175539
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Bacterial
                                                    
                                                        Topoisomerase
                                                    
                                                        DNA/RNA Synthesis
                                                    
                                                 | 
                                                
                                                    
                                                        Infection
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    DNA gyrase/Topo IV-IN-2 (Compound AK19) is an antibacterial agent with IC50 values of 0.783 μM and 7.136 μM against E. coli DNA gyrase and topoisomerase IV, respectively. DNA gyrase/Topo IV-IN-2 exhibits broad-spectrum antibacterial efficacy against both Gram-positive and Gram-negative pathogens. DNA gyrase/Topo IV-IN-2 can inhibit the biofilms of B. subtilis and MRSA, with an MIC of 1.9 μM against both B. subtilis and MRSA. DNA gyrase/Topo IV-IN-2 can be used in research related to anti-drug-resistant bacterial drugs .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-B0147R
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     Pefloxacinium (Standard) 
                                                 | 
                                                
                                                    
                                                        Reference Standards
                                                    
                                                        Topoisomerase
                                                    
                                                        DNA/RNA Synthesis
                                                    
                                                        Antibiotic
                                                    
                                                        Bacterial
                                                    
                                                        Parasite
                                                    
                                                 | 
                                                
                                                    
                                                        Infection
                                                    
                                                        Inflammation/Immunology
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Pefloxacin (Standard) (Pefloxacinium (Standard)) is the analytical standard of Pefloxacin (HY-B0147). This product is intended for research and analytical applications. Pefloxacin (Pefloxacinium) is a broad spectrum antibiotic. Pefloxacin blocks DNA replication by inhibiting DNA gyrase. Pefloxacin inhibits DNA relaxation catalyzed by topoisomerase I with an IC50 of 45 μg/mL. Pefloxacin exhibits antibacterial activity against Escherichia coli, Pseudomonas aeruginosa, and Bacteroides fragilis with MIC90s of 0.12, 4, and 16 mg/L, respectively. Pefloxacin has anti-Plasmodium yoelii infection activity. Pefloxacin increase UVA-induced edema and immunesuppression. Pefloxacin can be used for infection studies         .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-B0330BR
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     (-)-Ofloxacin hydrochloride (Standard) 
                                                 | 
                                                
                                                    
                                                        Reference Standards
                                                    
                                                        Antibiotic
                                                    
                                                        Bacterial
                                                    
                                                        DNA/RNA Synthesis
                                                    
                                                        Topoisomerase
                                                    
                                                        Orthopoxvirus
                                                    
                                                        Apoptosis
                                                    
                                                 | 
                                                
                                                    
                                                        Infection
                                                    
                                                        Neurological Disease
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Levofloxacin (hydrochloride) (Standard) is the analytical standard of Levofloxacin hydrochloride (HY-B0330B). This product is intended for research and analytical applications. Levofloxacin hydrochloride is an orally active antibiotic. Levofloxacin inhibits DNA gyrase and topoisomerase IV activity, inducing Apoptosis. Levofloxacin hydrochloride has antibacterial activity against both Gram-positive and Gram-negative bacteria. Levofloxacin hydrochloride exhibits anticancer activity against lung cancer. Levofloxacin hydrochloride has anti-acnegenic, anxiogenic, and analgesic effects. Levofloxacin hydrochloride shortens sleep duration in mice. Levofloxacin hydrochloride can be used in the research of infectious diseases (such as tuberculosis, chronic periodontitis, bacterial infections associated with stable COPD, and BK viremia) and lung cancer          .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-B0506S1
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     OPC7251-d5 
                                                 | 
                                                
                                                    
                                                        Isotope-Labeled Compounds
                                                    
                                                        Antibiotic
                                                    
                                                        Bacterial
                                                    
                                                        DNA/RNA Synthesis
                                                    
                                                        Interleukin Related
                                                    
                                                 | 
                                                
                                                    
                                                        Infection
                                                    
                                                        Inflammation/Immunology
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Nadifloxacin-d5 (OPC7251-d5) is deuterium labeled Nadifloxacin (HY-B0506). Nadifloxacin (OPC7251) is a broad-spectrum quinolone antibiotic. Nadifloxacin inhibits bacterial DNA gyrase and topoisomerase IV, interfering with DNA replication. It also suppresses the production of proinflammatory cytokines (such as IL-1α, IL-6, and IL-8). Nadifloxacin exhibits antibacterial activity against various pathogens, including Propionibacterium acnes and Staphylococcus aureus. Nadifloxacin also exhibits anti-inflammatory activity. Nadifloxacin can be used in the research of skin infections such as acne vulgaris, folliculitis, and impetigo     .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-B0147AR
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     Pefloxacinium mesylate (Standard) 
                                                 | 
                                                
                                                    
                                                        Reference Standards
                                                    
                                                        Topoisomerase
                                                    
                                                        DNA/RNA Synthesis
                                                    
                                                        Antibiotic
                                                    
                                                        Bacterial
                                                    
                                                        Parasite
                                                    
                                                 | 
                                                
                                                    
                                                        Infection
                                                    
                                                        Inflammation/Immunology
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Pefloxacin mesylate (Standard) (Pefloxacinium mesylate (Standard)) is the analytical standard of Pefloxacin mesylate (HY-B0147A). This product is intended for research and analytical applications. Pefloxacin (Pefloxacinium) mesylate is a broad spectrum antibiotic. Pefloxacin blocks DNA replication by inhibiting DNA gyrase. Pefloxacin mesylate inhibits DNA relaxation catalyzed by topoisomerase I with an IC50 of 45 μg/mL. Pefloxacin mesylate exhibits antibacterial activity against Escherichia coli, Pseudomonas aeruginosa, and Bacteroides fragilis with MIC90s of 0.12, 4, and 16 mg/L, respectively. Pefloxacin mesylate has anti-Plasmodium yoelii infection activity. Pefloxacin mesylate increase UVA-induced edema and immunesuppression. Pefloxacin mesylate can be used for infection studies         .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-B0147S1
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     Pefloxacinium-d3 
                                                 | 
                                                
                                                    
                                                        Isotope-Labeled Compounds
                                                    
                                                        Topoisomerase
                                                    
                                                        DNA/RNA Synthesis
                                                    
                                                        Antibiotic
                                                    
                                                        Bacterial
                                                    
                                                        Parasite
                                                    
                                                 | 
                                                
                                                    
                                                        Infection
                                                    
                                                        Inflammation/Immunology
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Pefloxacin-d3 (Pefloxacinium-d3) is the deuterium labeled Pefloxacin (HY-B0147). Pefloxacin (Pefloxacinium) is a broad spectrum antibiotic. Pefloxacin blocks DNA replication by inhibiting DNA gyrase. Pefloxacin inhibits DNA relaxation catalyzed by topoisomerase I with an IC50 of 45 μg/mL. Pefloxacin exhibits antibacterial activity against Escherichia coli, Pseudomonas aeruginosa, and Bacteroides fragilis with MIC90s of 0.12, 4, and 16 mg/L, respectively. Pefloxacin has anti-Plasmodium yoelii infection activity. Pefloxacin increase UVA-induced edema and immunesuppression. Pefloxacin can be used for infection studies         .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-B0147S
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     Pefloxacinium-d5 
                                                 | 
                                                
                                                    
                                                        Isotope-Labeled Compounds
                                                    
                                                        Topoisomerase
                                                    
                                                        DNA/RNA Synthesis
                                                    
                                                        Antibiotic
                                                    
                                                        Bacterial
                                                    
                                                        Parasite
                                                    
                                                 | 
                                                
                                                    
                                                        Infection
                                                    
                                                        Inflammation/Immunology
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Pefloxacin-d5 (Pefloxacinium-d5) is the deuterium labeled Pefloxacin (HY-B0147). Pefloxacin (Pefloxacinium) is a broad spectrum antibiotic. Pefloxacin blocks DNA replication by inhibiting DNA gyrase. Pefloxacin inhibits DNA relaxation catalyzed by topoisomerase I with an IC50 of 45 μg/mL. Pefloxacin exhibits antibacterial activity against Escherichia coli, Pseudomonas aeruginosa, and Bacteroides fragilis with MIC90s of 0.12, 4, and 16 mg/L, respectively. Pefloxacin has anti-Plasmodium yoelii infection activity. Pefloxacin increase UVA-induced edema and immunesuppression. Pefloxacin can be used for infection studies         .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-153360
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Drug-Linker Conjugates for ADC
                                                    
                                                        Topoisomerase
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    MC-GGFG-AM-(10Me-11F-Camptothecin) is a linker-payload conjugate used to synthesize ZW251. ZW251 an antibody-drug conjugate (ADC) targeting human GPC3. ZW251 consists of a humanized IgG1 antibody conjugated to a novel camptothecin-based topoisomerase 1 inhibitor, ZD06519, via a linker. The linker is the maleimide anchor and a glycyl glycyl phenylalanyl glycine (GGFG)-aminomethyl (AM) cleavable linker. ZW251 has high affinity with human and cynomolgus monkey GPC3. ZW251 displays rapid internalization in GPC3-expressing HCC cell lines, and bystander-mediated killing of GPC3 negative cancer cells .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-N0311R
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Reference Standards
                                                    
                                                        Aldose Reductase
                                                    
                                                        Topoisomerase
                                                    
                                                        SOD
                                                    
                                                        p38 MAPK
                                                    
                                                 | 
                                                
                                                    
                                                        Neurological Disease
                                                    
                                                        Inflammation/Immunology
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Emodin-8-glucoside (Standard) is the analytical standard of Emodin-8-glucoside. This product is intended for research and analytical applications. Emodin-8-glucoside is an anthraquinone derivative that can be isolated from Aloe vera. Emodin-8-glucoside is the inhibitor for MAPK with an inhibition constant of 430.14 pM. Emodin-8-glucoside exhibits moderate inhibitory activity against rat lens aldose reductase (ALAR) and topoisomerases II with IC50s of 14.4 μM and 66 μM. Emodin-8-glucoside exhibits antioxidant, anti-inflammatory and anti-fibrotic activities. Emodin-8-glucoside can cross the blood brain barrier     .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-B0147BR
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     Pefloxacinium mesylate dihydrate (Standard) 
                                                 | 
                                                
                                                    
                                                        Reference Standards
                                                    
                                                        Topoisomerase
                                                    
                                                        DNA/RNA Synthesis
                                                    
                                                        Antibiotic
                                                    
                                                        Bacterial
                                                    
                                                        Parasite
                                                    
                                                 | 
                                                
                                                    
                                                        Infection
                                                    
                                                        Inflammation/Immunology
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Pefloxacin (Pefloxacinium) mesylate dihydrate (Standard) is the analytical standard of Pefloxacin mesylate dihydrate (HY-B0147B). This product is intended for research and analytical applications. Pefloxacin (Pefloxacinium) mesylate dihydrate is a broad spectrum antibiotic. Pefloxacin mesylate dihydrate blocks DNA replication by inhibiting DNA gyrase. Pefloxacin mesylate dihydrate inhibits DNA relaxation catalyzed by topoisomerase I with an IC50 of 45 μg/mL. Pefloxacin mesylate dihydrate exhibits antibacterial activity against Escherichia coli, Pseudomonas aeruginosa, and Bacteroides fragilis with MIC90s of 0.12, 4, and 16 mg/L, respectively. Pefloxacin mesylate dihydrate has anti-Plasmodium yoelii infection activity. Pefloxacin mesylate dihydrate increase UVA-induced edema and immunesuppression. Pefloxacin mesylate dihydrate can be used for infection studies         .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-178029
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Ribosomal S6 Kinase (RSK)
                                                    
                                                        Topoisomerase
                                                    
                                                        Apoptosis
                                                    
                                                        Autophagy
                                                    
                                                        Reactive Oxygen Species (ROS)
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    RSK2/TOP2-IN-1 is a RSK2/TOP2 dual inhibitor. RSK2/TOP2-IN-1 targets key tumor progression enzymes including ribosomal S6 kinase 2 and topoisomerases IIα/IIβ. RSK2/TOP2-IN-1 shows selectivity index > 2 against all squamous cell carcinoma (SCC) cell lines. RSK2/TOP2-IN-1 can induce cell apoptosis, autophagy and ROS production. RSK2/TOP2-IN-1 can be used for the research of cancer, such as squamous cell carcinoma .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-177442
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     DS-3939 
                                                 | 
                                                
                                                    
                                                        Antibody-Drug Conjugates (ADCs)
                                                    
                                                        Mucin
                                                    
                                                        Topoisomerase
                                                    
                                                        Apoptosis
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    DS-3939a (DS-3939) is an anti-TA-MUC1 (tumor-associated mucin-1) antibody-drug conjugate (ADC). DS-3939a consists of a humanized anti-TA-MUC1 IgG1 monoclonal antibody Gatipotuzumab ( HY-P99634), a stable and cleavable tetrapeptide-based linker (Gly-Gly-Phe-Gly), and a DNA topoisomerase I inhibitor payload (DXd) (HY-13631D), and the drug-linker conjugate for ADC is Exatecan (HY-13631). DS-3939a inhibits the growth of TA-MUC1-positive cancer cells (CFPAC-1, NCI-H2110) by inducing DNA damage and apoptosis. DS-3939a exhibits significant antitumor activity in a variety of TA-MUC1-expressing advanced solid tumors. DS-3939a can be used for the study of TA-MUC1-expressing advanced cancers .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-Y0790R
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     p-Isopropylbenzaldehyde (Standard) 
                                                 | 
                                                
                                                    
                                                        α-synuclein
                                                    
                                                        Reference Standards
                                                    
                                                 | 
                                                
                                                    
                                                        Infection
                                                    
                                                        Neurological Disease
                                                    
                                                        Inflammation/Immunology
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Cuminaldehyde Standard is the analytical standard of Cuminaldehyde. This product is intended for research and analytical applications. Cuminaldehyde is the main component of Cuminum cyminum and has multiple biological activities, including anti-inflammatory, anti-cancer, anti-diabetic, anti-injury, anti-neuropathy and antibacterial effects. Cuminaldehyde is an inhibitor of aldose reductase (IC50= 0.00085 mg/mL) and α-glucosidase (IC50=0.5 mg/mL). Cuminaldehyde also inhibits the fibrillation of α-synuclein and prevents its aggregation Cuminaldehyde can induce apoptosis in colon adenocarcinoma cells by targeting topoisomerase I and II. In addition, Cuminaldehyde also exerts anti-inflammatory activity by inhibiting lipoxygenase. Cuminaldehyde has a strong inhibitory effect on the growth of Aspergillus flavus and the biosynthesis of aflatoxin B1 (AFB1). Cuminaldehyde can exert anti-injury and anti-neuropathy effects by participating in opioid receptors, L-arginine/NO/cGMP pathways and anti-inflammatory effects. Cuminaldehyde has potential application value in the research of neurodegenerative diseases, cancer, diabetes and neuropathic pain diseases       .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                        
                 
            
            
            
            
            
                
                    
                        
                            | Cat. No. | 
                            Product Name | 
                            Type | 
                        
                    
                    
                        
                            
                            - 
                                
                                    - HY-164152
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                    
                                                        
                                                            
                                                            
                                                                Chromogenic Assays
                                                            
                                                        
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    ADC Control Human IgG1-Deruxtecan (DAR 4) is a humanized monoclonal antibody that is an isotype control of ADC human IgG1-Deruxtecan and can inhibit DNA topoisomerase I. The antibody portion is Human IgG1 kappa, Isotype Control (HY-P99001), and the drug-linker conjugate for ADC is Deruxtecan (HY-13631E) .
                                                 | 
                                            
                                        
                                     
                                
                             
                        
                            
                            - 
                                
                                    - HY-164152A
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                    
                                                        
                                                            
                                                            
                                                                Chromogenic Assays
                                                            
                                                        
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    ADC Control Human IgG1-Deruxtecan (DAR 8) is a humanized monoclonal antibody that is an isotype control of ADC human IgG1-Deruxtecan and can inhibit DNA topoisomerase I. The antibody portion is Human IgG1 kappa, Isotype Control (HY-P99001), and the drug-linker conjugate for ADC is Deruxtecan (HY-13631E) .
                                                 | 
                                            
                                        
                                     
                                
                             
                        
                            
                            - 
                                
                                    - HY-13631AG
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     DX8951f (GMP) 
                                                 | 
                                                
                                                    
                                                        Fluorescent Dye
                                                    
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Exatecan mesylate (DX8951f ) GMP is a GMP-class Exatecan (HY-13631). Exatecan is a DNA topoisomerase I inhibitor, with an IC50 of 2.2 μM (0.975 μg/mL), and can be used in cancer research   .
                                                 | 
                                            
                                        
                                     
                                
                             
                        
                            
                            - 
                                
                                    - HY-164762
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     SHR-A1811 
                                                 | 
                                                
                                                    
                                                    
                                                        
                                                            
                                                            
                                                                Chromogenic Assays
                                                            
                                                        
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Trastuzumab rezetecan (SHR-A1811) is a HER2-targeting antibody-drug conjugate (ADC). Trastuzumab rezetecan is composed of a humanized anti-HER2 antibody (HY-P9907), a cleavable linker MC-Gly-Gly-Phe-Gly (HY-44246), and a topoisomerase I inhibitor payload Rezetecán (HY-147408). Trastuzumab rezetecan can be used for research in HER2-positive breast cancer .
                                                 | 
                                            
                                        
                                     
                                
                             
                        
                            
                            - 
                                
                                    - HY-138298A
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     DS-8201;  DS-8201a 
                                                 | 
                                                
                                                    
                                                    
                                                        
                                                            
                                                            
                                                                Chromogenic Assays
                                                            
                                                        
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Trastuzumab deruxtecan (DS-8201a) is an anti-human epidermal growth factor receptor 2 (HER2) antibody-drug conjugate (ADC). Trastuzumab deruxtecan is composed of a humanized anti-HER2 antibody, an enzymatically cleavable peptide-linker, a topoisomerase I inhibitor (a toxin component of Dxd), and the drug-linker conjugate for ADC is Deruxtecan (HY-13631E). Trastuzumab deruxtecan can be used for the research of HER2-positive breast cancer and gastric cancer  .
                                                 | 
                                            
                                        
                                     
                                
                             
                        
                            
                            - 
                                
                                    - HY-177434
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     Precem-TcT;  M 9140 
                                                 | 
                                                
                                                    
                                                    
                                                        
                                                            
                                                            
                                                                Chromogenic Assays
                                                            
                                                        
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Precemtabart tocentecan (Precem-TcT; M 9140) is an anti-CEACAM5 (carcinoembryonic antigen-related cell adhesion molecule 5) antibody-drug conjugate (ADC). Precemtabart tocentecan consists of a tumor-specific anti-CEACAM5 monoclonal antibody Precemtabart (HY-P990940), a highly hydrophilic and stable cleavable β-glucuronide linker, and a topoisomerase 1 inhibitor payload Exatecan (HY-13631), and the drug-linker conjugate for ADC is Mal-Gly-PAB-Exatecan-D-glucuronic acid (HY-153179). Precemtabart tocentecan inhibits the growth of CEACAM5-positive cancer cells. Precemtabart tocentecan exhibits significant antitumor activity in CEACAM5-expressing xenograft models. Precemtabart tocentecan can be used for the study of CEACAM5-expressing advanced solid tumors, especially mCRC .
                                                 | 
                                            
                                        
                                     
                                
                             
                        
                            
                            - 
                                
                                    - HY-N2306R
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     Aclarubicin (Standard) 
                                                 | 
                                                
                                                    
                                                    
                                                        
                                                            
                                                            
                                                                Fluorescent Dyes/Probes
                                                            
                                                        
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Aclacinomycin A (Standard) is the analytical standard of Aclacinomycin A. This product is intended for research and analytical applications. Aclacinomycin A (Aclarubicin) is an orally active and potent anthracycline antitumor antibiotic. Aclacinomycin A is an inhibitor of topoisomerase I and II. Aclacinomycin A inhibits synthesis of nucleic acid, especially RNA. Aclacinomycin A might inhibit the 26S protease complex as well as the ubiquitin-ATP-dependent proteolysis   .
                                                 | 
                                            
                                        
                                     
                                
                             
                        
                            
                            - 
                                
                                    - HY-16700G
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Fluorescent Dye
                                                    
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    PNU-159682 GMP is a GMP grade PNU-159682 (HY-16700). PNU-159682, a metabolite of the anthracycline Nemorubicin, is a highly potent DNA topoisomerase II inhibitor with excellent cytotoxicity. PNU-159682 acts as a more potent and tolerated ADC cytotoxin than Doxorubicin for ADC synthesis. PNU-159682 can be used in EDV-nanocell technology to overcome agent resistance.
                                                 | 
                                            
                                        
                                     
                                
                             
                        
                        
                    
                 
            
            
            
                
                    
                        
                            | Cat. No. | 
                            Product Name | 
                            Type | 
                        
                    
                    
                        
                            
                            - 
                                
                                    - HY-13631AG
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     DX8951f (GMP) 
                                                 | 
                                                
                                                    
                                                        Biochemical Assay Reagents
                                                    
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Exatecan mesylate (DX8951f ) GMP is a GMP-class Exatecan (HY-13631). Exatecan is a DNA topoisomerase I inhibitor, with an IC50 of 2.2 μM (0.975 μg/mL), and can be used in cancer research   .
                                                 | 
                                            
                                        
                                     
                                
                             
                        
                            
                            - 
                                
                                    - HY-143692
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                    
                                                        
                                                            
                                                            
                                                                Drug Delivery
                                                            
                                                        
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    SQDG inhibits topoisomerase I and P-selectin receptor, exhibits anti-inflammatory, antiviral and antitumor activities. SQDG is a glycolipid that possesses sugar moieties in their head groups. SQDG is a membrane lipid that can be used to investigate the effects of structural lipid in LNP formulations   .
                                                 | 
                                            
                                        
                                     
                                
                             
                        
                            
                            - 
                                
                                    - HY-16700G
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        Biochemical Assay Reagents
                                                    
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    PNU-159682 GMP is a GMP grade PNU-159682 (HY-16700). PNU-159682, a metabolite of the anthracycline Nemorubicin, is a highly potent DNA topoisomerase II inhibitor with excellent cytotoxicity. PNU-159682 acts as a more potent and tolerated ADC cytotoxin than Doxorubicin for ADC synthesis. PNU-159682 can be used in EDV-nanocell technology to overcome agent resistance.
                                                 | 
                                            
                                        
                                     
                                
                             
                        
                        
                    
                 
            
            
            
                
                    
                        
                            | Cat. No. | 
                            Product Name | 
                            Target | 
                            Research Area | 
                        
                    
                    
                        
                            
                            - 
                                
                                    - HY-P10765
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        
                                                        
                                                            Peptide-Drug Conjugates (PDCs)
                                                        
                                                    
                                                        
                                                        
                                                            Topoisomerase
                                                        
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    DTS-108 is a prodrug of SN38 (HY-13704) (a Topoisomerase I inhibitor). DTS-108 is a conjugate generated by linking SN38 to a human oligopeptide via an esterase sensitive cross-linker. DTS-108 exhibits anti-tumor activity against colorectal, lung, and mammary cancer  .
                                                 | 
                                            
                                        
                                     
                                
                             
                        
                        
                    
                 
            
            
            
            
            
                
                    
                        
                            | Cat. No. | 
                            Product Name | 
                            Target | 
                            Research Area | 
                        
                    
                    
                        
                            
                            - 
                                
                                    - HY-164152
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        
                                                        
                                                            Antibody-Drug Conjugates (ADCs)
                                                        
                                                    
                                                        
                                                        
                                                            Topoisomerase
                                                        
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    ADC Control Human IgG1-Deruxtecan (DAR 4) is a humanized monoclonal antibody that is an isotype control of ADC human IgG1-Deruxtecan and can inhibit DNA topoisomerase I. The antibody portion is Human IgG1 kappa, Isotype Control (HY-P99001), and the drug-linker conjugate for ADC is Deruxtecan (HY-13631E) .
                                                 | 
                                            
                                        
                                     
                                
                             
                        
                            
                            - 
                                
                                    - HY-P3371
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     DS-7300a;  MABX-9001a 
                                                 | 
                                                
                                                    
                                                        
                                                        
                                                            Antibody-Drug Conjugates (ADCs)
                                                        
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Ifinatamab deruxtecan (DS-7300a) is an ADC that binds an anti-B7-H3 antibody to the DNA topoisomerase I inhibitory anti-tumor drug DXd. Ifinatamab deruxtecan has antitumor activity .
                                                 | 
                                            
                                        
                                     
                                
                             
                        
                            
                            - 
                                
                                    - HY-P99813
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     HER3-DXd;  U3-1402 
                                                 | 
                                                
                                                    
                                                        
                                                        
                                                            Antibody-Drug Conjugates (ADCs)
                                                        
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Patritumab deruxtecan (HER3-DXd) is an antibody-drug conjugate (ADC) consisting of a fully human anti-HER3 IgG1 monoclonal antibody Patritumab (HY-P99275) attached to a topoisomerase I inhibitor payload via a tetrapeptide-based cleavable linker. Patritumab deruxtecan shows anticancer activity .
                                                 | 
                                            
                                        
                                     
                                
                             
                        
                            
                            - 
                                
                                    - HY-P99843
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                        
                                                        
                                                            TROP2
                                                        
                                                    
                                                        
                                                        
                                                            ADC Antibody
                                                        
                                                    
                                                 | 
                                                
                                                    
                                                        Cancer
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Datopotamab (CDP7657) is a humanized anti trophoblast cell surface antigen 2 (TROP2) antibody. Datopotamab can generate antibody drug conjugates (ADC) (HY-141598) with DNA topoisomerase I inhibitor Deruxtecan (HY-13631E). Datopotamab can be used in the study of triple negative breast cancer and non-small cell lung cancer .
                                                 | 
                                            
                                        
                                     
                                
                             
                        
                        
                    
                 
            
            
            
                
                    
                        
                            | Cat. No. | 
                            Product Name | 
                            Category | 
                            Target | 
                            Chemical Structure | 
                        
                    
                    
                        
                            
                            - 
                                
                                    - HY-N3488
 
                                    - 
                                        
                                    
 
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                             
                        
                            
                            - 
                                
                                    - HY-116933
 
                                    - 
                                        
                                    
 
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                             
                        
                            
                            - 
                                
                                    - HY-N15319
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     Canangine 
                                                 | 
                                                
                                                    
                                                    
                                                        
                                                            
                                                            
                                                                Alkaloids
                                                            
                                                        
                                                            
                                                            
                                                                Other Alkaloids
                                                            
                                                        
                                                            
                                                            
                                                                Cananga odorata
                                                            
                                                        
                                                            
                                                            
                                                                Source classification
                                                            
                                                        
                                                            
                                                            
                                                                Plants
                                                            
                                                        
                                                            
                                                            
                                                                Annonaceae
                                                            
                                                        
                                                    
                                                     
                                                        
                                                     
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                        Fungal
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Eupolauridine (Canangine) is a selective DNA topoisomerase II inhibitor with IC50 values of 20 μM for fungal topoisomerase I and 33 μM for human topoisomerase I. Eupolauridine exerts antifungal activity by inhibiting the catalytic activity of topoisomerase II and stabilizing its cleavage complex with DNA, leading to DNA damage. Eupolauridine is promising for research of fungal infectious diseases  .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                             
                        
                            
                            - 
                                
                                    - HY-N4329
 
                                    - 
                                        
                                    
 
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                             
                        
                            
                            - 
                                
                                    - HY-124552
 
                                    - 
                                        
                                    
 
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                             
                        
                            
                            - 
                                
                                    - HY-N10367
 
                                    - 
                                        
                                    
 
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                             
                        
                            
                            - 
                                
                                    - HY-N12129
 
                                    - 
                                        
                                    
 
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                             
                        
                            
                            - 
                                
                                    - HY-W713570
 
                                    - 
                                        
                                    
 
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                             
                        
                            
                            - 
                                
                                    - HY-167671
 
                                    - 
                                        
                                    
 
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                             
                        
                            
                            - 
                                
                                    - HY-N6054
 
                                    - 
                                        
                                    
 
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                             
                        
                            
                            - 
                                
                                    - HY-N15597
 
                                    - 
                                        
                                    
 
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                             
                        
                            
                            - 
                                
                                    - HY-N6054R
 
                                    - 
                                        
                                    
 
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                             
                        
                            
                            - 
                                
                                    - HY-N0872
 
                                    - 
                                        
                                    
 
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                             
                        
                            
                            - 
                                
                                    - HY-N0872R
 
                                    - 
                                        
                                    
 
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                             
                        
                            
                            - 
                                
                                    - HY-N10495
 
                                    - 
                                        
                                    
 
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                             
                        
                            
                            - 
                                
                                    - HY-16560
 
                                    - 
                                        
                                    
 
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                             
                        
                            
                            - 
                                
                                    - HY-19825
 
                                    - 
                                        
                                    
 
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                             
                        
                            
                            - 
                                
                                    - HY-N0354
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                    
                                                        
                                                            
                                                            
                                                                Seeds of Cassia tora Linn.
                                                            
                                                        
                                                            
                                                            
                                                                Quinones
                                                            
                                                        
                                                            
                                                            
                                                                other families
                                                            
                                                        
                                                            
                                                            
                                                                Classification of Application Fields
                                                            
                                                        
                                                            
                                                            
                                                                Leguminosae
                                                            
                                                        
                                                            
                                                            
                                                                Anthraquinones
                                                            
                                                        
                                                            
                                                            
                                                                Source classification
                                                            
                                                        
                                                            
                                                            
                                                                Other Diseases
                                                            
                                                        
                                                            
                                                            
                                                                Plants
                                                            
                                                        
                                                            
                                                            
                                                                Disease Research Fields
                                                            
                                                        
                                                    
                                                     
                                                        
                                                     
                                                 | 
                                                
                                                    
                                                        Virus Protease
                                                    
                                                        Topoisomerase
                                                    
                                                        Apoptosis
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Anthraquinone is used as a precursor for dye formation and agrochemicals, existing in different organisms, such as bacteria, fungi, plants, and some animals. Anthraquinone has biological activities: anticancer, antiinflammatory, diuretic, antiarthritic, antifungal, antibacterial, antimalarial and antioxidant. Anthraquinone also plays an important role in the primary metabolism of plants by acting on the electron transport chain through the inhibition of energy transfer in the photosynthetic process. Anthraquinone can intercalates into DNA and inhibits the topoisomerase II (topo II) enzyme, resulting in cell death via Apoptosis    .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                             
                        
                            
                            - 
                                
                                    - HY-123589
 
                                    - 
                                        
                                    
 
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                             
                        
                            
                            - 
                                
                                    - HY-N6800
 
                                    - 
                                        
                                    
 
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                             
                        
                            
                            - 
                                
                                    - HY-N6800A
 
                                    - 
                                        
                                    
 
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                             
                        
                            
                            - 
                                
                                    - HY-121309
 
                                    - 
                                        
                                    
 
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                             
                        
                            
                            - 
                                
                                    - HY-119458
 
                                    - 
                                        
                                    
 
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                             
                        
                            
                            - 
                                
                                    - HY-15552
 
                                    - 
                                        
                                    
 
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                             
                        
                            
                            - 
                                
                                    - HY-13768A
 
                                    - 
                                        
                                    
 
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                             
                        
                            
                            - 
                                
                                    - HY-N10115
 
                                    - 
                                        
                                    
 
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                             
                        
                            
                            - 
                                
                                    - HY-N6714
 
                                    - 
                                        
                                    
 
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                             
                        
                            
                            - 
                                
                                    - HY-N8473
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     (+)-Pericosine A 
                                                 | 
                                                
                                                    
                                                    
                                                        
                                                            
                                                                Natural Products
                                                            
                                                            
                                                        
                                                            
                                                            
                                                                Microorganisms
                                                            
                                                        
                                                            
                                                            
                                                                Source classification
                                                            
                                                        
                                                    
                                                     
                                                        
                                                     
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Pericosine A ((+)-Pericosine A) is a topoisomerase II (Topoisomerase II) inhibitor that can be isolated from the Periconia byssoides strain. Pericosine A has significant antitumor activity in vitro and in vivo and can be used in cancer research. Pericosine A also inhibits the protein kinase epidermal growth factor receptor .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                             
                        
                            
                            - 
                                
                                    - HY-15753
 
                                    - 
                                        
                                    
 
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                             
                        
                            
                            - 
                                
                                    - HY-15753A
 
                                    - 
                                        
                                    
 
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                             
                        
                            
                            - 
                                
                                    - HY-N11698
 
                                    - 
                                        
                                    
 
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                             
                        
                            
                            - 
                                
                                    - HY-106702A
 
                                    - 
                                        
                                    
 
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                             
                        
                            
                            - 
                                
                                    - HY-N6714R
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                    
                                                        
                                                            
                                                            
                                                                Microorganisms
                                                            
                                                        
                                                            
                                                            
                                                                Source classification
                                                            
                                                        
                                                            
                                                            
                                                                Phenols
                                                            
                                                        
                                                            
                                                            
                                                                Polyphenols
                                                            
                                                        
                                                    
                                                     
                                                        
                                                     
                                                 | 
                                                
                                                    
                                                        Reference Standards
                                                    
                                                        Topoisomerase
                                                    
                                                        Androgen Receptor
                                                    
                                                        Estrogen Receptor/ERR
                                                    
                                                        Apoptosis
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Alternariol (Standard) is the analytical standard of Alternariol. This product is intended for research and analytical applications. Alternariol is an orally ingested mycotoxin produced by Alternaria, capable of inhibiting the activity of topoisomerase I and II (topoisomerase I, topoisomerase II). Alternariol has weak estrogenic (Estrogen Receptor/ERR) and androgen/antiandrogen (Androgen Receptor) effects. Alternariol can induce apoptosis, trigger cell cycle arrest, suppress innate immune responses, and exhibit anti-tumor activity. Alternariol has genotoxic, mutagenic, and endocrine-disrupting effects     .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                             
                        
                            
                            - 
                                
                                    - HY-16562A
 
                                    - 
                                        
                                    
 
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                             
                        
                            
                            - 
                                
                                    - HY-N2331
 
                                    - 
                                        
                                    
 
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                             
                        
                            
                            - 
                                
                                    - HY-121309R
 
                                    - 
                                        
                                    
 
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                             
                        
                            
                            - 
                                
                                    - HY-100309
 
                                    - 
                                        
                                    
 
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                             
                        
                            
                            - 
                                
                                    - HY-N0275
 
                                    - 
                                        
                                    
 
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                             
                        
                            
                            - 
                                
                                    - HY-W897655
 
                                    - 
                                        
                                    
 
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                             
                        
                            
                            - 
                                
                                    - HY-N12747
 
                                    - 
                                        
                                    
 
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                             
                        
                            
                            - 
                                
                                    - HY-15142
 
                                    - 
                                        
                                    
 
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                             
                        
                            
                            - 
                                
                                    - HY-18258
 
                                    - 
                                        
                                    
 
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                             
                        
                            
                            - 
                                
                                    - HY-15552R
 
                                    - 
                                        
                                    
 
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                             
                        
                            
                            - 
                                
                                    - HY-13768AR
 
                                    - 
                                        
                                    
 
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                             
                        
                            
                            - 
                                
                                    - HY-17577
 
                                    - 
                                        
                                    
 
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                             
                        
                            
                            - 
                                
                                    - HY-N6880
 
                                    - 
                                        
                                    
 
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                             
                        
                            
                            - 
                                
                                    - HY-15753R
 
                                    - 
                                        
                                    
 
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                             
                        
                            
                            - 
                                
                                    - HY-N8745
 
                                    - 
                                        
                                    
 
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                             
                        
                            
                            - 
                                
                                    - HY-15753AR
 
                                    - 
                                        
                                    
 
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                             
                        
                            
                            - 
                                
                                    - HY-15142A
 
                                    - 
                                        
                                    
 
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                             
                        
                            
                            
                                
                                    - HY-15142R
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     Hydroxydaunorubicin hydrochloride (Standard); ADR (Standard) 
                                                 | 
                                                
                                                    
                                                    
                                                        
                                                            
                                                            
                                                                Quinones
                                                            
                                                        
                                                            
                                                            
                                                                Microorganisms
                                                            
                                                        
                                                            
                                                            
                                                                Anthraquinones
                                                            
                                                        
                                                            
                                                            
                                                                Source classification
                                                            
                                                        
                                                    
                                                     
                                                        
                                                     
                                                 | 
                                                
                                                    
                                                        Reference Standards
                                                    
                                                        Topoisomerase
                                                    
                                                        ADC Payload
                                                    
                                                        AMPK
                                                    
                                                        Autophagy
                                                    
                                                        Apoptosis
                                                    
                                                        HIV
                                                    
                                                        HBV
                                                    
                                                        Mitophagy
                                                    
                                                        Antibiotic
                                                    
                                                        Bacterial
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Doxorubicin hydrochloride (Standard) is the analytical standard of Doxorubicin hydrochloride. This product is intended for research and analytical applications. Doxorubicin (Hydroxydaunorubicin) hydrochloride, a cytotoxic anthracycline antibiotic, is an anti-cancer chemotherapy agent. Doxorubicin hydrochloride is a potent human DNA topoisomerase I and topoisomerase II inhibitor with IC50s of 0.8 μM and 2.67 μM, respectively. Doxorubicin hydrochloride reduces basal phosphorylation of AMPK and its downstream target acetyl-CoA carboxylase. Doxorubicin hydrochloride induces apoptosis and autophagy   .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-N2063
 
                                    - 
                                        
                                    
 
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-N2331R
 
                                    - 
                                        
                                    
 
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-N2198
 
                                    - 
                                        
                                    
 
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-16562AR
 
                                    - 
                                        
                                    
 
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-13555
 
                                    - 
                                        
                                    
 
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-10529
 
                                    - 
                                        
                                    
 
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-122550
 
                                    - 
                                        
                                    
 
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-118726
 
                                    - 
                                        
                                    
 
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-18258R
 
                                    - 
                                        
                                    
 
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-13629
 
                                    - 
                                        
                                    
 
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-N0275R
 
                                    - 
                                        
                                    
 
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-116529
 
                                    - 
                                        
                                    
 
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-13744
 
                                    - 
                                        
                                    
 
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-N6011
 
                                    - 
                                        
                                    
 
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-17577R
 
                                    - 
                                        
                                    
 
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-N0716B
 
                                    - 
                                        
                                    
 
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-N11536
 
                                    - 
                                        
                                    
 
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-B0398
 
                                    - 
                                        
                                    
 
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-N2306A
 
                                    - 
                                        
                                    
 
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-A0210
 
                                    - 
                                        
                                    
 
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-N2306
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     Aclarubicin 
                                                 | 
                                                
                                                    
                                                    
                                                        
                                                            
                                                            
                                                                Quinones
                                                            
                                                        
                                                            
                                                            
                                                                Microorganisms
                                                            
                                                        
                                                            
                                                            
                                                                Anthraquinones
                                                            
                                                        
                                                    
                                                     
                                                        
                                                     
                                                 | 
                                                
                                                    
                                                        Topoisomerase
                                                    
                                                        DNA/RNA Synthesis
                                                    
                                                        Proteasome
                                                    
                                                        Antibiotic
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Aclacinomycin A (Aclarubicin) is an orally active and potent anthracycline antitumor antibiotic. Aclacinomycin A is an inhibitor of topoisomerase I and II. Aclacinomycin A inhibits synthesis of nucleic acid, especially RNA. Aclacinomycin A might inhibit the 26S protease complex as well as the ubiquitin-ATP-dependent proteolysis   .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-10529R
 
                                    - 
                                        
                                    
 
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-13704
 
                                    - 
                                        
                                    
 
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-13629R
 
                                    - 
                                        
                                    
 
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-13555R
 
                                    - 
                                        
                                    
 
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-N5038
 
                                    - 
                                        
                                    
 
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-N0716
 
                                    - 
                                        
                                    
 
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-B0398R
 
                                    - 
                                        
                                    
 
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-N0716BR
 
                                    - 
                                        
                                    
 
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-N2306R
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     Aclarubicin (Standard) 
                                                 | 
                                                
                                                    
                                                    
                                                        
                                                            
                                                            
                                                                Quinones
                                                            
                                                        
                                                            
                                                            
                                                                Microorganisms
                                                            
                                                        
                                                            
                                                            
                                                                Anthraquinones
                                                            
                                                        
                                                    
                                                     
                                                        
                                                     
                                                 | 
                                                
                                                    
                                                        Reference Standards
                                                    
                                                        Topoisomerase
                                                    
                                                        DNA/RNA Synthesis
                                                    
                                                        Proteasome
                                                    
                                                        Antibiotic
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Aclacinomycin A (Standard) is the analytical standard of Aclacinomycin A. This product is intended for research and analytical applications. Aclacinomycin A (Aclarubicin) is an orally active and potent anthracycline antitumor antibiotic. Aclacinomycin A is an inhibitor of topoisomerase I and II. Aclacinomycin A inhibits synthesis of nucleic acid, especially RNA. Aclacinomycin A might inhibit the 26S protease complex as well as the ubiquitin-ATP-dependent proteolysis   .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-W046353
 
                                    - 
                                        
                                    
 
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-13062A
 
                                    - 
                                        
                                    
 
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-13062
 
                                    - 
                                        
                                    
 
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-N0095
 
                                    - 
                                        
                                    
 
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-13704R
 
                                    - 
                                        
                                    
 
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-N6769
 
                                    - 
                                        
                                    
 
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-13502B
 
                                    - 
                                        
                                    
 
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-13502
 
                                    - 
                                        
                                    
 
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-13502A
 
                                    - 
                                        
                                    
 
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-W046353R
 
                                    - 
                                        
                                    
 
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-13062R
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     Daunomycin hydrochloride (Standard); RP 13057 hydrochloride (Standard); Rubidomycin hydrochloride (Standard) 
                                                 | 
                                                
                                                    
                                                    
                                                        
                                                            
                                                            
                                                                Quinones
                                                            
                                                        
                                                            
                                                            
                                                                Microorganisms
                                                            
                                                        
                                                            
                                                            
                                                                Anthraquinones
                                                            
                                                        
                                                            
                                                            
                                                                Source classification
                                                            
                                                        
                                                            
                                                            
                                                                Phenols
                                                            
                                                        
                                                            
                                                            
                                                                Polyphenols
                                                            
                                                        
                                                    
                                                     
                                                        
                                                     
                                                 | 
                                                
                                                    
                                                        Reference Standards
                                                    
                                                        Topoisomerase
                                                    
                                                        DNA/RNA Synthesis
                                                    
                                                        ADC Payload
                                                    
                                                        Bacterial
                                                    
                                                        Autophagy
                                                    
                                                        Apoptosis
                                                    
                                                        Antibiotic
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Daunorubicin (hydrochloride) (Standard) is the analytical standard of Daunorubicin (hydrochloride). This product is intended for research and analytical applications. Daunorubicin (Daunomycin) hydrochloride is a topoisomerase II inhibitor with potent anti-tumor activity. Daunorubicin hydrochloride inhibits DNA and RNA synthesis. Daunorubicin hydrochloride is a cytotoxin that inhibits cancer cell viability and induces apoptosis and necrosis. Daunorubicin hydrochloride is also an anthracycline antibiotic. Daunorubicin hydrochloride can be used in the research of infection and variety of cancers, including leukemia, non-Hodgkin lymphomas, Ewing's sarcoma, Wilms' tumor    .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-N6865
 
                                    - 
                                        
                                    
 
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-N0498
 
                                    - 
                                        
                                    
 
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-16560R
 
                                    - 
                                        
                                    
 
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-13502AR
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     Mitozantrone dihydrochloride (Standard); NSC 301739 dihydrochloride (Standard) 
                                                 | 
                                                
                                                    
                                                    
                                                        
                                                            
                                                            
                                                                Quinones
                                                            
                                                        
                                                            
                                                            
                                                                Anthraquinones
                                                            
                                                        
                                                            
                                                            
                                                                Source classification
                                                            
                                                        
                                                            
                                                            
                                                                Endogenous metabolite
                                                            
                                                        
                                                    
                                                     
                                                        
                                                     
                                                 | 
                                                
                                                    
                                                        Reference Standards
                                                    
                                                        Topoisomerase
                                                    
                                                        PKC
                                                    
                                                        Orthopoxvirus
                                                    
                                                        Apoptosis
                                                    
                                                        Endogenous Metabolite
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Mitoxantrone (dihydrochloride) (Standard) is the analytical standard of Mitoxantrone (dihydrochloride). This product is intended for research and analytical applications. Mitoxantrone dihydrochloride is a potent topoisomerase II inhibitor. Mitoxantrone dihydrochloride also inhibits protein kinase C (PKC) activity with an IC50 of 8.5 μM. Mitoxantrone dihydrochloride induces apoptosis of B-CLL (B-chronic lymphocytic leukaemia) cells. Mitoxantrone dihydrochloride shows antitumor activity    . Mitoxantrone dihydrochloride also has anti-orthopoxvirus activity with EC50s of 0.25 μM and and 0.8 μM for cowpox and monkeypox, respectively .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-N0498R
 
                                    - 
                                        
                                    
 
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-N2150
 
                                    - 
                                        
                                    
 
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-13502R
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     Mitozantrone (Standard); NSC 301739 (Standard) 
                                                 | 
                                                
                                                    
                                                    
                                                        
                                                            
                                                            
                                                                Quinones
                                                            
                                                        
                                                            
                                                            
                                                                Anthraquinones
                                                            
                                                        
                                                            
                                                            
                                                                Source classification
                                                            
                                                        
                                                            
                                                            
                                                                Endogenous metabolite
                                                            
                                                        
                                                    
                                                     
                                                        
                                                     
                                                 | 
                                                
                                                    
                                                        Reference Standards
                                                    
                                                        Topoisomerase
                                                    
                                                        PKC
                                                    
                                                        Orthopoxvirus
                                                    
                                                        Apoptosis
                                                    
                                                        Endogenous Metabolite
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Mitoxantrone (Standard) is the analytical standard of Mitoxantrone. This product is intended for research and analytical applications. Mitoxantrone is a potent topoisomerase II inhibitor. Mitoxantrone also inhibits protein kinase C (PKC) activity with an IC50 of 8.5 μM. Mitoxantrone induces apoptosis of B-CLL (B-chronic lymphocytic leukaemia) cells. Mitoxantrone shows antitumor activity    . Mitoxantrone also has anti-orthopoxvirus activity with EC50s of 0.25 μM and and 0.8 μM for cowpox and monkeypox, respectively .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-B0147
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     Pefloxacinium 
                                                 | 
                                                
                                                    
                                                    
                                                        
                                                            
                                                            
                                                                Infection
                                                            
                                                        
                                                            
                                                            
                                                                Classification of Application Fields
                                                            
                                                        
                                                            
                                                            
                                                                Disease Research Fields
                                                            
                                                        
                                                    
                                                     
                                                        
                                                     
                                                 | 
                                                
                                                    
                                                        Antibiotic
                                                    
                                                        Bacterial
                                                    
                                                        Parasite
                                                    
                                                        DNA/RNA Synthesis
                                                    
                                                        Topoisomerase
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Pefloxacin (Pefloxacinium) is a broad spectrum antibiotic. Pefloxacin blocks DNA replication by inhibiting DNA gyrase. Pefloxacin inhibits DNA relaxation catalyzed by topoisomerase I with an IC50 of 45 μg/mL. Pefloxacin exhibits antibacterial activity against Escherichia coli, Pseudomonas aeruginosa, and Bacteroides fragilis with MIC90s of 0.12, 4, and 16 mg/L, respectively. Pefloxacin has anti-Plasmodium yoelii infection activity. Pefloxacin increase UVA-induced edema and immunesuppression. Pefloxacin can be used for infection studies         .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-N0095R
 
                                    - 
                                        
                                    
 
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-N0311
 
                                    - 
                                        
                                    
 
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-N0311R
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                
                                                    
                                                    
                                                        
                                                            
                                                            
                                                                Quinones
                                                            
                                                        
                                                            
                                                            
                                                                other families
                                                            
                                                        
                                                            
                                                            
                                                                Anthraquinones
                                                            
                                                        
                                                            
                                                            
                                                                Source classification
                                                            
                                                        
                                                            
                                                            
                                                                Phenols
                                                            
                                                        
                                                            
                                                            
                                                                Polyphenols
                                                            
                                                        
                                                            
                                                            
                                                                Plants
                                                            
                                                        
                                                    
                                                     
                                                        
                                                     
                                                 | 
                                                
                                                    
                                                        Reference Standards
                                                    
                                                        Aldose Reductase
                                                    
                                                        Topoisomerase
                                                    
                                                        SOD
                                                    
                                                        p38 MAPK
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Emodin-8-glucoside (Standard) is the analytical standard of Emodin-8-glucoside. This product is intended for research and analytical applications. Emodin-8-glucoside is an anthraquinone derivative that can be isolated from Aloe vera. Emodin-8-glucoside is the inhibitor for MAPK with an inhibition constant of 430.14 pM. Emodin-8-glucoside exhibits moderate inhibitory activity against rat lens aldose reductase (ALAR) and topoisomerases II with IC50s of 14.4 μM and 66 μM. Emodin-8-glucoside exhibits antioxidant, anti-inflammatory and anti-fibrotic activities. Emodin-8-glucoside can cross the blood brain barrier     .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                            
                            
                                
                                    - HY-Y0790R
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                     p-Isopropylbenzaldehyde (Standard) 
                                                 | 
                                                
                                                    
                                                    
                                                        
                                                            
                                                            
                                                                Ketones, Aldehydes, Acids
                                                            
                                                        
                                                            
                                                            
                                                                Rudbeckia laciniata L.
                                                            
                                                        
                                                            
                                                            
                                                                Source classification
                                                            
                                                        
                                                            
                                                            
                                                                Umbelliferae
                                                            
                                                        
                                                            
                                                            
                                                                Plants
                                                            
                                                        
                                                            
                                                            
                                                                Endogenous metabolite
                                                            
                                                        
                                                    
                                                     
                                                        
                                                     
                                                 | 
                                                
                                                    
                                                        α-synuclein
                                                    
                                                        Reference Standards
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Cuminaldehyde Standard is the analytical standard of Cuminaldehyde. This product is intended for research and analytical applications. Cuminaldehyde is the main component of Cuminum cyminum and has multiple biological activities, including anti-inflammatory, anti-cancer, anti-diabetic, anti-injury, anti-neuropathy and antibacterial effects. Cuminaldehyde is an inhibitor of aldose reductase (IC50= 0.00085 mg/mL) and α-glucosidase (IC50=0.5 mg/mL). Cuminaldehyde also inhibits the fibrillation of α-synuclein and prevents its aggregation Cuminaldehyde can induce apoptosis in colon adenocarcinoma cells by targeting topoisomerase I and II. In addition, Cuminaldehyde also exerts anti-inflammatory activity by inhibiting lipoxygenase. Cuminaldehyde has a strong inhibitory effect on the growth of Aspergillus flavus and the biosynthesis of aflatoxin B1 (AFB1). Cuminaldehyde can exert anti-injury and anti-neuropathy effects by participating in opioid receptors, L-arginine/NO/cGMP pathways and anti-inflammatory effects. Cuminaldehyde has potential application value in the research of neurodegenerative diseases, cancer, diabetes and neuropathic pain diseases       .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                            
                        
                        
                 
            
            
            
            
            
                
                    
                        
                            | Cat. No. | 
                            Product Name | 
                            Chemical Structure | 
                        
                    
                    
                        
                            
                            - 
                                
                                    - HY-16562S1
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Irinotecan-d10 (hydrochloride) is the deuterium labeled Irinotecan. Irinotecan ((+)-Irinotecan) is a topoisomerase I inhibitor, preventing religation of the DNA strand by binding to topoisomerase I-DNA complex  .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                             
                        
                            
                            - 
                                
                                    - HY-16562S
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Irinotecan-d10 is a deuterium labeled Irinotecan ((+)-Irinotecan). Irinotecan ((+)-Irinotecan) is a topoisomerase I inhibitor, preventing religation of the DNA strand by binding to topoisomerase I-DNA complex .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                             
                        
                            
                            - 
                                
                                    - HY-13566AS
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Belotecan-d7 (hydrochloride) is the deuterium labeled Belotecan hydrochloride. Belotecan hydrochloride (CKD-602 hydrochloride), a Topoisomerase I inhibitor, is a synthetic camptothecin derivative  .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                             
                        
                            
                            - 
                                
                                    - HY-13562AS
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Banoxantrone-d12 (dihydrochloride)  is the deuterium labeled Banoxantrone dihydrochloride. Banoxantrone is a novel bioreductive agent that can be reduced to a stable, DNA-affinic compound AQ4, which is a potent topoisomerase II inhibitor.
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                             
                        
                            
                            - 
                                
                                    - HY-121309S
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Doxorubicinone-d3 is the deuterium labeled Doxorubicinone. Doxorubicinone is a metabolite of an anti-cancer chemotherapy agent Doxorubicin . Doxorubicin is a potent human?DNA topoisomerase I?and?topoisomerase II?inhibitor with?IC50s of 0.8 μM and 2.67 μM, respectively.
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                             
                        
                            
                            - 
                                
                                    - HY-W653896
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Alternariol-d2 is deuterium labeled Alternariol. Alternariol is an orally ingested mycotoxin produced by Alternaria, capable of inhibiting the activity of topoisomerase I and II (topoisomerase I, topoisomerase II). Alternariol has weak estrogenic (Estrogen Receptor/ERR) and androgen/antiandrogen (Androgen Receptor) effects. Alternariol can induce apoptosis, trigger cell cycle arrest, suppress innate immune responses, and exhibit anti-tumor activity. Alternariol has genotoxic, mutagenic, and endocrine-disrupting effects      .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                             
                        
                            
                            - 
                                
                                    - HY-121309S1
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Doxorubicinone- 13C,d3 (Adriamycin aglycone- 13C,d3) is  13C labeled Doxorubicinone. Doxorubicinone is a metabolite of an anti-cancer chemotherapy agent Doxorubicin . Doxorubicin is a potent human DNA topoisomerase I and topoisomerase II inhibitor with IC50s of 0.8 μM and 2.67 μM, respectively.
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                             
                        
                            
                            - 
                                
                                    - HY-15552S
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Podofilox-d6 is the deuterium labeled Podofilox. Podofilox (Podophyllotoxin) is a potent inhibitor of microtubule assembly and DNA topoisomerase II  .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                             
                        
                            
                            - 
                                
                                    - HY-10581AS
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Gatifloxacin-d3 (hydrochloride) is the deuterium labeled Gatifloxacin (hydrochloride). Gatifloxacin hydrochloride (AM-1155; BMS-206584; PD135432) is a potent fluoroquinolone antibiotic with broad-spectrum antibacterial activity. Gatifloxacin hydrochloride inhibits bacterial type II topoisomerases (IC50=13.8 μg/ml for S. aureus topoisomerase IV) and E. coli DNA gyrase (IC50 = 0.109 μg/ml). Gatifloxacin hydrochloride can be used to treat bacterial conjunctivitis in vivo.
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                             
                        
                            
                            - 
                                
                                    - HY-16562AS
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Irinotecan-d5 hydrochloride is deuterated labeled Irinotecan hydrochloride (HY-16562A). Irinotecan hydrochloride ((+)-Irinotecan hydrochloride) is a topoisomerase I inhibitor mainly used to treat colon cancer and rectal cancer .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                             
                        
                            
                            - 
                                
                                    - HY-13562S
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Banoxantrone-d12 is the deuterium labeled banoxantrone. Banoxantrone is a novel bioreductive agent that can be reduced to a stable, DNA-affinic compound AQ4, which is a potent topoisomerase II inhibitor.
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                             
                        
                            
                            - 
                                
                                    - HY-18258S
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Berberine-d6 (chloride) is the deuterium labeled Berberine chloride. Berberine chloride is an alkaloid that acts as an antibiotic. Berberine chloride induces reactive oxygen species (ROS) generation and inhibits DNA topoisomerase. Antineoplastic properties .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                             
                        
                            
                            - 
                                
                                    - HY-B0526S
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Flumequine- 13C3 is the  13C3 labeled Flumequine. Flumequine (R-802) is a quinolone antibiotic, and acts as a topoisomerase II inhibitor, with an IC50 of 15 μM (3.92 μg/mL).
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                             
                        
                            
                            - 
                                
                                    - HY-13631AS1
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Exatecan-d3 (DX8951f-d3) mesylate is deuterium-labeled Exatecan mesylate (HY-13631A). Exatecan mesylate is a DNA topoisomerase I inhibitor, with an IC50 of 0.975 μg/mL .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                             
                        
                            
                            - 
                                
                                    - HY-13502S
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Mitoxantrone-d8 (mitozantrone-d8) is the deuterium labeled Mitoxantrone. Mitoxantrone is a topoisomerase II inhibitor and also inhibits protein kinase C (PKC) activity with an IC50 of 8.5 μM  .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                             
                        
                            
                            - 
                                
                                    - HY-13631DS
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Dxd-d5 is a deuterium labeled Dxd. Dxd is a potent DNA topoisomerase I inhibitor, with an IC50 of 0.31 μM, used as a conjugated drug of HER2-targeting ADC (DS-8201a)  .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                             
                        
                            
                            - 
                                
                                    - HY-13631AS
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Exatecan-d5 (DX8951f-d5) mesylate is deuterium labeled Exatecan mesylate (HY-13631A). Exatecan mesylate is a DNA topoisomerase I inhibitor, with an IC50 of 2.2 μM (0.975 μg/mL). Exatecan mesylate can be used in cancer research .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                             
                        
                            
                            - 
                                
                                    - HY-126373S1
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    SN-38 glucuronide- 13C6 is the  13C labeled SN-38 glucuronide (HY-126373) . SN-38 glucuronide is an inactive metabolite of the cancer agent Irinotecan. Irinotecan is a topoisomerase I inhibitor which can be used for researching colon and rectal cancer .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                             
                        
                            
                            - 
                                
                                    - HY-13629S1
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Etoposide- 13C,d3 is the  13C- and deuterium labeled Etoposide. Etoposide (VP-16; VP-16-213) is an anti-cancer chemotherapy agent. Etoposide inhibits topoisomerase II, thus stopping DNA replication. Etoposide induces cell cycle arrest, apoptosis and autophagy .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                             
                        
                            
                            - 
                                
                                    - HY-13629S
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Etoposide-d3 (VP-16-d3) is the deuterium labeled Etoposide (HY-13629). Etoposide (VP-16) is an anti-cancer chemotherapy agent. Etoposide inhibits topoisomerase II, thus stopping DNA replication. Etoposide induces cell cycle arrest, apoptosis and autophagy .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                             
                        
                            
                            - 
                                
                                    - HY-B0398S
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Nalidixic Acid-d5 is the deuterium labeled Nalidixic acid. Nalidixic acid, a quinolone antibiotic, is effective against both gram-positive and gram-negative bacteria. Nalidixic acid acts in a bacteriostatic manner in lower concentrations and is bactericidal in higher concentrations. Nalidixic acid inhibits a subunit of DNA gyrase and topoisomerase IV and reversibly blocks DNA replication in susceptible bacteria .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                             
                        
                            
                            - 
                                
                                    - HY-W744739
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Betulinic acid-d3 (Lupatic acid-d3) is a deuterium labeled Betulinic acid (HY-10529). Betulinic acid is a natural pentacyclic triterpenoid, acts as a eukaryotic topoisomerase I inhibitor, with an IC50 of 5 μM, and possesses anti-HIV, anti-malarial, anti-inflammatory and anti-tumor properties    .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                             
                        
                            
                            - 
                                
                                    - HY-13704S
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    SN-38-d3 is the deuterium labeled SN-38. SN-38 (NK012) is an active metabolite of the Topoisomerase I inhibitor Irinotecan. SN-38 (NK012) inhibits DNA and RNA synthesis with IC50s of 0.077 and 1.3 μM, respectively    .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                             
                        
                            
                            - 
                                
                                    - HY-145397S
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    (4-NH2)-Exatecan-d5 is a deuterated labeled (4-NH2)-Exatecan . (4-NH2)-Exatecan (compound A), a topoisomerase inhibitor, is a derivative of Exatecan. (4-NH2)-Exatecan can be used in the synthesis of antibody-drug conjugates (ADCs) .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                             
                        
                            
                            - 
                                
                                    - HY-W653919
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    SN-38 glucuronide-d3 is deuterium labeled SN-38 glucuronide. SN-38 glucuronide is an inactive metabolite of the anticancer active molecule Irinotecan (HY-16562) and has toxic effects on the gastrointestinal tract. Irinotecan is a topoisomerase I inhibitor which can be used for researching colon and rectal cancer    .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                             
                        
                            
                            - 
                                
                                    - HY-132561S
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    RPR121056-d3 is the deuterium labeled RPR121056. RPR121056 is a metabolite of Irinotecan (HY-16562), which is generated by CYP3A4. Irinotecan (CPT-11) is an antineoplastic agent that inhibits topoisomerase type I, causing cell death, and is widely used in the treatment of colorectal cancer. Irinotecan also directly inhibits AChE  .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                             
                        
                            
                            - 
                                
                                    - HY-B0330BS1
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Levofloxacin-d3 ((-)-Ofloxacin-d3) hydrochlorideis deuterium labeled Levofloxacin (hydrochloride). Levofloxacin ((-)-Ofloxacin) hydrochloride is an orally active antibiotic and is active against both Gram-positive and Gram-negative bacteria. Levofloxacin hydrochloride inhibits the DNA gyrase and topoisomerase IV.  Levofloxacin hydrochloride can be used for chronic periodontitis, airway inflammation and BK Viremia research.  Levofloxacin hydrochloride shows anti-orthopoxvirus activity      .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                             
                        
                            
                            - 
                                
                                    - HY-W744243
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Etoposide-d4 (VP-16-d4; VP-16-213-d4) is the deuterium labeled Etoposide (HY-13629). Etoposide (VP-16; VP-16-213) is an anti-cancer chemotherapy agent. Etoposide inhibits topoisomerase II, thus stopping DNA replication. Etoposide induces cell cycle arrest, apoptosis and autophagy .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                             
                        
                            
                            - 
                                
                                    - HY-W744235
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Levofloxacin-d3 sodium is the deuterium labeled Levofloxacin sodium (HY-B0330C). Levofloxacin ((-)-Ofloxacin) sodium is an orally active antibiotic and is active against both Gram-positive and Gram-negative bacteria. Levofloxacin sodium inhibits the DNA gyrase and topoisomerase IV.  Levofloxacin sodium can be used for chronic periodontitis, airway inflammation and BK Viremia research. Levofloxacin sodium shows anti-orthopoxvirus activity     .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                             
                        
                            
                            - 
                                
                                    - HY-13768S1
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Topotecan-d6 is the deuterium labeled Topotecan. Topotecan (SKF 104864A; NSC 609669) is a Topoisomerase I inhibitor. The IC50 values of Topotecan at 24 h are 2.73±0.25 μM of U251 cells, 2.95±0.23 μM of U87 cells, 5.46±0.41 μM of GSCs-U251 and 5.95 μM of GSCs-U87  .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                             
                        
                            
                            - 
                                
                                    - HY-B0356S2
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Ciprofloxacin-d4 (Bay-09867-d4) is deuterium labeled Ciprofloxacin. Ciprofloxacin (Bay-09867) is a potent, orally active topoisomerase IV inhibitor. Ciprofloxacin induces mitochondrial DNA and nuclear DNA damage and lead to mitochondrial dysfunction, ROS production. Ciprofloxacin has anti-proliferative activity and induces apoptosis. Ciprofloxacin is a fluoroquinolone antibiotic, exhibiting potent antibacterial activity    .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                             
                        
                            
                            - 
                                
                                    - HY-13768S
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Topotecan-d5 is the deuterium labeled Topotecan. Topotecan (SKF 104864A; NSC 609669) is a Topoisomerase I inhibitor. The IC50 values of Topotecan at 24 h are 2.73±0.25 μM of U251 cells, 2.95±0.23 μM of U87 cells, 5.46±0.41 μM of GSCs-U251 and 5.95±0.24 μM of GSCs-U87  .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                             
                        
                            
                            - 
                                
                                    - HY-B0330DS
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    (R)-Ofloxacin-d3 is the deuterium labeled (R)-Ofloxacin. (R)-Ofloxacin is the dextrorotatory enantiomer of Ofloxacin (HY-B0125) and is an orally effective fluoroquinolone antibiotic. (R)-Ofloxacin can inhibit the activity of bacterial DNA topoisomerase II, interfere with bacterial DNA replication and repair, and exert a bactericidal effect. (R)-Ofloxacin has a broad-spectrum antibacterial activity and has inhibitory effects on both Gram-negative and Gram-positive bacteria   .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                             
                        
                            
                            - 
                                
                                    - HY-16560S
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Camptothecin-d5 is the deuterium labeled Camptothecin. Camptothecin (CPT), a kind of alkaloid, is a DNA topoisomerase I (Topo I) inhibitor with an IC50 of 679 nM . Camptothecin (CPT) exhibits powerful antineoplastic activity against colorectal, breast, lung and ovarian cancers, modulates hypoxia-inducible factor-1α (HIF-1α) activity by changing microRNAs (miRNA) expression patterns in human cancer cells  .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                             
                        
                            
                            - 
                                
                                    - HY-B0395DS
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                 | 
                                            
                                            
                                                
                                                    (1R,2S,7R)-Sitafloxacin-d4 hydrochloride is deuterium labeled  (1R,2S,7R)-Sitafloxacin hydrochloride (HY-B0395D).  (R)-Sitafloxacin (DU-6857), a stereoisomer of Sitafloxacin (DU-6859a), is also an inhibitor of topoisomerases, with an IC50 of 0.18 μg/mL of DNA gyrase . 
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                             
                        
                            
                            - 
                                
                                    - HY-W654130
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Daunorubicin- 13C,d3 is  13C and deuterium labeled Daunorubicin. Daunorubicin (Daunomycin) is a topoisomerase II inhibitor with potent anti-tumor activity. Daunorubicin inhibits DNA and RNA synthesis. Daunorubicin is a cytotoxin that inhibits cancer cell viability and induces apoptosis and necrosis. Daunorubicin is also an anthracycline antibiotic. Daunorubicin can be used in the research of infection and variety of cancers, including leukemia, non-Hodgkin lymphomas, Ewing's sarcoma, Wilms' tumor   .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                             
                        
                            
                            - 
                                
                                    - HY-N0095S
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    (S)-10-Hydroxycamptothecin-d5 (10-HCPT-d5) is the deuterium labeled (S)-10-Hydroxycamptothecin. (S)-10-Hydroxycamptothecin (10-HCPT) is a DNA topoisomerase I inhibitor. (S)-10-Hydroxycamptothecin exhibits a remarkable apoptosis-inducing effect. (S)-10-Hydroxycamptothecin has the potential for hepatoma, gastric carcinoma, colon cancer and leukaemia research    .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                             
                        
                            
                            - 
                                
                                    - HY-13502AS
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Mitoxantrone-d8 dihydrochloride is deuterated labeled Mitoxantrone dihydrochloride (HY-13502A). Mitoxantrone dihydrochloride is a potent topoisomerase II inhibitor. Mitoxantrone dihydrochloride also inhibits protein kinase C (PKC) activity with an IC50 of 8.5 μM. Mitoxantrone dihydrochloride induces apoptosis of B-CLL (B-chronic lymphocytic leukaemia) cells. Mitoxantrone dihydrochloride shows antitumor activity    . Mitoxantrone dihydrochloride also has anti-orthopoxvirus activity with EC50s of 0.25 μM and and 0.8 μM for cowpox and monkeypox, respectively .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                             
                        
                            
                            - 
                                
                                    - HY-13502AS1
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Mitoxantrone-d8 (hydrochloride) (Mitozantrone-d8 (hydrochloride)) is deuterium labeled Mitoxantrone (dihydrochloride). Mitoxantrone dihydrochloride is a potent topoisomerase II inhibitor. Mitoxantrone dihydrochloride also inhibits protein kinase C (PKC) activity with an IC50 of 8.5 μM. Mitoxantrone dihydrochloride induces apoptosis of B-CLL (B-chronic lymphocytic leukaemia) cells. Mitoxantrone dihydrochloride shows antitumor activity    . Mitoxantrone dihydrochloride also has anti-orthopoxvirus activity with EC50s of 0.25 μM and and 0.8 μM for cowpox and monkeypox, respectively .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                             
                        
                            
                            - 
                                
                                    - HY-B0268S2
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Enoxacin-d8 (hydrate) is deuterium labeled Enoxacin. Enoxacin (AT 2266), a fluoroquinolone, interferes with DNA replication and inhibits bacterial DNA gyrase (IC50=126 μg/ml) and topoisomerase IV (IC50=26.5 μg/ml). Enoxacin is a miRNA processing activator and enhances siRNA-mediated mRNA degradation and promotes the biogenesis of endogenous miRNAs. Enoxacin has potent activities against gram-positive and -negative bacteria. Enoxacin is a cancer-specific growth inhibitor that acts by enhancing TAR RNA-binding protein 2 (TRBP)-mediated microRNA processing     .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                             
                        
                            
                            - 
                                
                                    - HY-B0268S1
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Enoxacin-d8 (hydrochloride) is deuterium labeled Enoxacin. Enoxacin (AT 2266), a fluoroquinolone, interferes with DNA replication and inhibits bacterial DNA gyrase (IC50=126 μg/ml) and topoisomerase IV (IC50=26.5 μg/ml). Enoxacin is a miRNA processing activator and enhances siRNA-mediated mRNA degradation and promotes the biogenesis of endogenous miRNAs. Enoxacin has potent activities against gram-positive and -negative bacteria. Enoxacin is a cancer-specific growth inhibitor that acts by enhancing TAR RNA-binding protein 2 (TRBP)-mediated microRNA processing    .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                             
                        
                            
                            - 
                                
                                    - HY-B0506S1
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Nadifloxacin-d5 (OPC7251-d5) is deuterium labeled Nadifloxacin (HY-B0506). Nadifloxacin (OPC7251) is a broad-spectrum quinolone antibiotic. Nadifloxacin inhibits bacterial DNA gyrase and topoisomerase IV, interfering with DNA replication. It also suppresses the production of proinflammatory cytokines (such as IL-1α, IL-6, and IL-8). Nadifloxacin exhibits antibacterial activity against various pathogens, including Propionibacterium acnes and Staphylococcus aureus. Nadifloxacin also exhibits anti-inflammatory activity. Nadifloxacin can be used in the research of skin infections such as acne vulgaris, folliculitis, and impetigo     .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                             
                        
                            
                            - 
                                
                                    - HY-B0147S1
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Pefloxacin-d3 (Pefloxacinium-d3) is the deuterium labeled Pefloxacin (HY-B0147). Pefloxacin (Pefloxacinium) is a broad spectrum antibiotic. Pefloxacin blocks DNA replication by inhibiting DNA gyrase. Pefloxacin inhibits DNA relaxation catalyzed by topoisomerase I with an IC50 of 45 μg/mL. Pefloxacin exhibits antibacterial activity against Escherichia coli, Pseudomonas aeruginosa, and Bacteroides fragilis with MIC90s of 0.12, 4, and 16 mg/L, respectively. Pefloxacin has anti-Plasmodium yoelii infection activity. Pefloxacin increase UVA-induced edema and immunesuppression. Pefloxacin can be used for infection studies         .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                             
                        
                            
                            - 
                                
                                    - HY-B0147S
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    Pefloxacin-d5 (Pefloxacinium-d5) is the deuterium labeled Pefloxacin (HY-B0147). Pefloxacin (Pefloxacinium) is a broad spectrum antibiotic. Pefloxacin blocks DNA replication by inhibiting DNA gyrase. Pefloxacin inhibits DNA relaxation catalyzed by topoisomerase I with an IC50 of 45 μg/mL. Pefloxacin exhibits antibacterial activity against Escherichia coli, Pseudomonas aeruginosa, and Bacteroides fragilis with MIC90s of 0.12, 4, and 16 mg/L, respectively. Pefloxacin has anti-Plasmodium yoelii infection activity. Pefloxacin increase UVA-induced edema and immunesuppression. Pefloxacin can be used for infection studies         .
                                                 | 
                                            
                                        
                                     
                                    - 
                                        
                                        
                                            
                                        
                                     
                                
                             
                        
                        
                    
                 
            
            
            
            
            
                
                    
                        
                            | Cat. No. | 
                            Product Name | 
                             | 
                            Classification | 
                        
                    
                    
                        
                            
                            - 
                                
                                    - HY-164792
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                 | 
                                                
                                                    
                                                        
                                                        
                                                            DBCO
                                                        
                                                        
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    DBCO-PEG3-VC-Exatecan (compound 25) is a Drug-Linker Conjugate for ADC. DBCO-PEG3-VC-Exatecan contains the ADC linker (DBCO-PEG3-VC) and a DNA topoisomerase I inhibitor Exatecan (HY-13631) .
                                                 | 
                                            
                                        
                                     
                                
                             
                        
                            
                            - 
                                
                                    - HY-160788
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                 | 
                                                
                                                    
                                                        
                                                        
                                                            DBCO
                                                        
                                                        
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    DBCO-β-Glu-PEG12-Exatecan (Compound 107) is an inhibitor for topoisomerase I. DBCO-β-Glu-PEG12-Exatecan can be used as a Drug-Linker Conjugate for ADC molecule .
                                                 | 
                                            
                                        
                                     
                                
                             
                        
                            
                            - 
                                
                                    - HY-134723
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                 | 
                                                
                                                    
                                                        
                                                        
                                                            DBCO
                                                        
                                                        
                                                    
                                                        
                                                        
                                                            ADC Synthesis
                                                        
                                                        
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    DBCO-PEG4-GGFG-Dxd is a agent-linker conjugate for ADC with potent antitumor activity by using Dxd (a DNA topoisomerase I inhibitor), linked via the cleavable ADC linker DBCO-PEG4-GGFG . DBCO-PEG4-GGFG-Dxd is a click chemistry reagent, it contains a DBCO group that can undergo strain-promoted alkyne-azide cycloaddition (SPAAC) with molecules containing Azide groups.
                                                 | 
                                            
                                        
                                     
                                
                             
                        
                            
                            - 
                                
                                    - HY-163099
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                 | 
                                                
                                                    
                                                        
                                                        
                                                            Alkynes
                                                        
                                                        
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    P5(PEG24)-VC-PAB-Exatecan (LP5) is a drug-linker conjugate composed of a potent a DNA Topoisomerase I inhibitor Exatecan (HY-13631) and a linker P5(PEG24)-VC-PAB to make antibody agent conjugate (ADC). P5(PEG24)-VC-PAB-Exatecan can be used for the research of tumor .
                                                 | 
                                            
                                        
                                     
                                
                             
                        
                            
                            - 
                                
                                    - HY-173625
 
                                    - 
                                        
                                            
                                                | 
                                                    
                                                    
                                                 | 
                                                 | 
                                                
                                                    
                                                        
                                                        
                                                            Alkynes
                                                        
                                                        
                                                    
                                                 | 
                                            
                                            
                                                | 
                                                    P5(PEG12)-VC-PAB-Exatecan (LP3) is a drug-linker conjugate composed of a potent a DNA Topoisomerase I inhibitor Exatecan (HY-13631) and a linker P5(PEG24)-VC-PAB to make antibody agent conjugate (ADC). P5(PEG12)-VC-PAB-Exatecan can be used for the research of tumor .
                                                 | 
                                            
                                        
                                     
                                
                             
                        
                        
                    
                 
            
                
                
                    
                        
                            
                                | Cat. No. | 
                                Product Name | 
                                 | 
                                Classification | 
                            
                        
                        
                            
                            
                        - 
                            
                                - HY-W010800
 
                                - 
                                    
                                        
                                            | 
                                                
                                                
                                             | 
                                             | 
                                            
                                                
                                                    
                                                    
                                                        Cholesterol
                                                    
                                                    
                                                
                                             | 
                                        
                                        
                                            | 
                                                
                                                    Cholesteryl hemisuccinate is a with hepatoprotective an anticancer activity. Cholesteryl hemisuccinate inhibits Acetaminophen (AAP, HY-66005) hepatotoxicity, and prevents AAP-induced hepatic apoptosis and necrosis. Cholesteryl hemisuccinate inhibits DNA polymerase and DNA topoisomerase to inhibit DNA replication and repair and cell division. Thus, Cholesteryl hemisuccinate inhibits tumor growth  .
                                                
                                                
                                             | 
                                        
                                    
                                 
                            
                         
                        
                        
                    
                     
                
         
        
        
        
        
        
        
            
            Your information is safe with us.  * Required Fields. 
             
            
         
        
        
            
            
                
                
                Inquiry Information
                
                    - Product Name:
 
                    
                    - Cat. No.:
 
                    
                    - Quantity:
 
                    
                    
                    - MCE Japan Authorized Agent: